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ABSTRACT 
Biological enzymes, referred in this dissertation as biocatalysts, offer targeted and rapid 
destruction of micropollutants such as perchlorate. This targeted destruction of perchlorate even 
in the presence of orders of magnitude higher concentrations of co-competing compounds offers 
a distinct advantage over traditional and emerging perchlorate treatment technologies.  
In this work, the bacterial biocatalysts perchlorate reductase and chlorite dismutase from 
Azospira oryzae had 3 to 4 orders of magnitude faster activity than catalytic technologies while 
maintaining activity in the presence of oxygen and nitrate. Activity was retained even when 
molar concentrations of nitrate were 500 times greater than perchlorate. The biocatalysts are 
active in a range of water quality conditions relevant to groundwater, including operation in hard 
water conditions, temperatures from 5ºC to 30ºC, and pH from 6.0 to 9.0. The robustness of this 
activity was further confirmed using two real-world groundwaters where the biocatalysts had no 
statistically significant difference in activity compared to laboratory-buffered conditions. 
However, perceptions of the costs and environmental impacts of biocatalytic drinking 
water treatment have hindered implementation. To overcome these perceptions, a detailed 
economic and environmental assessment was performed. In the analysis, the conservative, 
baseline biocatalytic scenario (single-use in batch reactors) was found to have median costs of 
$1.92 and global warming potential of 3.72 kg CO2 eq per m
3 of drinking water treated. These 
values are more than current drinking water treatment price and emissions. To accelerate the 
advancement and bring down costs and environmental impacts of biocatalytic technologies, 
several critical improvements were evaluated. These improvements include achieving 
biocatalytic reuse and implementing alternative electron donors. Upon realization of these goals, 
biocatalytic technologies are projected to have comparable costs and emissions to an idealized, 
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highly selective ion-exchange technology.   
Realizing these improvements requires development of the biocatalysts. To achieve reuse, 
two methods were tested. The biocatalysts were encapsulated in nanoreactors and modified to 
include a tag that allows for attachment to larger resin beads. The nanoreactors demonstrated full 
perchlorate reduction; however, the reactors are still relatively small, approximately 100nm, and 
were activity limited. Tagged forms of chlorite dismutase showed activity in free, attached, and 
column-packed formats. Attached and column-packed biocatalysts were mass transfer limited 
over a range of environmental chlorite concentrations. To understand the limitations of mass 
transfer, a model including kinetic and mass transfer parameters was developed. This model 
better fit the activity data of the attached biocatalysts.  
To gain acceptance for biocatalytic drinking water treatment, the biocatalysts were tested 
for potential use in a hybrid system, one step removed from direct drinking water treatment. 
Using an ion-exchange waste brine, the biocatalytic treatment system treated the contaminants, 
nitrate and perchlorate. The perchlorate biocatalytic system, as well as a novel nitrate biocatalytic 
system, were employed to treat the waste brine. The treatment would prevent the reintroduction 
of the contaminants into the environment. Biocatalysts reduced perchlorate into chloride and 
oxygen in synthetic, 12% sodium chloride and real-world waste brine. Nitrate biocatalysts from 
Paracoccus denitrificans and Haloferax denitrificans reduced nitrate. Tracking dinitrogen 
formation using stable isotopes in the 12% sodium chloride solution, the combined P. 
denitrificans and H. denitrificans biocatalysts reduced nitrate into a mixture of nitrous oxide and 
dinitrogen.  
Overall, this work demonstrates the potential application of biocatalysts to treat both 
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micropollutants and traditional contaminants in drinking water as well as the integration of 
biocatalysts in hybrid treatment systems. Using sustainability analysis, critical technology 
advancements were identified and explored experimentally. Biocatalytic technologies represent 
the next generation of treatment, breaking the current cycle of moving contaminants between 
environmental matrixes and assuring access to safe drinking water treatment for all. 
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CHAPTER 1: INTRODUCTION AND OBJECTIVES 
Micropollutants have toxic effects at micromolar concentrations.1 Endocrine disrupting 
compounds (EDCs), a subclass of micropollutants, disrupt hormone homeostasis and can have 
toxic effects. The presence of these EDCs in our drinking water poses a growing threat to human 
health and safety, and their toxicity is not limited to a particular gender or age.2 EDCs have been 
connected with low male birth rates; low semen counts; and an increase in hormone-related 
cancers, immune disorders, and neurological disorders in children. The occurrences of these 
disorders are increasing.2  
The presence of EDCs in drinking water is a problem that will likely be exacerbated by a 
dwindling supply of pristine freshwater, fluctuations in water availability due to climate change, 
and increasing human population. Our awareness of this problem grows with the improvement in 
our analytical techniques which can detect a greater variety of contaminants and achieve a lower 
detection threshold. However, traditional drinking water treatment technologies are unable to 
target these EDCs at low concentrations.1 To address the challenge of EDCs in drinking water, 
we must develop advanced water treatment technologies that target micropollutant contamination 
while minimizing cost and environmental impacts.  
1.1. Perchlorate: A Model Micropollutant 
Perchlorate is a negatively charged anion comprised of a central chloride atom 
surrounded by four oxygen atoms (Figure 1.1). These atoms make a tetrahedral structure with an 
approximate diameter of 3.5 Å. In the solid form, perchlorate is associated with a hydrogen or a 
monovalent cation such as ammonium, potassium, or sodium. Perchlorate is an endocrine 
disrupting compound and, as detailed below, is a model micropollutant due to its persistence in 
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the environment;3 toxicity at very low concentrations for sensitive subpopulations, including 
fetuses, infants, and young children;4 and resistance to treatment by traditional drinking water 
treatment technologies.5 For these reasons, perchlorate was used to assess a new drinking water 
treatment technology, biocatalysis.  
 
Figure 1.1: Perchlorate anion with Cl-O bond length and angle degree between oxygen atoms. 
Perchlorate’s persistence in the environment is not due to its thermodynamic stability. 
Perchlorate has a reduction potential at 1.388 V 6 placing it as a strong enough oxidizing agent to 
oxidize water. However, perchlorate has a large activation energy required to initiate reduction to 
chloride. This activation energy is estimated at 123.8 kJ mole-1 for temperatures below 240ºC.7  
This kinetic barrier is likely responsible for its stability in the environment.  
Perchlorate contamination of our drinking water poses a threat to sensitive 
subpopulations. These populations include fetuses, infants, and young children. One primary 
mechanism for this toxicity is well established. Perchlorate inhibits the proper uptake of iodide in 
the thyroid by competitively transporting through the sodium-iodide symporter. This symporter 
is also located in other major areas of the human body, including the gut, lactating breasts, 
placenta and chloroid plexus.2 This competition results in decreased production of essential 
hormones, predominantly triiodothyronine (T3) and thyroxine (T4), required for the maturation 
of the nervous system and lungs in fetuses and newborns.8, 9 Perchlorate is also thought to affect 
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another iodide transporter known as Pendrin.10  
While the primary mechanism of perchlorate toxicity is well understood, the literature 
initially included mixed reports on the exposure required for toxic effects. Literature comparing 
populations with and without perchlorate impacted drinking water in both the United States11 and 
Chile12 found no differences in blood-serum iodine-containing hormones. However, later work 
on the subjects from the United States showed that adults were also exposed to perchlorate by 
other sources, likely through contaminated food. Controlling for these conditions, perchlorate 
was a negative predictor of iodine-containing hormones for women.13 A human clinical trial by 
Greer, et al.4 demonstrated inhibitory effects in iodide uptake for adults at 200 µg L-1. As a result 
of the human clinical trial, the U.S. National Academy of Science established a reference dose of 
0.7 µg kg-1 day-1,14 and the U.S. Environmental Protection Agency (EPA) proposed a drinking 
water standard of 15 µg L-1.15 Perchlorate is already regulated in California16 at 6 µg L-1 and 
Massachusetts17 at 2 µg L-1.  
However, perchlorate is difficult to treat using conventional technologies.5 Perchlorate 
treatment technologies are broadly divided into two different types: sequestering and degradative 
technologies. Sequestering technologies are defined as technologies that transfer perchlorate 
between environmental matrices. These technologies include granular activated carbon, 
membranes, and ion exchange. Degradative technologies are capable of reducing perchlorate into 
innocuous end products: oxygen or water and chloride. These consist of chemical reduction, 
chemical catalytic reduction, and whole-cell biological reduction (Table 1.1). The following two 
sections are dedicated to discussing the basis of each technology type, their advantages and 
disadvantages, and their current state of implementation in drinking water treatment. 
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Table 1.1: A summary of perchlorate-specific drinking water treatment technologies5 
Type of 
Technology 
Technology State of Development Comments 










   
Membranes 
 
Established (but generally 







Established Produces concentrated 
brine waste  
Selective Ion Exchange Established Unable to regenerate 
Degradative 
Chemical Reduction Emerging Requires acidic or 
elevated temperatures 
 
Catalytic Reduction Emerging Requires acidic or 
elevated temperatures 
Requires removals of 




Implementing Requires removals of 
oxygen and nitrate 
 
1.2. Sequestering Treatment Technologies 
Sequestering technologies, including activated carbon, membranes, and ion exchange, 
transfer the contaminant between environmental matrices. This transfer results in the 
reintroduction of the contaminant into the environment and possible cycling through municipal 
wastewater and drinking water treatment facilities.18  
Activated carbon is generally unsuitable for sorption of charged ions.5 However, 
enriching the activated carbon with nitrogen results in enhanced perchlorate sorption capacity.5 
Membrane technologies are a powerful tool to remove a wide variety of contaminants, including 
perchlorate; however, membranes have high operating costs.19 To the best of my knowledge, no 
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known examples of granular activated carbon or membrane systems designed specifically for 
perchlorate exist at full scale. 
In contrast, ion exchange is considered the best available technology for perchlorate 
treatment16 and has been implemented in drinking water.5 Several companies offer resins (e.g., 
ResinTech, Purolite, and Dow Dowex) with the resin backbone constructed using cross-linked 
styrenic, vinylstyrenic, acrylic or methacrylic repeating subunits.5, 20 Further classification of the 
ion-exchange resins is based on the surface chemistry and characteristics of the resin and 
includes three categories: cationic or anionic selectivity, strong acid/base or weak acid/base 
chemistry, and porous or gel matrices. In general, municipalities use strong-base anionic resins 
with either porous and gel matrices.21 Perchlorate resins have an additional classification: non-
selective and selective. The classification is based on two criteria: surface chemistry enhancing 
perchlorate sorption and the ability to regenerate the resins using concentrated sodium chloride 
solutions. 
Non-selective perchlorate resins are strong-base resins using quaternary ammonium to 
facilitate sorption of anions. Type 1 resins, using trimethyl ammonium groups, are more stable 
but can be difficult to regenerate. Type 2 resins, having dimethylethanolamine groups, are easier 
to regenerate. These resins have broad specificity for anions and generally can not target specific 
anions. However, these resins can be regenerated to extend their operation life using 
concentrated sodium hydroxide or sodium chloride solutions.20  
Alternatively, resins can have enhanced selectivity for perchlorate by incorporating new 
types of surface chemistry. This selectivity is based on alternating the functional groups of the 
resins, referred to as bifunctional resins.22 These resins contain quaternary ammonium groups 
6 
 
with alternating long and short alkyl chains.22 However, this enhanced selectivity limits the 
ability to regenerate the resins using traditional brines. Specialized regeneration solutions are 
required. These solutions consist of tetrachloroferrate23 or iron trichloride-hydrochloric acid24 
and have been shown to effectively displace perchlorate on the resin. Once perchlorate is eluted, 
the resin is washed to bring the pH back to a normal operating range. With the change in pH, the 
tetrachloroferrate anion will release chloride and become a neutral or positively charged 
molecule. The ferrate will desorb from the resin due to the positive-positive charge interaction. A 
chloride anion will occupy the site. While promising, these solutions have not been demonstrated 
for full-scale treatment. Despite the absence of a viable, full-scale regeneration solution, studies 
have shown an economic and environmental advantage when using the selective resin (e.g.25). 
1.3. Degradative Treatment Technologies 
In contrast to sequestering technologies, degradative technologies, including chemical 
reduction, catalytic reduction, and biological reduction, break down the contaminant with the 
goal of producing non-toxic end products. However, as these processes are reductive in nature, 
they require the addition of electron donors as well as the removal of competing electron 
acceptors such as oxygen and nitrate. 
Chemical reduction of perchlorate supplies electrons using reduced metals such as 
elemental iron26, 27 and ferrous iron.28 These systems are advantageous for their simplicity. 
However, the systems require elevated temperatures and acidic pH.27-29 Catalytic reduction relies 
on a metal catalyst such as titanium, iron, and copper and an electron donor such as hydrogen. 
An advantage of using inorganic electron donors is that their use can minimize the formation of 
unwanted biomass in the drinking water treatment system. Recent work with heterogeneous 
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catalytic reduction relies on rhenium and palladium.29 One study identified that rhenium is an 
essential component of perchlorate reduction,30 but the activity could be enhanced by including 
ligands on the rhenium catalyst.31 The palladium, used in the oxidation of hydrogen for 
perchlorate reduction, could be replaced with alternatives such as platinum, iridium, rhodium, 
and ruthenium.30 However, to achieve measurable perchlorate-reducing rates, the process still 
requires acidic pH.29, 32 In addition, oxygen and nitrate irreversibly inactivate the chemical 
catalysts’ perchlorate activity.33 Alternatively, in an electrocatalytic system, rhodium electrodes 
were shown to effectively reduce perchlorate.34 For chemical catalytic and chemical reduction, 
technologies have been demonstrated at the bench scale for perchlorate treatment. However, no 
known examples of full-scale treatment exist. 
Biological perchlorate reduction is further along in implementation in drinking water 
treatment and has been demonstrated at the pilot and full-scale levels.35 In these systems, whole-
cell biological reduction of perchlorate has been demonstrated with support media, including 
sand-packed columns,36, 37 diatomaceous earth pellets,38 and activated carbon in fixed beds.5, 39, 40 
Several alternative configurations have been explored, including membrane-biofilm reactors,41 
ion-exchange membrane biofilm reactors,42 and hollow fiber membrane biofilm reactors.43 These 
systems have used a variety of electron donors,44 including hydrogen43, elemental sulfur, or 
elemental iron. However, these processes use more electron donor than required for perchlorate 
reduction as the cells must grow and maintain homeostasis. Also, the bacteria involved in the 
reduction of perchlorate are sensitive to the presence of oxygen and nitrate, as these compounds 
are preferred electron acceptors. 5, 45-47  
While several perchlorate-treatment technologies are available, these are unable to target 
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perchlorate directly. Also, chemical and catalytic reduction require extreme environments 
atypical of drinking water treatment.  
1.4. Biocatalytic Technologies 
To address these undesirable technology characteristics, we propose biocatalytic 
reduction of perchlorate. Biocatalysts, defined here as cell-free enzymes, have specificity for 
their targets and could be a promising technology for water treatment. To date, biocatalytic 
technologies have been utilized in a wide range of applications in the pharmaceutical industry 
such as the production of 6-aminopenicillanic acid and cephalexin.48, 49 This is likely due to the 
high-cost value offsetting the perceived costs of biocatalytic technologies. In low-cost, high-flow 
products such as wastewater and drinking water, no known examples of biocatalytic technologies 
have been implemented in full-scale treatment. As detailed below, several examples of the 
application of biocatalytic technologies have been demonstrated in the laboratory, including 
organophosphorus acid anhydrolase and organophosphorus hydrolase, biocatalytic mixtures, and 
laccase.  
Organophosphorus acid anhydrolase and organophosphorus hydrolase have been shown 
to degrade a variety of compounds, including pesticides and nerve agents50 (Russian-VX51 and 
G-type agents such as soman, sarin, and tabun52). In mixtures, biocatalysts can target the 
components of biofilms, including polysaccharides, proteins, and DNA. 53 These mixtures can 
have a variety of biocatalysts, including proteolytic enzymes such as subtilisin and lysostaphin; 
polysaccharide-degrading enzymes such as amylase and lyase; oxidative enzymes, including 
lysozyme,54, 55 hydrogen-producing enzymes, and haloperoxidase; and anti-quorum proteins.53 
The most commonly studied biocatalyst for water treatment application is laccase. 
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Laccase oxidizes a wide spectrum of phenol-containing compounds in wastewater. The oxidation 
of the compounds increases their bioavailability in downstream whole-cell biological processes. 
Examples of laccase treatment include wastewater from olive mill production,56 dye production 
and use,57 human waste.58 Compounds that are targeted by laccase in wastewater treatment 
include natural and synthetic estrogens,59, 60 bisphenol A,61 chlorpyrifos,62 and tetracycline.63 
However, the activity of laccase at environmentally relevant concentrations of micropollutants is 
a limiting factor for water treatment.61 Even using activity-enhancing electron shuttles (such as 
2,2-azinobis-3-ethylbenzothiazoline-6-sulfonate (ABTS)), the activity was low, achieving only 
50% degradation in a 30 hour period.61  
1.5. Biocatalytic Treatment of Perchlorate 
Two biocatalysts are involved in microbial perchlorate reduction: perchlorate reductase 
(PR or Pcr) and chlorite dismutase (Cld) (Figure 1.2). The application of these biocatalysts for 
drinking water treatment is novel. While the system mimics whole-cell biological reduction of 
perchlorate, the drawbacks of biological treatment are minimized. This includes less interference 
from co-competing nitrate and lower electron donor requirements.  
  
Figure 1.2: Biological reduction of perchlorate. PR: perchlorate reductase (Pcr); Cld: chlorite 
dismutase.64 
1.5.1. Perchlorate Reductase 
Perchlorate reductase is responsible for the two-step reduction of perchlorate to chlorite 
through the transfer of four external electrons.65 It is located in the periplasmic space and belongs 
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to the type II dimethyl sulfoxide (DMSO) reductase family.66 Perchlorate reductase is 
structurally similar to nitrate reductase. Both biocatalysts have activity for perchlorate; however, 
they have vastly different kinetic parameters.67 Perchlorate reductase has a lower Vmax but a 
much lower Km, resulting in effective perchlorate reduction at very low substrate concentrations. 
Conversely, nitrate reductase is not as efficient at reducing perchlorate at low concentrations. The 
enhanced selectivity of perchlorate reductase is hypothesized to come from a tunneling 
mechanisms that promotes entry of the perchlorate anion, while effectively acting as a gate 
preventing the entrance of nitrate.67 
Active microbial perchlorate reductase is composed of three subunits: α, β, and γ. These 
subunits come as heterotrimers.66 The α subunit is thought to be the site of perchlorate 
reduction67 and contains a molybdenum cofactor known as bis(molybdopterin guanine 
dinucleotide)- molybdenum.68 The β subunit contains iron-sulfur clusters thought to aid in the 
internal shuttling of electrons. Selenium has also been detected during the purification of the α 
and β subunits; however, the exact location and function of the selenium has not been clarified.69 
The γ subunit is a cytochrome b moiety. In studies purifying the perchlorate reductase, the γ 
subunit is lost and thought to be strongly associated with the inner membrane.70 Despite the loss 
of the γ subunit, perchlorate reductase still reduces perchlorate in biochemical assays. 
Perchlorate reductase subunit δ is thought to function as a chaperone protein in the formation of 
the α β heterodimer.66 The genes for the perchlorate reductase subunits α, β, γ, and δ were 
historically referred to as the perchlorate reductase operon.69 
The understanding of the genes responsible for perchlorate reduction has expanded in two 
phases. The first was a metagenomic study that examined four perchlorate-reducing organisms.71 
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This study identified several conserved genes colocated to the perchlorate reductase operon. This 
set of genes including the original operon as well as chlorite dismutase was referred to as the 
perchlorate reduction genomic island. The second phase included a knockout analysis of the 
genes in the perchlorate-reducing organism, Azospira oryzae PS. This study further expanded the 
perchlorate reduction genomic island. As expected, the four original units of the operon were 
identified.72 The role of the additional genes is indirect. For example, chlorite dismutase is 
required for cellular growth to detoxify chlorite.73 However, the protein is unlikely to play a 
direct role in the correct formation of perchlorate reductase. Two of the required genes had no 
known function. Three genes are hypothesized to be part of a signaling system for perchlorate in 
bacteria. Several other genes were also critical for both growth on perchlorate and nitrate, 
including those responsible for the formation of the molybdenum metal cofactor.  
1.5.2. Chlorite Dismutase 
Chlorite dismutase is the biocatalyst responsible for the last step of perchlorate 
degradation. Chlorite dismutase is a highly-conserved biocatalyst in perchlorate-reducing 
bacteria. The biocatalyst is located in the periplasm74 and contains heme. The biocatalyst, part of 
clade 1, comes as a homotetramer, homopentamer or homohexamer,75 and has been purified from 
Azospira oryzae PS76 and Ideonella dechloratans.77 In perchlorate and chlorate reducing 
organisms, the accumulation of chlorite is toxic.73 Chlorite dismutase decomposes chlorite by an 
intramolecular transfer of four electrons from the oxygen atoms to the chloride. The biocatalyst 
forms diatomic oxygen66 with both oxygen atoms coming directly from chlorite.78 Two 
mechanisms have been proposed for chlorite decomposition with both involving the formation of 
a radical. The first proposed mechanism involves an iron radical,79 and the second mechanism 
includes a hypochlorite radical.80, 81 Experiments that utilized hypochlorite radical quenching 
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agents provide stronger evidence for the mechanism involving the hypochlorite radical.80  
Important factors in utilizing biocatalysts for drinking water treatment are specificity, 
stability, and longevity. The biocatalyst is very specific to chlorite, showing no activity with 
hydrogen peroxide, perchlorate, chlorate, or nitrite 82. We demonstrated that the chlorite 
dismutase is very stable, as measured by the shelf life.83 Shelf life is defined as activity 
remaining after storage periods at specific temperatures. The chlorite dismutase maintained 
activity at 90 days in the purified form when stored at 4ºC.83 At 22ºC, the purified biocatalyst 
quickly lost activity. In the non-purified form, the biocatalyst when stored at 4ºC and 22ºC had 
similar activity profiles. This suggests the SPF had an unidentified stabilizing effect on the 
activity when stored at room temperature. 
To determine the length of operation in drinking water treatment, consideration of 
longevity is required. The longevity of chlorite dismutase is impacted by catalytic inactivation. 
Chlorite dismutase undergoes catalytic inactivation after performing a number of chlorite 
decomposition reactions. Catalytic inactivation has been quantified for two isozymes: 
recombinant Cld from Klebsiella pneumoniae MGH 7857884 and recombinant Cld from 
Dechloromonas aromatic RCB.85 These isozymes have different catalytic inactivation numbers 
of 6,000 and 17,000, respectively, indicating that differences in the amino acid sequences of Cld 
could confer greater biocatalytic longevity. To test this hypothesis, we collected a library of 
seven chlorite dismutase isozymes and tested for differences in catalytic inactivation.83 Results 
showed that natural isozymatic diversity provided a chlorite dismutase with six-times greater 
resistance to catalytic inactivation than in previous studies. Also, no significant tradeoffs 
concerning catalytic efficiency were observed with the enhanced longevity. With a general 
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knowledge of the two biocatalysts involved in perchlorate-reduction established, the factors 
important for the biocatalysts’ application in drinking water treatment were explored further.  
1.6. Objectives of This Dissertation 
The objectives were to 1) quantify the activity of biocatalysts in laboratory and real-
world groundwaters, 2) determine the economic and environmental impacts of biocatalytic 
technologies, 3) identify advancements required to make biocatalytic technologies competitive 
with current treatment technologies, 4) explore methods to achieve these advancements, and 5) 
combine the biocatalysts with current technologies to form hybrid technologies. These objectives 
were accomplished in an iterative methodology that included experimentation, performance 
modeling, sustainability analysis, and comparison to current treatment technologies.  
The chapters of this dissertation are organized based on these objectives. Chapter 2 and 3 
focus on demonstrating biocatalytic reduction of perchlorate in buffered laboratory and real-
world waters. Chapter 4 assesses the economic and environmental impacts of biocatalysis and 
identifies advancements for the technology to be a competitive treatment technology. These 
advancements include immobilizing the biocatalysts for reuse (Chapter 5) and identifying 
alternative electron donors for redox processes (Appendix E). Finally, Chapter 6 provides proof-
of-concept of the ability of the biocatalysts to integrate with ion exchange technologies. Below 
are the questions each chapter sought to answer and a summary of the outcomes. 
The overarching questions for Chapter 2 are: 1) Can biocatalysts target perchlorate in the 
presence of co-competing compounds such as nitrate? and 2) How long do the biocatalysts retain 
activity? This chapter utilized various ratios of perchlorate, nitrate, and sulfate to determine the 
impact on perchlorate reduction. The biocatalysts reduced perchlorate even in the presence of 
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500 molar excess nitrate. The biocatalysts demonstrated robust shelf life, maintaining 
perchlorate-reducing activity longer than 23 days.  
Having demonstrated the activity of the biocatalysts in laboratory buffers, Chapter 3 
examines the questions: 1) Do the biocatalysts maintain activity in synthetic and real-world 
groundwaters? and 2) If differences in activity are observed, what are the causes of the activity 
difference? Results indicated no statistical difference in the kinetic parameters was observed for 
groundwater matrices. Two major components not unique to groundwater were found to 
influence the activity of the biocatalysts: perchlorate concentration and temperature. The activity 
with respect to perchlorate concentration was well characterized by single-substrate Michaelis-
Menten kinetics and temperature was well characterized by the Arrhenius equation.  
With the biocatalysts maintaining robust activity in real-world groundwaters and 
information available to develop a performance model, Chapter 4 looks at questions: 1) Is 
biocatalytic reduction economically and environmentally sustainable compared to current 
technologies? and 2) If biocatalytic technologies were found not to be competitive, what 
advancements are required to bring the costs and environmental impacts down to a comparable 
levels? The results indicated that biocatalytic treatment in its current form, batch treatment with 
no mechanism of biocatalytic reuse, was not sustainable economically or environmentally. This 
was determined by comparing to two implemented technologies (non-selective and selective ion 
exchange), one technology undergoing implementation (whole-cell biological reduction), and 
one emerging technology (chemical catalytic reduction) for drinking water treatment. Using 
correlation analysis, three technology developmental goals (improving biocatalysts yield, 
retaining biocatalysts, and eliminating the electron shuttle) were identified. These improvements 
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were evaluated for their potential to bring cost and environmental impacts down relative to 
implemented drinking water treatment technologies.  
In Chapter 5, the question is: 1) Can the biocatalysts be immobilized?, 2) Can the first 
principles be used to model the attached biocatalysts?, and 3) Are the values for the model 
parameters acceptable? Using an affinity-attached chlorite dismutase, the decomposition activity 
was lower in batch and column studies compared to the free biocatalysts in batch studies. 
Activity models were developed using Michaelis-Menten and mass transfer equations. The 
models indicated that the diffusion layer surrounding the particle was approximated by the 
diameter of the particle. Based on the model, the attached biocatalytic activity at environmentally 
relevant substrate concentrations was limited by mass transfer. Work for attachment systems 
using spore-displayed chlorite dismutase and affinity-attached perchlorate reductase are 
preliminary (Appendix D). Initial analysis using electrochemistry as a source of electrons for 
perchlorate reductase was performed (Appendix E).  
The final data chapter focuses on the questions: Can biocatalysts integrate with ion 
exchange technologies by treating waste brine? The biocatalysts were able to reduce perchlorate 
and nitrate in a real-world ion-exchange waste brine. For perchlorate, the biocatalysts achieved 
complete reduction into chloride and oxygen. For nitrate in 12% sodium chloride solutions, the 
biocatalysts could reduce nitrate to dinitrogen; however, this reaction was incomplete with a 
majority of the nitrate ending as nitrous oxide. Optimization of this process could minimize the 
formation of nitrous oxide. By implementing treatment of ion exchange waste brine, risks 





This dissertation explores biocatalytic reduction of perchlorate, highlighting the ability of 
the biocatalysts to perform in real-world scenarios. Biocatalytic technologies show promise for 
water treatment applications; however, they have not been implemented in full-scale treatment. 
Typical of the development of drinking water treatment technologies, the maturation process is 
extended (e.g., reverse osmosis with forty-plus years86). This work demonstrates that biocatalysts 
can be competitive with current drinking water treatment technologies with strategic 
advancements. To accelerate the adoption of biocatalytic technologies, they can be integrated 
with existing technologies such as ion exchange. This provides technology exposure to treatment 




CHAPTER 2: PERCHLORATE REDUCTION USING FREE AND ENCAPSULATED 
AZOSPIRA ORYZAE ENZYMES 
This chapter has been published. The citation is Hutchison, J. M.; Poust, S.K.; Kumar, 
M.; Cropek, D.M.; MacAllister, I.E.; Arnett, C.M.; Zilles, J. L., Perchlorate reduction using free 
and encapsulated Azospira oryzae enzymes. Environmental Science and Technology 2013, 47, 
(17), 9934-9941. Explicit copyright permission is not required as I am the author of this work. 
Preliminary data on the nitrate and perchlorate competition and lipid vesicles was presented in 
my Master’s Thesis found at http://hdl.handle.net/2142/34559. I performed all experimental 
work in this chapter. 
2.1. Abstract  
Existing methods for perchlorate remediation are hampered by the common co-
occurrence of nitrate, which is structurally similar and a preferred electron acceptor. In this work, 
the potential for perchlorate removal using cell-free bacterial enzymes as biocatalysts was 
investigated using crude cell lysates and soluble protein fractions of Azospira oryzae PS, as well 
as soluble protein fractions encapsulated in lipid and polymer vesicles. The crude lysates showed 
activities between 41,700 to 54,400 U L-1 (2.49 to 3.06 U mg-1 total protein). Soluble protein 
fractions had activities of 15,400 to 29,900 U L-1 (1.70 to 1.97 U mg-1) and still retained an 
average of 58.2% of their original activity after 23 days of storage at 4°C under aerobic 
conditions. Perchlorate was removed by the soluble protein fraction at higher rates than nitrate. 
Importantly, perchlorate reduction occurred even in the presence of 500-fold excess nitrate. The 
soluble protein fraction retained its function after encapsulation in lipid or polymer vesicles, with 
activities of 13.8 to 70.7 U L-1, in agreement with theoretical calculations accounting for the 
volume limitation of the vesicles. Further, encapsulation mitigated enzyme inactivation by 
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proteinase K. Enzyme-based technologies could prove effective at perchlorate removal from 
water co-contaminated with nitrate or sulfate. 
2.2. Introduction 
Regulations for perchlorate in drinking water are under development by the United States 
Environmental Protection Agency (EPA), with initial assessments recommending a limit of 15 μg 
L-1,15, 87, 88 and states such as California (6 µg L-1)89 and Massachusetts (2 µg L-1)17 have already 
instituted even stricter regulatory standards. Perchlorate affects human health through 
competitive transport into the thyroid, causing an iodide deficiency that results in stunted growth 
and mental retardation in fetuses and young children.15 In adults, iodide deficiency has been 
linked to hypothyroidism, with common symptoms of fatigue, weight gain or difficulty losing 
weight, and muscle cramps.90 Chlorate and chlorite can be produced during disinfection with 
chlorine dioxide and also have toxic effects.91 Perchlorate has been detected in over four percent 
of public water supplies in the United States,15 with an average concentration of 5 to 20 μg L-1.4, 
92 Military and industrial sites present even greater health risks, with concentrations exceeding 
600 mg L-1.93, 94 Due to perchlorate’s high water solubility, it is highly mobile with the potential 
for off-site migration.95  
At the municipal level, perchlorate treatment is accomplished primarily through ion 
exchange and, to a lesser degree, biological processes.96 Traditional anion exchange resins 
remove perchlorate, although they are less effective in the presence of high concentrations of 
competing anions such as nitrate and sulfate.21 Nitrate is generally present at concentrations 
below its EPA maximum contaminant level (MCL) of 44 mg L-1 in surface waters, but has been 
found to exceed the limit in agricultural groundwater wells.97 However, even when below its 
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MCL, nitrate may be present at 2-3 orders of magnitude above the perchlorate concentration, 
presenting a competitive challenge for perchlorate removal using ion exchange. Sulfate, having a 
secondary maximum contaminant level (SMCL) of 250 mg L-1, can have an even larger 
concentration ratio to perchlorate.98 For the non-selective anion exchange systems, life cycle 
assessment suggests that salt used for regeneration is the major contributor of environmental 
impacts.25 Specialized resins target perchlorate more specifically, using bifunctional resins to 
prevent the larger but structurally similar competing anions from binding.24 While effective at 
perchlorate removal, the specialized resins are not easily regenerated and require either 
incineration after perchlorate saturation or specialized regeneration solutions,24 which both 
increase remediation costs and environmental impacts.25 Chlorate and chlorite can be removed 
with zero-valent iron and ferrous iron respectively.99-101 
An alternative to ion exchange is the use of biological perchlorate treatment. Biological 
treatment has been used at sites with concentrations of perchlorate ranging from 50 to 200,000 
µg L-1, which are higher than typical groundwater wells,39, 96 and for concentrated brine from 
regenerative ion exchange processes.102, 103 A variety of biological treatment methods have been 
explored, including fixed beds,39, 104 bioelectrochemical reduction,105 and membrane biofilm 
reactors.106 However, co-contaminating nitrate also affects biological perchlorate removal,45, 103, 
107 since the microorganisms responsible for perchlorate reduction are facultative anaerobes that 
preferentially utilize oxygen and nitrate as electron acceptors. Sulfate can also serve as an 
electron acceptor for competing microorganisms. Additionally, oxygen exposures lasting twelve 
or more hours are reported to impact perchlorate removal for several days after anaerobic 
conditions were restored,108, 109 despite the fact that induction of the relevant enzymes increases 
perchlorate-reducing activity within a matter of hours (e.g. 46). While the reason for the 
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difference in these timescales is not fully understood, it does not appear to be due to inhibition or 
oxygen sensitivity of the enzymes directly involved in perchlorate reduction. Since most 
operational costs and environmental impacts of the biological process are associated with 
supplying an electron donor, the utility of biological processes is highly sensitive to the source 
water quality and in particular to the presence of other potential electron acceptors, including 
nitrate.25  
Seeking a more selective biologically-based process, in this work we investigated the 
potential for perchlorate removal using extracted enzymes as biocatalysts, rather than whole cells 
of perchlorate-reducing microorganisms. Extracted enzymes are used for synthesis of high value 
pharmaceutical products such as 6-aminopenicillanic acid and cephalexin,48 but are not 
commonly used in water treatment. However, adsorption of the cationic Moringa oleifera protein 
to sand yields a material with flocculent and antimicrobial properties that has been studied for 
use in water treatment.110 A biocatalytic approach has also been previously proposed for 
perchlorate remediation.111 Enzymes may be immobilized via attachment to a surface112 or 
through entrapment or encapsulation approaches.113 As compared to attachment, entrapment and 
encapsulation can protect the enzymes, but these approaches also introduce diffusion limitations. 
Two enzymes are involved in the biological conversion of perchlorate to innocuous 
chloride and oxygen (Figure 1.2). Perchlorate reductase (PR or Pcr, E.C.1.97.1.1) catalyzes the 
conversion of perchlorate into chlorite. In Azospira oryzae, previously known as Dechlorosoma 
suillum,114 PR is located in the periplasm and contains a molybdenum cofactor, selenium, and 
iron-sulfur clusters.70 It is active in cell-free, soluble protein fractions, based on a colorimetric, 
methyl viologen-based assay.70, 111 Activity of PR has also previously been shown when the 
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enzyme was immobilized on a glassy carbon electrode for biosensing applications115 and on 
celite and calcium alginate in batch studies.111 Chlorite dismutase (Cld, E.C.1.13.11.49) is 
responsible for the conversion of chlorite to molecular oxygen and chloride. Cld is a highly-
conserved enzyme located in the periplasm of perchlorate-reducing bacteria such as A. oryzae.74 
Interestingly, cld genes have also been found in microorganisms not known to degrade 
perchlorate,116, 117 and Cld is expressed in at least one of these organisms,117 although the 
physiological relevance is unknown. To our knowledge, the combined activity of the two 
enzymes, providing the complete biological perchlorate reduction pathway, has not been 
demonstrated in a cell-free system. 
The focus of this work was to investigate the potential for direct application of the 
perchlorate-reducing enzymes, PR and Cld, for removal of perchlorate from drinking water by 
quantifying their activity, selectivity, and stability. We focused on the known perchlorate reducer 
A. oryzae due to the availability of published activity assays70, 118 and a full genome sequence.119 
Cell-free lysates and soluble protein fractions were used to avoid purification costs. Enzyme 
activity and protease resistance were also tested following encapsulation in lipid and polymer 
vesicles. 
2.3. Materials and Methods 
2.3.1. Chemicals, Strains, and Media  
Unless otherwise specified, chemicals were purchased from Sigma Aldrich (St. Louis, 
MO). Nanopure water (18 megaohm cm) was purified from deionized water in a Barnstead 
NANOpure system (Pittsburgh, PA) and used to prepare all solutions. The perchlorate-reducing 
A. oryzae strain PS was obtained from the American Type Culture Collection (ATCC number 
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BAA-33) and grown anaerobically at 35°C swirling at 150 rpm in a modified mineral medium 
(pH 7.2) consisting of (per liter): 0.8 g NaCl, 1.0 g NH4Cl, 0.1 g KCl, 0.02 g MgSO47H2O, 1.35 
g KH2PO4, 1.75 g K2HPO4, 1.5 g NaHCO3, 4.6 g TES buffer, 10 mL trace metal solution, and 10 
mL vitamins (Appendix A). Trace metal and vitamin solutions were prepared as previously 
described.120 Sodium acetate trihydrate (14.8 mM) (Fisher Scientific, Pittsburgh, PA) served as 
the electron donor, and sodium perchlorate monohydrate (8.2 mM) (Fisher Scientific, Pittsburgh, 
PA) served as the electron acceptor. The medium was autoclaved, and headspace was exchanged 
with 80% N2:20% CO2 (1.3 atm) three times. Cultures were grown to an OD600nm of ~0.4 and 
preserved in 10% glycerol at -80°C.  
The Escherichia coli strain, BL21(DE3) omp8 (ΔlamB ompF:: Tn5 ΔompA ΔompC 
pGOmpF) was used to produce OmpF porin for vesicle experiments.121 It was grown in Lennox 
Luria Broth (LB) at 37ºC shaking at 250 rpm, preserved in 50% glycerol at -80°C, and streaked 
fresh for each protein preparation.  
2.3.2. Preparation of A. oryzae Lysate and Soluble Protein Fraction  
Ten mL of A. oryzae culture stock was used to inoculate 2.5 L media in custom 5 L 
anaerobic bottles (Chemglass, Vineland, NJ). Cultures were grown to an OD600nm of ~0.6 and 
harvested by centrifugation at 4ºC and 6000xg for 10 minutes.  Anoxic preparation of lysate and 
soluble protein fraction was performed under a 97% N2:3% H2 atmosphere in an anoxic glove 
box and sealed centrifuge tubes, while aerobic preparations were performed on the bench top. 
Cell pellets were resuspended in 50 mM potassium phosphate buffer (pH 6.0) containing 0.1 mg 
L-1 DNase (Life Technologies, Grand Island, NY) and lysed using a sonic dismembrator set to an 
amplitude of 35% (Fisher Scientific Model 500 with Branson Tip Model 101-148-062, Waltham, 
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MA). Three lysis cycles of five minutes (alternating three-second pulse and two seconds off), 
followed by five minutes on ice, were performed. The crude cell extract, henceforth referred to 
as lysate in this paper, was centrifuged at 5000xg for 15 minutes at 4°C. To assess the lysates’ 
perchlorate-reducing activity, 0.5 mL samples of the supernatant were collected, treated with a 
final concentration of 10% glycerol and assayed. To prepare soluble protein fractions, cell lysates 
were centrifuged at 145,000xg for one hour at 4°C, with the supernatant containing the soluble 
protein fraction retained and stored in 10% glycerol.70 All protein concentrations were 
determined using the Bicinchoninic acid (BCA) assay (Pierce, Rockford, IL).  
2.3.3. Protease Treatment  
To analyze the enzymes’ susceptibility to protease, soluble protein fractions were diluted 
1:100 (v/v) with 50 mM phosphate buffer (pH 6.0). Dilute fractions and undiluted vesicle 
suspensions were treated with 5% (v/v) 20 mg mL-1 Proteinase K (Roche Applied Science, 
Indianapolis, IN) in double distilled water122 and incubated at room temperature for one hour. 
The negative control was a corresponding incubation containing the soluble protein fraction or 
vesicle suspension but without Proteinase K. 
2.3.4. Preparation of OmpF Protein  
OmpF was produced and purified as previously described,123 with modification of the 
lysis method. Cells were disrupted using a sonic dismembrator as detailed for A. oryzae, except 
that the amplitude was 20% for a gentler extraction. Purification was confirmed by SDS-PAGE 
and protein concentration was determined using BCA assays. Protein yields were between 2.22 
and 5.78 mg protein L-1 of culture. OmpF protein was stored in sterile 1.5 mL microcentrifuge 
tubes at 4°C for up to three months. 
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2.3.5. Activity Assays for Perchlorate, Nitrate, and Sulfate Reduction  
Enzyme activities were analyzed using the colorimetric methyl viologen (MV) electron 
donor as previously described.70 Assays were performed in stoppered anaerobic cuvettes 
(Absorption Cells 117.104, Hellma USA, Inc., Plainview, NY) at 25°C with sodium dithionite as 
the electron donor. Twenty μL of cell lysate or soluble protein fraction or 400 µL of vesicle 
preparation was monitored until the absorbance (578 nm) stabilized, then 20 μL of 100 mM 
sodium perchlorate monohydrate was added and perchlorate reduction was indirectly monitored 
using the same wavelength. Activities for nitrate and sulfate were also measured by substituting 
20 μL of 100 mM potassium nitrate or sodium sulfate for perchlorate. The decreasing absorbance 
was measured until a zero value was achieved. The linear slope of the decreasing absorbance and 
an extinction coefficient of 13.1 mM-1 cm-1 124 were used to calculate activity. Activity is given in 
Units (U), defined as one µmole of MV oxidized per minute, per liter of lysate, soluble protein 
fraction or vesicle suspension. Eight µmoles of MV are oxidized upon reduction of one µmole of 
perchlorate to chloride, four in the reduction of perchlorate to chlorite and four by the oxygen 
produced by chlorite dismutase.70 For the vesicle assays, due to the low protein concentrations, 
the assays were performed in anaerobic cuvettes and inside an anoxic glove box. Controls 
included enzyme and vesicle activity without perchlorate and MV reduction without enzyme or 
vesicle addition. The lysates, soluble protein fraction, and vesicles had reducing power, resulting 
in background activity when no perchlorate was present. This background activity, which was 
typically 1-2% of the measured rate for the soluble protein fraction and 5-14% of the measured 
rates for the vesicle experiments, was subtracted from experimental values to produce the 
reported values. Activity measurements were performed in triplicate. 
To directly monitor perchlorate removal and chloride formation, and to assess specificity, 
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endpoint activity assays were also used. These assays used nicotinamide adenine dinucleotide 
disodium salt (NADH) (Calbiochem, Philadelphia, PA) as an electron donor and phenazine 
methosulfate (PMS) (Acros Organics, New Jersey) as an electron carrier.118 Twenty μL of soluble 
protein fraction were incubated in 4 mL reactions with 50 mM 3-(N-morpholino) 
propanesulfonic acid (MOPS, pH 7.0), NADH (200 or 1000 µM) and PMS (100 µM).118 
Perchlorate (1 µM to 100 µM) and nitrate (1 µM to 500 µM) were added as specified. Reactions 
were incubated for 10 hours at 25°C and frozen at -20°C to halt enzyme activity. Controls 
included reactions without enzymes. Endpoint assays were performed in triplicate with duplicate 
analytical measurements. 
Perchlorate was quantified using ion chromatography (IC) on an Ion Pac AG-16 and AS-
16,125 and nitrate, chlorate and chlorite were analyzed on an Ion Pac AG -18 and AS-18 
Hydroxide-Selective Anion-Exchange Column on a Dionex ICS-2000 system with an ASRS 300 
Self-Regenerating Suppressor (Dionex, Sunnyvale, CA).125 For perchlorate, system setup 
included 50 mM KOH eluent, 1.0 mL min-1 eluent flow rate, 1000 µL injection loop and 
suppression at 193 mA. For nitrate, chlorate, and chlorite, system setup included 36 mM KOH 
eluent, 1.0 mL min-1 eluent flow rate, 1000 µL injection loop and suppression at 90 mA. 
Detection limits were 5 ppb for perchlorate, 10 ppb for nitrate, 10 ppb for chlorate, and 50 ppb 
for chlorite.  
2.3.6. Vesicle Formation  
Lipid and polymer vesicles were formed using film rehydration126 in the presence of 
soluble protein fractions from A. oryzae and, where specified, purified OmpF protein. The lipids 
consisted of a 9:1 ratio of soy asolectin and cholesterol, while the polymer was an ABA triblock 
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copolymer of poly-(2-methyloxazoline)-poly-(dimethylsiloxane)-poly-(2-methyloxazoline) 
(PMOXA15-PDMS110-PMOXA15).
126 A detailed description of vesicle formation methods and 
vesicle characterization by dynamic light scattering and transmission electron microscopy is 
available in B.1. 
2.3.7. Statistical Analysis  
Statistical analysis was performed using independent-samples t-test assuming equal 
variance. The variance of samples was tested using F-test.  
2.4. Results and Discussion 
2.4.1. Perchlorate Reduction in A. oryzae Lysate and Soluble Protein Fraction  
Independently prepared lysates of A. oryzae showed perchlorate-reducing activities of 
41,700 to 54,400 U L-1, as measured with the MV assay. These activities correspond to 518 to 
676 mg perchlorate removed per min per liter of lysate. Normalizing to total protein content gave 
enzyme activities of 2.49 to 3.06 U mg-1. The activity in the soluble protein fraction ranged from 
15,400 to 29,900 U L-1 (1.70–1.97 U mg-1 total protein). These values are similar to the 1.10 ± 
0.093 U mg-1 reported by Coates et al.65 for Dechloromonas agitata strain CKB and 
approximately five-fold higher than A. oryzae strain GR-1,70 taking into account Kengen et al.’s 
use of a lower extinction coefficient for MV of 9.7 mM-1 cm-1 at 578 nm. 
Based on previous analyses of perchlorate-reducing enzymes, the effects of oxygen and 
glycerol on enzyme stability were tested.70 Avoiding exposure to oxygen during lysis did not 
result in a significant change in lysate activity, with an average activity of 47,300 U L-1 for 
anaerobic and 46,400 U L-1 for aerobic conditions (n = 3, P = 0.439). Subsequent lysates were 
routinely prepared aerobically. This is in contrast to the slight oxygen sensitivity reported for PR 
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from strain GR-170 and may reflect strain differences.127 For potential water treatment 
applications, the fact that lysates from the strain PS retain activity following exposure to oxygen, 
avoiding the need for anaerobic lysate preparation, is an advantage. Addition of glycerol to a 
final concentration of 10% also had no significant effect on the initial soluble protein fraction 
activity (n = 3, P = 0.388). However, over 48 hours, 10% glycerol improved the stability of the 
enzymes, preventing a 48.8% loss of activity (n=3, P = <0.01), and was therefore routinely 
added.  
2.4.2. Specificity for Perchlorate  
Given the common occurrence and higher concentrations of nitrate and sulfate in 
perchlorate-contaminated drinking water sources,97 it was important to determine whether these 
anions affect the soluble protein fraction’s ability to reduce perchlorate. The use of soluble 
protein fraction provides a conservative test of the enzymes’ specificity since it is a crude 
preparation containing many enzymes in addition to those involved in perchlorate reduction. For 
example, the A. oryzae genome contains a putative periplasmic nitrate reductase,119 and A. oryzae 
is capable of growing using nitrate as an electron acceptor128 which could result in simultaneous 
nitrate reduction even if the perchlorate-reducing enzymes are highly specific. Using the MV 
colorimetric assay, for our soluble protein fractions, nitrate was reduced at only 24.9 ± 3.6% of 
the rate for perchlorate. Sulfate was not reduced by the soluble protein fractions. Using IC 
analysis, initial tests were performed with 1:1 ratios of perchlorate to nitrate or sulfate at 
concentrations of 100, 400 and 500 µM to facilitate detection. Nitrate and perchlorate were 
reduced; however, sulfate was not reduced whether or not the assay conditions included 
perchlorate. This is consistent with A. oryzae’s metabolism, which is not known to include 
sulfate reduction. Sulfate also had no effect on the rate of perchlorate reduction.  
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To further investigate the impact of nitrate on perchlorate reduction, perchlorate and 
nitrate were studied at lower concentrations of 1, 5, 50 and 100 µM. When incubated with 1:1 
ratios of perchlorate: nitrate, in the presence of 1000 µM NADH, the soluble protein fractions 
reduced 79.2% to 99.3% of the perchlorate (Table 2.1). With less electron donor (200 µM 
NADH), 54.7% to 97.4% of the perchlorate was removed. Accumulation of intermediate 
compounds chlorate and chlorite was not detected, indicating both PR and Cld activity. In the 
presence of 1000 µM NADH, similar levels of removal were observed for both perchlorate and 
nitrate at the higher concentrations, but at the lower concentrations, the relative perchlorate 
removal is superior to that of nitrate. At 200 µM NADH, nitrate removal decreased substantially. 
Based on these encouraging results, conditions with excess nitrate, similar to concentrations 
observed in water sources, were also tested. For perchlorate concentrations of 1, 5, 25 and 50 
µM, in the presence of 500 µM nitrate, substantial perchlorate removal was observed (Table 2.1). 
No accumulation of chlorate or chlorite was observed in these experiments.  
The ability of perchlorate-reducing enzymes to preferentially treat perchlorate over 
nitrate, at environmentally relevant ppb perchlorate concentrations with excess nitrate, is 
particularly important for potential drinking water applications. These results emphasize some 
potential advantages of enzyme-based treatment, as it can circumvent metabolic regulation - A. 
oryzae does not normally reduce perchlorate in the presence of nitrate and oxygen46 – and also 
provide selective utilization of the added electron donor. Model electron donors were used in the 
current work; a broader range of electron donors appropriate for large-scale applications has not 
yet been evaluated. Although the addition of electron donor during drinking water treatment also 
has the potential to increase microbial growth and/or formation of disinfection byproducts, we 
anticipate that the enzyme-based process will require less electron donor than existing biological 
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treatment processes, and therefore is likely to have less of these deleterious effects. 





NADH (µM) Perchlorate 
Removed (%) 
Nitrate Removed (%) 
     
1 -- 1000 > 99.5%a na 
5 -- 1000 99.1 ± 1.0 na 
50 -- 1000 99.9 ± 0.00008 na 
100 -- 1000 99.9 ± 0.0002 na 
-- 1 1000 na 35.0 ± 8.0 
-- 5 1000 na 60.0 ± 11.4 
-- 50 1000 na 93.9 ± 2.4 
-- 100 1000 na 97.5 ± 0.9 
1 1 1000 79.5 ± 20.2 43.3 ± 0.3 
5 5 1000 79.2 ± 27.8 45.8 ± 20.7 
50 50 1000 98.8 ± 2.5 94.8 ± 0.6 
100 100 1000 99.3 ± 0.4 98.1 ± 0.2 
1 -- 200 95.6 ± 1.8 na 
5 -- 200 98.3 ± 1.6 na 
50 -- 200 99.7 ± 0.005 na 
100 -- 200 97.0 ± 4.7 na 
-- 1 200 na 21.0 ± 10.8 
-- 5 200 na 68.7 ± 5.0 
-- 50 200 na 97.7 ± 1.36 
-- 100 200 na 98.7 ± 1.6 
1 1 200 54.7 ± 18.2 14.7 ± 16.7 
5 5 200 75.2 ± 21.3 63.2 ± 31.2 
50 50 200 97.4 ± 3.3 68.0 ± 52.8 
100 100 200 89.1 ± 7.3 45.8 ± 47.2 
     
1 500 200 14.0 ± 7.5 na 
5 500 200 72.0 ± 20.9 na 
25 500 200 81.1 ± 23.1 na 
50 500 200 79.5 ± 24.9 na 
-- anion was not included 
na measurement not taken  
a measurement below the detection limit 
 
2.4.3. Stability of Perchlorate-Reducing Soluble Protein Fractions 
The stability of proteins varies widely, with half-lives ranging from minutes to days. To 
provide an initial assessment of the stability of the extracted perchlorate-reducing enzymes, 
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soluble protein fractions were stored in 10% glycerol at 4ºC or room temperature in the presence 
of oxygen and assayed over time. As measured by the MV assay (Figure 2.1A), the rate of 
perchlorate reduction slowly declined over the first two weeks of storage at 4ºC, then appeared to 
stabilize, retaining an average of 58.2% of the initial activity after 23 days. Samples stored at 
room temperature declined steadily in activity, but still had an average of 10.6% of initial activity 
after 23 days. To assess whether 100 µM of perchlorate was completely degraded, selected 
samples were analyzed for perchlorate, chlorate, and chlorite with IC. Despite the decreasing 
activity, perchlorate removal from a 10-hour incubation persisted quite well over the 23 days of 
these experiments (Figure 2.1B). However, the subsequent degradation steps appeared slightly 
less robust, with chlorite accumulation occurring in some replicates beginning on day 13 and 
chlorate accumulation at day 23. 
 
Figure 2.1: Shelf life of the perchlorate-reducing SPF measured by perchlorate removal (A) and 
SPF activity (B) both represented as percent remaining with biocatalysts stored at 4ºC (blue, 




These results suggest that PR and Cld are relatively stable, with half-lives on the order of 
days to weeks. Considering that these results were obtained with minimal optimization and 
without adding chemicals to inhibit microbial growth during storage, these experiments are 
likely to represent a conservative estimate of stability, supporting the potential application of 
these enzymes in remediation. The stability observed here is greater than the previously 
published half-life of 2 – 3 days for perchlorate-reducing activity from strain GR-1.70 However, 
in that work oxygen sensitivity was reported as a key factor, with longer half-lives observed 
under anaerobic conditions, while oxygen sensitivity was not observed in our work. The 
accumulation of chlorite prior to other intermediates, which to our knowledge has not been 
investigated previously, suggests that Cld has a shorter half-life than PR and should be the initial 
target for improvement if increased stability were required. 
2.4.4. Activity of Encapsulated A. oryzae Soluble Protein Fraction  
As part of this initial feasibility assessment, one potential immobilization and protection 
mechanism, encapsulation of A. oryzae soluble protein fraction in lipid or polymer vesicles, was 
investigated. Encapsulation occurs when vesicles are formed in the presence of soluble protein 
fraction; unencapsulated free proteins are separated from vesicles by size exclusion (methods 
detailed in B.1). To minimize limitations from slow diffusion of perchlorate through the vesicle 
wall, the effect of incorporating an open channel porin, OmpF, into the vesicle membranes was 
also tested. The OmpF porin, with pore dimensions of 7 by 11 Å,129 allows for size-restricted 
diffusion of small molecules; in this case perchlorate and MV can move in and out of the vesicles 
freely, but the larger PR and Cld enzymes are retained inside the vesicles.  
Vesicle formation was confirmed using dynamic light scattering and transmission 
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electron microscopy (B.2). Comparing vesicle preparations of the same material with and 
without OmpF, the concentration of vesicles was similar, based on count rates obtained from 
dynamic light scattering. OmpF incorporation in the vesicle membrane was confirmed using 
leakage of encapsulated carboxyfluorescein as compared to vesicles without OmpF (B.2).  
Both lipid and polymer vesicles showed perchlorate-reducing activity in the MV assay 
(Figure 2.2). The activity of the vesicles was significantly lower, as compared to activity of the 
soluble protein fraction. This was expected since the volume of the vesicles limits the amount of 
enzyme present in a given liquid volume. Theoretical calculations of the volume limitations 
imposed by the 150 nm diameter vesicles (B.2) provide a maximum predicted the perchlorate-
reducing activity of 95 U L-1, in good agreement with experimental results, which had a 
maximum activity of 70.7 U L-1. Under these assay conditions, perchlorate diffusion was not 






Figure 2.2: Perchlorate-reducing activity of A. oryzae soluble protein fractions encapsulated in 
lipid and polymer vesicles, as measured with the MV assay. Results shown are average activities 
with standard deviations from triplicate vesicle preparations. Activity is defined as one µmole of 
MV oxidized per minute per liter of vesicle suspension. Purified E. coli OmpF porin was 
included in specified samples to improve entry of perchlorate into the vesicles. 
Perchlorate-reducing activity was observed in the absence of the OmpF porin. This 
activity is not likely to be due to free enzymes, as these were removed by size exclusion during 
vesicle purification. This activity could be due to perchlorate diffusion through the vesicle 
membrane, particularly since detergent is present, or to endogenous A. oryzae channel proteins or 
transporters, which may be present in the soluble protein fraction and could have been 
incorporated adventitiously into the vesicle membrane during the encapsulation process. There is 
precedent for increased diffusion through the vesicle membrane for detergents Triton X and octyl 
glucoside.130-132 Control experiments investigating the effects of the detergent used here, n-octyl-
oligo-oxyethylene, were inconclusive, as no vesicles were produced in the absence of detergent.  
The addition of OmpF in lipid vesicles significantly increased perchlorate-reducing 
activity (161.0%, n=3, P=0.012) (Figure 2.2), suggesting that perchlorate entry into lipid vesicles 
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was limiting activity in the vesicles without OmpF. Polymer vesicles showed the same trend, 
with a 61.8% increase in activity upon the inclusion of OmpF (n=3, P=0.0028). Due to the small 
volume of vesicles prepared, the perchlorate-reducing activity in these experiments was too low 
for effective quantification of perchlorate or its degradation products by analytical techniques, so 
the activity of the complete reduction pathway has not been conclusively demonstrated. 
Optimization of encapsulation, for example by further purification of the relevant enzymes, 
could increase the activity by producing vesicles containing a higher concentration of 
encapsulated PR and Cld. The good agreement between the observed rates and the theoretical 
calculations suggests that the full degradation pathway is functional when encapsulated.  
The potential protective effects of encapsulation were tested by protease treatment. With 
a molecular weight of 28.9 kDa and molecular dimensions of 38 Å, 43 Å, and 38Å,133 Proteinase 
K is occluded from passage through the OmpF pore. For the soluble protein fraction, without 
encapsulation, Proteinase K treatment decreased perchlorate-reducing activity by 49.8% (n = 3, P 
= 0.02). For polymer vesicles containing OmpF, treatment with Proteinase K only resulted in a 
14.3% decrease in activity, from 70.7±5.9 to 60.6±4.4 U L-1. These results demonstrate the 
feasibility of using enzymes for treatment schemes while encapsulated within lipid or polymer 
vesicles and support the idea that the vesicles provided a protective microenvironment.  
2.5. Environmental Implications 
Reducing perchlorate contamination in drinking water is a requirement in several states 
and a goal of the EPA, with maximum contaminant level regulations under development. This 
work investigates a potential biocatalyst for removing perchlorate from drinking water sources, 
using PR and Cld enzymes extracted from a perchlorate-reducing bacterium. The concentrations 
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of perchlorate tested in this study ranged from 100 to 10,000 ppb. The lower perchlorate 
concentrations are more typical of contaminated municipal drinking water sources,15 while the 
higher concentrations tested in this study represent those found at many military and industrial 
sites.94 The results are promising, both in terms of substrate specificity and enzyme stability. In 
particular, perchlorate was removed under environmentally relevant conditions: low perchlorate 
concentrations and low perchlorate: nitrate ratios, to below the current California regulatory limit 
of 6 ppb.96 Furthermore, the ability to remove perchlorate was maintained and protected from 
inactivation by protease treatment when the soluble protein fractions were encapsulated in lipid 
or polymer vesicles. Activity and stability in natural waters and life cycle assessment of this 
technology are essential considerations for future work.  
Potential advantages of the biocatalysts, as compared to traditional ion exchange resins 
and emerging chemical catalysts, include higher specificity for the contaminant over competing 
anions and higher reaction rates than rhenium- and molybdenum-based catalysts.29 Like 
biological processes, the enzyme-based approach completely degrades perchlorate into chloride 
and oxygen, avoiding the production of concentrated wastes and the associated disposal costs. As 
compared to whole-cell biological degradation, the enzyme-based approach allows activity in the 
presence of competing anions, potentially decreasing the amount of electron donor required. The 
enzyme-based approach also circumvents the cellular regulation of PR and Cld expression, 
providing the potential to maintain perchlorate reduction under more diverse environmental 
conditions and fluctuating loads.  
2.6. Supporting Information 
The Supporting Information includes detailed methods for vesicle preparation, 
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transmission electron microscopy, dynamic light scattering, and fluorescence retention and 
results from the characterization of vesicles, including transmission electron microscopy images, 
size, and polydispersity index. This material is available free of charge via the Internet at 
http://pubs.acs.org and in Appendix B. 
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CHAPTER 3: BIOCATALYTIC PERCHLORATE REDUCTION: KINETICS AND 
EFFECTS OF GROUNDWATER CHARACTERISTICS 
This chapter has been published. The citation is Hutchison, J. M.; Zilles, J. L., 
Biocatalytic perchlorate reduction: kinetics and effects of groundwater characteristics. 
Environmental Science: Water Research and Technology. 2015, 1, (6), 913-921. As author, I 
retain copyright of this work. Brittany Webb, an undergraduate research student, assisted with the 
collecttion of temperature, NOM, and cation activity data. I performed all other experiments. 
3.1. Abstract 
Biocatalytic reduction of perchlorate can minimize the effects of competitive electron 
acceptors and completely reduce perchlorate into chloride and oxygen, but to date has only been 
demonstrated under idealized laboratory conditions. This work investigated biocatalytic 
perchlorate reduction in two groundwater drinking water sources, under a range of conditions 
and with a variety of electron donors. The biocatalysts, perchlorate reductase and chlorite 
dismutase from Azospira oryzae, had a maximum activity of 162.5 ± 8.4 U (µg Mo)-1 in buffered 
solution and retained 82-94% of their activity in groundwater samples. The half-saturation 
concentration for perchlorate was 92.0 µM. Perchlorate reduction rates were higher than nitrate 
reduction rates, with nitrate as the sole electron acceptor having reduction rates 7.5 to 9.7 % of 
the maximum perchlorate reduction rates in groundwater. Activity was consistent from pH 6.5 to 
9.0. The temperature dependence of biocatalytic perchlorate reduction was well defined by the 
Arrhenius equation. No significant difference in biocatalytic activity was observed with calcium 
and magnesium concentrations over the tested range of 0 to 400 mg L-1 or with natural organic 
matter up to 6 mg L-1. Ascorbic acid with addition of an electron shuttle resulted in reduction of 
more than 99% of perchlorate in less than 6 hours, an order of magnitude loss in activity 
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compared to methyl viologen. These results suggest the potential of the biocatalysts for treating 
perchlorate over a range of concentrations and conditions representative of industrial and 
groundwater perchlorate contamination.  
3.2. Introduction 
Widespread perchlorate contamination of drinking water has been found in over 20 U.S. 
states, resulting in advisory or regulatory limits in several states and a pending regulatory limit of 
15 µg L-1 from the United States Environmental Protection Agency.87, 96, 134 These regulations are 
intended to prevent developmental defects in fetuses and young children arising from the 
preferential uptake of perchlorate in the thyroid.4, 135, 136  
To remove perchlorate from drinking water, municipalities primarily use non-selective or 
selective ion exchange.96 Whole-cell biological processes have also been shown to reduce 
perchlorate.96 However, these technologies have significant drawbacks. Non-selective ion 
exchange produces brine waste with elevated perchlorate concentrations and is less effective for 
perchlorate removal in the presence of high concentrations of competing anions such as nitrate 
and sulfate.21 Specialized, bi-functional resins target perchlorate more specifically, reducing the 
impact of competing anions.24 The disadvantage is that these specialized resins are not easily 
regenerated and are generally incinerated after saturation,24 increasing costs and environmental 
impacts. Whole-cell biological reduction has been explored in a number of configurations, 
including fixed beds,39, 104 bioelectrochemical reduction,105 and membrane biofilm reactors.106 
However, biological reduction of perchlorate also performs poorly in the presence of co-
contaminating nitrate, sulfate, and oxygen, since these are preferred electron acceptors for many 
microorganisms.45, 103, 107 Other challenges associated with biological perchlorate removal 
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include the potential for hydrogen sulfide production, the possible growth of pathogenic 
organisms, and public perception.  
Because co-contaminating nitrate and sulfate are common in drinking water sources,3 
these problems necessitate advances in perchlorate treatment. To that end, a wide variety of 
approaches are being investigated, including chemical33 and biological137 processes to treat 
perchlorate in waste brines, direct biological regeneration of perchlorate-selective resins,138, 139 
ion exchange membrane bioreactors,42 and two-stage membrane biofilm reactors that minimize 
sulfate reduction.140 We recently proposed a system that selectively reduces perchlorate into 
innocuous chloride and oxygen using cell-free biocatalysts, specifically perchlorate reductase 
(PR) and chlorite dismutase (CD) from Azospira oryzae, and provided proof of concept for this 
approach in buffered, laboratory solutions.64 PR is a soluble, periplasmic protein with similarity 
to nitrate reductases.70 CD is also a soluble protein and catalyzes an intramolecular electron 
transfer to form the final products of chloride and oxygen.76 
Biocatalytic treatment is generally attractive due to high substrate affinities and reaction 
rates, specificity, and optimal activities under ambient conditions of temperature, pressure, and 
pH. However, to date biocatalysts have largely been used only for high-value products such as 
pharmaceuticals.48 A prominent exception is the extracellular biocatalyst laccase, which has been 
used to treat phenolic compounds in industrial wastewater (e.g., forest products industry141 and 
textile and dye-making industry57). Laccase has also been proposed for oxidation of phenolic 
compounds such as pharmaceuticals in wastewater effluent.58  
For treatment of perchlorate and other chlorine oxyanions, a biocatalytic approach shares 
with biological treatment processes the advantage of completely degrading the contaminant but 
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avoids some of the challenges associated with whole-cell reduction of perchlorate. Specifically, 
unlike whole cells, which preferentially use nitrate, the biocatalysts target perchlorate even in the 
presence of excess nitrate and have no activity with sulfate, reducing the amount of electron 
donor that would be required to treat perchlorate in the presence of competing anions.64 
Furthermore, because the biocatalysts are non-living, the process can operate under nutrient-
limited conditions, avoiding the formation of hydrogen sulfide, mitigating any hazard posed by 
pathogenic organisms, and minimizing the formation of biofilms. In addition, these biocatalysts 
showed good stability, maintaining perchlorate reduction up to 23 days.64 While promising, this 
initial proof-of-concept study did not determine kinetic parameters for perchlorate reduction. It 
was further limited by its exclusive use of buffered laboratory solutions and ideal electron 
donors. 
To better understand the potential advantages and limitations of the biocatalytic system 
for perchlorate removal, this work measured the biocatalysts’ kinetic activities in two real-world 
groundwater samples and laboratory buffered conditions. The effects of temperature, pH, natural 
organic matter (NOM), calcium, and magnesium were specifically investigated, and a variety of 
potential electron donors were tested. The results provide a basis for evaluating the practical 
potential for biocatalytic removal of perchlorate during drinking water treatment.  
3.3. Materials and Methods 
3.3.1. Biocatalyst Preparation, Media, and Chemicals. 
Biocatalysts were obtained from the perchlorate-reducing A. oryzae strain PS (ATCC 
number BAA-33). The anaerobic growth media was as previously described,64 with 14.7 mM 
acetate as electron donor and 7 mM perchlorate as electron acceptor (Appendix A). Preparation 
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of A. oryzae soluble protein fraction containing PR and CD was also as previously described, 
including the addition of glycerol to a final concentration of 10% before storage.64  
To normalize activity across different preparations, two measurements were used: 
molybdenum content, as an indirect measure of PR concentration, and total protein. To determine 
molybdenum content, aliquots of each soluble protein fraction were taken prior to addition of 
glycerol and dialyzed to remove salts and free molybdenum using 3,000 Dalton molecular 
weight cut off dialysis cassettes (Thermo Scientific) with three 50mM phosphate buffer 
exchanges. The original volume of sample was maintained. Samples were analyzed with 
inductively coupled plasma-optical emission spectrometry (ICP-OES) (PerkinElmer Optima 
2000DV, Waltham, MA). To facilitate comparison to the literature, activity was also normalized 
to total protein concentrations in the soluble protein fractions, as determined using the 
Bicinchoninic acid (BCA) assay (Pierce, Rockford, IL). Soluble protein fractions produced in 
this work contained an average of 21.22 ±1.76 mg mL-1 protein and 357±39 µg L-1 molybdenum.  
All solutions were prepared with Nanopure water (18 MΩ cm), produced from deionized 
water in an EMD Millipore Milli-Q (Model Number: Z00QSV0US) System (Billerica, MA). 
Unless otherwise specified, chemicals were purchased from Fisher Scientific (Pittsburgh, PA). 
Anaerobic solutions were prepared by degassing with N2:CO2 for 30 minutes, and the headspace 
was degassed with the same mixture for 5 minutes. The ratio of N2:CO2 was varied in the range 
of 80:20 to 100:0 to maintain the desired pH.  
3.3.2. Groundwater Sampling and Characterization 
Groundwater was collected from two sources.  The Illinois groundwater (Illinois GW) 
was harvested from a depth of 46.3 meters in the Illinoisian Formation above the Mahomet 
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Aquifer. This water was known to have high amounts of iron and manganese and was therefore 
pretreated in a manganese greensand filter. Water was also collected in Eastern Iowa (Iowa GW), 
from a depth of 151 meters in the Silurian-Devonian Aquifer, without pretreatment. Five-gallon 
samples were collected and stored in polypropylene jerricans in the dark at 4°C.  
The groundwater samples were characterized after equilibration with the atmosphere and, 
for the Illinois sample, after pretreatment, corresponding to the expected placement of the 
biocatalysts in the treatment train for drinking water prior to disinfection. Oxygen concentration 
was measured using a rugged dissolved oxygen (RDO) probe (Thermo Scientific, 087020MD). 
pH was measured using a Thermo Orion 8172 BN ROSS Sure-Flow pH electrode. Bicarbonate 
concentration was estimated from alkalinity pH titration measurement using 0.1, 0.01 and 0.001 
M HCl. Hardness was tested by titration (Hach Total Hardness Kit, HA-71A). Selected metals 
were analyzed with inductively coupled plasma-optical emission spectrometry (ICP-OES) 
(PerkinElmer Optima 2000DV). Total ammonia (NH3/NH4 mg L
-1 NH-N) was analyzed by 
colorimetric analysis (Hach salicylate kit). Halides were measured using Thermo Scientific Ion 
Selective Electrodes. Perchlorate was quantified using ion chromatography (IC) with 
conductivity detection (IC-CD; Dionex ICS-2000) on an Ion Pac AG-16 and AS-16,125 and 
nitrate, sulfate, chlorate and chlorite were analyzed on an Ion Pac AG-18 and AS-18 Hydroxide-
Selective Anion-Exchange Column as previously described.64  
3.3.3. Colorimetric Biocatalytic Activity Assays  
Biocatalytic activities were analyzed using a standard colorimetric assay for perchlorate 
reduction, which uses methyl viologen (MV) as an electron donor.70 As previously described,64 
the assays were performed in stoppered anaerobic cuvettes (Absorption Cells 117.104, Hellma 
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USA, Inc., Plainview, NY) at room temperature. In brief, the methyl viologen was first reduced 
with sodium dithionite, twenty μL soluble protein fraction was added and monitored until the 
absorbance (578 nm) slope stabilized, and then the electron acceptor (perchlorate, chlorate, 
nitrate, sulfate, or anion combinations as specified) was added and the reaction was followed by 
absorbance measurements. The background activity of the soluble protein fraction (measured 
without electron acceptor) was subtracted. An extinction coefficient of 13.1 mM-1 cm-1 was 
used.124 Units (U) represent one µmole of MV oxidized per minute. Because MV donates 
electrons for perchlorate reduction and can also react with the oxygen that is produced, up to 
eight moles of MV could be oxidized per mole of perchlorate reduced to chloride. Activity 
measurements were performed in triplicate from independent growths (biological replicates) and 
reported with standard deviation. Data was fit to the single substrate Michaelis-Menten Kinetic 
(Equation 3.1): 




where v is the activity of the biocatalysts at a given substrate concentration, Vmax is the maximum 
activity for the biocatalysts, [S] is the substrate concentration, and Km is the substrate 
concentration at half Vmax. Kinetic parameters, Vmax and Km, reported with standard error were 
calculated using the Marquardt-Levenberg algorithm in the Enzyme Kinetic Module in 
SigmaPlot 13 from triplicate biological replicates. 
Using the MV assay, biocatalytic activity was tested over a range of conditions. The pH 
was varied from 6 – 9 in increments of 0.5 in assays conducted with 1mM perchlorate and Iowa 
GW. Iowa GW pH was adjusted with hydrochloric acid or sodium hydroxide prior to degassing. 




Biocatalytic activity was also determined over a temperature range from 5°C to 30°C in 
increments of 5°C, again using the MV assay, 1mM perchlorate, and Iowa GW. The temperature 
was controlled by putting the spectrophotometer (Thermo Scientific Genesys 20) in an incubator 
(Thermo Scientific MaxQ 6000). Solutions were allowed to equilibrate to the specified 
temperature before measurement. The data was fit to the Arrhenius equation (Equation 3.2) 
shown:  
Equation 3.2  𝑘 = 𝐴𝑒−𝐸𝑎/(𝑅𝑇) 
where k is the rate constant, A is the pre-exponential factor, Ea is the activation energy, R is the 
universal gas constant, and T is the temperature.  
The effects of calcium, magnesium, and NOM were determined in 50mM Tris-Cl- (pH 
7.5) buffered conditions. Calcium chloride and magnesium chloride were tested individually at 
concentrations up to 400mg L-1. Suwanee River NOM (IHSS, St. Paul, MN) was tested from 1 to 
6 mg L-1.  
3.3.4. Alternative Electron Donors 
To characterize the range of electron donors that can be used by the biocatalysts, a variety 
of organic electron donors were tested in buffered solutions. Based on previous work with 
NADH,118 each of these potential donors was tested with and without the electron shuttle 5-
methylphenazinium methyl sulfate (PMS) (Acros Organics, New Jersey). Twenty μL of soluble 
protein fraction were incubated in 10 mL samples containing 5mM electron donor, 0 or 100 µM 
PMS, and 1 mM perchlorate. Initial assays were incubated on the benchtop (approximately 
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22°C) for 24 hours and then frozen at -80°C to halt enzyme activity. Perchlorate removal was 
monitored by IC as detailed in Section 3.3.2. Controls included no soluble protein fraction and 
no perchlorate samples for each reaction mixture. The initial reaction rate was quantified for one 
promising candidate, ascorbic acid, by scaling the reaction up to 100mL with 1mL of soluble 
protein fraction in stoppered anaerobic media bottles and withdrawing 3mL samples hourly for 
perchlorate measurements. 
3.3.5. Preliminary Design Calculations 
Initial calculations for perchlorate treatment in a batch reactor system were determined 
using an influent perchlorate concentration of 100 µg/L and an effluent concentration of 10 µg/L. 
The reactor was modeled using an integrated form of the Michaelis-Menten equation and a 
hydraulic retention time (HRT) of two hours. For initial calculations, nitrate was not included as 
an inhibitory effect.   
3.3.6. Statistical Analysis  
The assumption of equal variance was tested using F-test. Statistical analysis was 
performed using the independent-samples t-test with equal variance. Samples were considered 
significantly different with an alpha of less than 0.05.  
3.4. Results 
3.4.1. Characterization of Groundwater  
The two groundwater samples were similar in composition (Table 3.1). The hardness and 
alkalinity measurements are characteristic of very hard water in the United States.142 The 
alkalinity of the samples nevertheless represents a decrease in buffering capacity as compared to 
the laboratory-buffered system. Other than hardness, the groundwater characteristics were within 
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typical ranges (Table 3.1). No perchlorate, chlorate or nitrate were detected, and the levels of 
sulfate were below the EPA regulatory and advisory limits.134  
Table 3.1: Constituent values for groundwater samples from Illinois and Iowa GW 




      
pH  7.34 7.19 6.5-8.5b 6.0-8.5 
Alkalinity 
mg L-1 as 
HCO3
- 
393.0 378.9 -- -- 
Hardness 
mg L-1 of 
CaCO3 
342.0 376.2 -- 121-180 
Ca ppm 66.8 70.5 -- >15 
Fe ppb 0.5 480 300b <10,000 
K ppm 1.62 0.78 -- <10 
Mg ppm 26.9 28.5 -- <300 
Mn ppb 68 37 50b <200 
Mo ppm 0 0 0.03-1 -- 
Na ppm 26.2 12.08 0.2 <1000 
P ppm 0.16 0.13 -- -- 




<0.4 <0.4   
Fluoride ppm 0 0 4a/2b <10 
Chloride ppm 61 52 250b <10 
Bromide ppm 2 0 -- -- 
Iodide ppm 0 0 -- -- 
Perchlorate ppm NDd ND -- -- 
Chlorate ppm ND ND -- -- 
Chlorite ppm ND ND 1.0 -- 
Nitrate ppm ND ND 44a <50 
Sulfate ppm 9.5 9.7 250b <1000 
TOC ppm 1.74 1.22 -- 0.1 - 6 
Temperature °C   -- 2.78 – 25e 
DO mg L-1 9.66 10.06 -- -- 
a Maximum Contaminant Level 134 
b National Secondary Drinking Water Regulations 134 
c 142 









3.4.2. Biocatalytic Activity in Groundwater 
To determine activities of the biocatalysts at realistic perchlorate concentrations and in 
groundwater, the soluble protein fractions were assayed in real groundwater over a range of 
perchlorate concentrations. Although the biocatalysts were not purified, throughout this work the 
measured activity is attributed to PR and CD. This assumption is supported by the high 
expression of PR in A. oryzae cells grown on perchlorate70 and by the unique activity of CD. It 
is, however, possible that some of the measured activity was due to a nitrate reductase, which 
can also show activity for perchlorate.70 To account for variation in biocatalyst content across 
different preparations, activities were normalized to molybdenum concentration, because subunit 
α of PR has one molecule of molybdenum.70 The biocatalysts showed good activity in 
groundwater (Figure 3.1), maintaining 82% (Illinois GW) and 94% (Iowa GW) of their activity 
in laboratory solutions. To facilitate comparison to previously published results,64, 70 the 
biocatalysts’ activity was also normalized to total protein content. The activity values were 2.49 
± 0.22 U mg total protein-1 in buffer, 2.22 ± 0.38 U mg total protein-1 in the Illinois GW, and 2.28 
± 0.12 U mg total protein-1 in Iowa GW. The background activity in groundwater was less than 
0.1% of the maximum perchlorate-reducing rates. The maximum reaction rates (Vmax) and half 
saturation constants (Km) of the soluble protein fractions were calculated using the single 
substrate form of Michaelis Menten kinetic equation (Table 3.2). Kinetic values for Illinois GW 




Figure 3.1: Biocatalytic perchlorate reduction in buffered systems (a) and groundwater (b, Iowa 
GW; c, Illinois GW). Results of MV activity assays conducted on triplicate independent soluble 
protein fractions at perchlorate concentrations from .0005 – 1 mM. Activity is given in Units (U), 
defined as 1 μmol MV oxidized per minute, and is normalized to molybdenum as an indirect 
measure of PR concentration. The solid line represents Michaelis-Menten Kinetics model. Error 
bars represent standard error.  
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Table 3.2: Kinetic parameters of the perchlorate-reducing biocatalytic system in buffered and 
groundwater sample matrices  
Component Illinois GW Iowa GW Buffer System 
    
Maximum Velocitya 
(Vmax) (U (µg Mo)
-1)b 
 
132.9 ± 9.8 152.4 ± 6.3 162.5 ± 8.4 
Half Saturation 
Constanta (Km) (mM) 
0.091 ± 0.026  0.105 ± 0.016 0.092 ± 0.019  
a average ± standard error 
b Units (U) are defined as 1μmol MV oxidized per minute and are normalized to molybdenum 
as an indirect measure of PR concentration.  
 
When chlorate was supplied instead of perchlorate, the maximum activity was higher 
(658.3 ± 36.8 U (µg Mo)-1 versus 152.4± 6.3 U (µg Mo)-1), and the half saturation constant was 
lower (50 ± 12 µM versus 105 ± 16 µM) in Iowa GW. This suggests the system will also be 
effective for chlorate remediation and that chlorate will not accumulate during perchlorate 
removal. The activity with chlorite could not be tested in this assay because it reacts with MV. 
Because a key advantage of the biocatalytic system is the specificity it exhibits for 
perchlorate,64 the specificity was confirmed in groundwater. Assays with 1mM nitrate as the sole 
electron acceptor showed slow reduction, with rates only 9.7 ± 0.4% of perchlorate reduction 
rates in Iowa GW and 7.5 ± 2.3% in Illinois GW. These results are slightly better than previous 
results in a buffered system, where nitrate had 24.9 ± 3.6% of perchlorate activity.64 Nitrate 
activity could be due to the presence of a putative nitrate reductase119 in the soluble protein 
fractions or to the similarity between PR and nitrate reductase.66 Simultaneous addition of 1 mM 
nitrate and 1 mM perchlorate lowered the observed reduction rates to 72.1 ± 1.1% of perchlorate 
reduction rates in Iowa GW and 71.8 ± 3.2% in Illinois GW. This rate is difficult to interpret 
since the colorimetric response could come from either electron acceptor. However, by 
quantifying perchlorate in endpoint assays, prior work demonstrated that the biocatalysts showed 
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good perchlorate removal even in the presence of 100-fold excess nitrate.64 There was no 
observed sulfate activity in either groundwater or in previous work.64 
3.4.3. Effects of Groundwater Characteristics on Activity 
In addition to rapid and selective perchlorate reduction in real-world waters, application 
of biocatalysts requires an understanding of their response to common variables. Several 
important factors: pH, temperature, calcium, magnesium, and NOM, were tested here for their 
impact on the perchlorate-reducing activities of the biocatalysts. pH and temperature were tested 
in Iowa GW, while calcium, magnesium, and NOM were tested in buffered conditions.  
Over the pH range tested here (6.0-9.0), the biocatalysts showed robust perchlorate 
reduction (Figure 3.2). Activity decreased only at pH 6.0, with a 48% loss of activity, but even at 
pH 6.0, the values were not significantly different (P=0.10) from pH 7.0. A stronger response to 
temperature was observed, with a gradual decrease in activity as temperature decreased, 
culminating in a 68% decrease in activity when comparing activity at 10°C to 25°C. Using the 
Arrhenius equation, the activation energy of the biocatalysts was 45.6 kJ mole-1, and the pre-
exponential factor was ln (21.6) s-1. Data fit the equation with a coefficient of determination of 




Figure 3.2: Effect of pH on biocatalytic perchlorate reduction.  Results of MV assays conducted 
in Iowa GW with 1mM perchlorate. Activity is given in Units (U), defined as 1 μmol MV 
oxidized per minute, and are normalized to molybdenum as an indirect measure of PR 
concentration. Average and standard deviation of triplicate independent soluble protein fractions 
are presented. 
 
Figure 3.3: Effect of temperature on biocatalytic perchlorate reduction. Results of MV assays 
conducted in Iowa GW with 1mM perchlorate at specified temperature. Average and standard 
deviation of triplicate independent soluble protein fractions are presented. Black line indicates 
Arrhenius equation fit, and red lines indicate 95% confidence interval. 
No statistically significant differences in biocatalyst activity were observed over calcium 
and magnesium concentrations from 0 to 400 m L-1, although a slight decreasing trend might be 
occurring for calcium (Figure 3.4A), culminating with a drop in activity of 24.2%. Suwanee 
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River NOM also had no statistically significant impact on perchlorate-reducing activity over the 
range from 1-6 mg L-1 of NOM tested (Figure 3.4B). Slight differences in the zero-point 
reference activities are due to fluctuations in room temperature.  
 
Figure 3.4: Effect of calcium and magnesium (a) and NOM (b) on biocatalytic perchlorate 
reduction.  Results of MV assays conducted in a buffered system with 1mM perchlorate.  
Activity is given in Units (U), defined as 1 μmol MV oxidized per minute, and are normalized to 
molybdenum as an indirect measure of PR concentration. Average and standard deviation of 
triplicate independent soluble protein fractions are presented.  
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3.4.4. Alternative Electron Donors 
Previous studies on perchlorate reduction have used either MV or NADH/PMS as 
electron donors (e.g., 64, 70, 118). However, these compounds are relatively expensive. MV and 
PMS are also oxygen-sensitive. We therefore tested a variety of alternative organic electron 
donors: sodium acetate, ascorbic acid, citric acid, ethanol, formic acid, and sodium pyruvate. The 
electron donors tested in this study are common metabolites. In conditions without an additional 
electron shuttle, there was no detectable perchlorate removal.  
However, with the addition of 100 µM PMS as an electron shuttle, the results were more 
promising. Ascorbic acid showed the most potential to act as an electron donor for the 
perchlorate-reducing enzymes, achieving a statistically significant 32.0 ± 15.7% decrease as 
compared to the initial concentration of perchlorate (P=.028). With formic acid 14.3 ± 9.7% of 
the perchlorate was reduced as compared to the initial perchlorate concentration; however, the 
results were not statistically significant (P=0.086). Citric acid and pyruvate also were able to 
reduce perchlorate; however, these results were inconsistent across replicates, perhaps due to the 
involvement of an additional component from the soluble protein fraction. No perchlorate 
reduction was detected with acetate or ethanol. No perchlorate reduction was observed in 
controls without biocatalysts. 
As ascorbic acid with PMS demonstrated the most promise for perchlorate reduction, the 
rate of perchlorate reduction was tested for this system. Robust perchlorate reduction was 
observed, with 52.3 ± 8.4 % perchlorate reduced within the first hour (Figure 3.5). This initial 
perchlorate reduction rate corresponds to 2.2 µmol of perchlorate reduced per min per µg of 
molybdenum. For comparison to MV assay results, assuming the methyl viologen reaction 
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consumes 8 electrons for each perchlorate molecule, the perchlorate reduction rate for methyl 
viologen at 1mM perchlorate would be 19.6 µmol min-1 µg-1. Using ascorbic acid with PMS as 
an electron donor system, therefore, results in approximately an order of magnitude loss in 
activity. After six hours, over 99% of the perchlorate had been reduced. 
 
Figure 3.5: Biocatalytic perchlorate reduction with ascorbic acid and PMS. Reactions were 
conducted in buffer with an initial concentration of 1 mM perchlorate, and reaction progress was 
monitored by quantification of perchlorate. Average and standard deviation of triplicate 
independent soluble protein fractions are presented. 
3.5. Discussion  
This work demonstrates the activity of the perchlorate-reducing biocatalysts under 
application-appropriate conditions. Activities in real groundwater were only slightly lower than 
in laboratory buffered solutions, comparing to buffered values measured here and in previous 
reports.64, 118 Considering a broader range of typical groundwater conditions, the activity was 
relatively insensitive to pH, hardness, and NOM, and showed a gradual decrease with decreasing 
temperature. Substitution of ascorbic acid and electron shuttle PMS for MV resulted in 
approximately an order of magnitude drop in activity. Here we discuss these findings in the 
context of the literature and describe their implications for process design.  
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The half saturation constants measured here (91-105 µM) were within the range of 
reported values for PR and perchlorate, which span a bacterial consortium reported at 0.28 µM 
107 to 4700 µM for Dechlorosoma sp KJ with the electron donor acetate.47 They are higher than 
that published for purified PR from another A. oryzae strain, GR-1, which was 27 µM Km for 
perchlorate.70 This discrepancy could reflect differences in the PR encoded by these two strains, 
or it could be due to our use of soluble protein fractions rather than purified protein. Another 
component in the soluble protein fractions could cause some type of interference or competition 
that raises the apparent Km. If the affinity for perchlorate becomes a limiting factor for 
technology development, it should be possible to improve it by removing interfering factors 
and/or using a higher-affinity homolog.  
The effects of groundwater characteristics reported here are generally consistent with the 
limited information available in prior publications. Our soluble protein fraction has shown 
perchlorate-reducing activity as low as 5°C, with the highest activity at the highest temperature 
tested, 30°C. Purified PR from strain perc1ace has perchlorate-reducing activity in the range of 
20 to 40°C with optimal activity at 25 to 35°C.143 To our knowledge, no prior reports of 
activation energy for PR or CD exist, but a related enzyme, nitrate reductase, has activation 
energies of 41-42 kJ mol-1,144,145 very similar to the value of 45.6 kJ mol-1 reported here for 
perchlorate reduction. Work with strain perc1ace showed consistent PR activity over a pH range 
from 7.0 to 9.0, in agreement with our results.143 For strain GR-1, optimal CD activity is 
achieved at a pH of 6.0 and drops precipitously below 6.0.76 A direct comparison of our results 
with these CD results is, however, not possible, because the colorimetric assay used in our 
experiments measures the combined effects of PR and CD. To our knowledge, the effects of 
magnesium, calcium, and NOM on perchlorate reduction have not been previously studied. 
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The electron donors tested in this study were selected based on their occurrence in 
bacterial metabolism, which was anticipated to increase the likelihood of successful interaction 
with PR. However, these common electron donors were unable to donate electrons directly for 
perchlorate reduction; the addition of a shuttle was required. While the biocatalysts are able to 
reduce perchlorate in the presence of oxygen, at this point, the known options for supplying 
reducing power (MV or a shuttle with NADH or ascorbic acid) for biocatalytic perchlorate 
reduction all involve an oxygen-sensitive component. Biocatalytic treatment of perchlorate for 
drinking water, therefore, would require anaerobic operation of the system. Alternatively, 
development of an oxygen-stable electron donor or shuttle would provide a broader range of 
potential operational conditions. 
In comparison to ligand-enhanced rhenium complex/palladium catalysts under 
development for perchlorate reduction,146 the biocatalysts show much higher activity. To 
correspond as nearly as possible to the chemical convention of normalizing to the active site, we 
used the Mo-normalized values for the biocatalysts. Comparing perchlorate reduction rates at 1 
mM initial perchlorate, these chemical catalysts reduced 0.317 mmol perchlorate min-1 (mmol 
Rh)-1, compared to the biocatalysts’ rate of 1900 mmol min-1 (mmol Mo) -1. This represents a 
6000 fold higher activity for the biocatalysts. Another option is to compare the kcat for the 
biocatalysts (1716 min-1) to these chemical catalysts’ kobs value of 0.0415 min
-1 value: a 41,000 
fold larger turnover number for the biocatalysts. For large-scale application, the biocatalysts’ 
activity at neutral pH is also a significant advantage, as the chemical catalysts’ activities were 
reported at pH 3, where they are most active. 
Considering the implications of the kinetics reported here for practical application of the 
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biocatalysts, the best available basis for comparison is a recent life cycle analysis (LCA) of 
perchlorate treatment options. For traditional rhenium/palladium catalysts, this LCA projected 
that a 20-fold increase in activity was required for the technology to be competitive versus ion 
exchange and biological reduction.25, 31 Considering that the ligand-enhanced catalysts used as a 
comparison here already represent an approximately 140-fold increase in activity over the values 
used in the LCA,146 and that the biocatalytic activities reported in this work are orders of 
magnitude higher than the enhanced catalysts, suggests that a biocatalytic process will be 
competitive with existing technologies. However, a comprehensive evaluation of the costs and 
environmental impacts of the biocatalysts is needed to guide continued progress towards 
application. The results presented here provide a solid basis for conducting such an evaluation. 
This work also provides a basis for preliminary design calculations. For treatment of 
groundwater-sourced drinking water, in their current soluble form, the biocatalysts could be 
applied in batch reactors. Based on the kinetic results, a batch reactor operating at 25°C and an 
average HRT of 2 hours would require a dosing rate of 0.1 µg molybdenum equivalence of 
biocatalyst for each liter of water treated. This dosage corresponds to 280 µL of biocatalysts for 
each liter of water treated. If the pH were at or below pH 6.5, the dosage would be 0.15 µg 
molybdenum equivalence of biocatalyst each liter of water treated. Operating at 5°C would 
require dosing rates of 0.38 µg molybdenum equivalence of biocatalyst for each liter of water 
treated. From prior applications of enzymes industrially, there are also a variety of methods for 
immobilizing enzymes, which could be applied to PR and CD to reduce the dosage, costs and 
environmental impacts. Finally, it is important to note that while molybdenum is an essential 
trace element, it can also contribute to copper deficiency and cause toxic effects at high levels of 
consumption. However, even if all of the molybdenum was released from PR, these dosage 
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values are approximately two orders of magnitude lower than the reference dose limits for 
molybdenum of 5 µg kg-1 day-1 recommended by the US EPA.147  
3.6. Conclusions 
This work demonstrates the potential of biocatalysts for perchlorate reduction in drinking 
water treatment. The biocatalysts showed effective perchlorate reduction over a perchlorate 
range from 0.5µM to 1 mM, representing perchlorate contamination found in municipal drinking 
water to industrial/military industrial sites, in real groundwater and under typical ranges of 
groundwater characteristics. Preliminary design calculations suggest that perchlorate could be 
removed to concentrations less than the likely EPA regulation limit of 15 ppb with hydraulic 
retention times of 2 hours, supporting its practical potential, although a detailed economic and 
environmental assessment is still needed. 
The biocatalysts have advantages compared to traditional treatment technologies. As 
compared to the industry standard of ion exchange, the biocatalysts completely reduce 
perchlorate to innocuous chloride and oxygen and show minimal interference from competing 
anions nitrate and sulfate. In comparison to whole-cell based biological perchlorate remediation, 
the biocatalysts have a lower demand for electron donor, because they show specificity for 
perchlorate over nitrate. Because the biocatalysts are non-living, they should pose a lower risk 
and be more widely accepted for use in drinking water treatment. 
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CHAPTER 4: EVALUATING THE DEVELOPMENT OF BIOCATALYTIC 
TECHNOLOGY FOR THE TARGETED REMOVAL OF PERCHLORATE FROM 
DRINKING WATER 
This chapter has been published. The citation is Hutchison, J. M.; Guest, J.S.; Zilles, J. 
L., Evaluating the development of biocatalytic technology for the targeted removal of perchlorate 
from drinking water. Environmental Science and Technology 2017, 51, (12), 7178-7186. Explicit 
copyright permission is not required as I am the author of this work. I performed all the work in 
this chapter. 
4.1. Abstract 
Removing micropollutants is challenging in part because of their toxicity at low 
concentrations. A biocatalytic approach could harness the high affinity of enzymes for their 
substrates to address this challenge. The potential of biocatalysis relative to mature (non-
selective ion exchange, selective exchange, and whole-cell biological reduction) and emerging 
(catalysis) perchlorate-removal technologies was evaluated through a quantitative sustainable 
design framework, and research objectives were prioritized to advance economic and 
environmental sustainability. In its current undeveloped state, the biocatalytic technology was 
approximately one order of magnitude higher in costs and environmental impacts than non-
selective ion exchange. Biocatalyst production was highly correlated with costs and impacts. 
Realistic improvement scenarios targeting biocatalyst yield, biocatalyst immobilization for reuse, 
and elimination of an electron shuttle could reduce total costs to $0.034 m-3 and global warming 
potential (GWP) to 0.051 kg CO2 eq m
-3: roughly 6.5% of cost and 7.3% of GWP of the 
background from drinking water treatment and competitive with the best performing technology, 
selective ion exchange. With less stringent perchlorate regulatory limits, ion exchange 
technologies had increased costs and impacts, in contrast to biocatalytic and catalytic 
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technologies. Targeted advances in biocatalysis could provide affordable and sustainable 
treatment options to protect the public from micropollutants. 
4.2. Introduction 
A growing number of micropollutants are threatening drinking water supplies, with the 
problem exacerbated by the increasing water reuse required by growing populations and larger 
fluctuations in water availability caused by climate change.2, 148 Biocatalytic technologies could 
harness the speed and selectivity of biological enzymes to remove micropollutants under 
environmental conditions typical of drinking water. Compared to its current uses, such as 
pharmaceutical production,48, 149 the use of biocatalysts in drinking water or wastewater 
treatment represents a more challenging application: high volume, low-value products, and, for 
micropollutants, low concentrations compared to co-contaminants (often >3 orders-of-magnitude 
difference). To our knowledge, only two biocatalytic applications have been investigated for 
water or wastewater treatment: perchlorate reduction for drinking water treatment64, 150 and 
removal of phenolic compounds in wastewater treatment.61, 151 The economics and environmental 
impacts of biocatalytic water treatment have not previously been evaluated; we do so here for the 
endocrine-disruptor perchlorate.  
Perchlorate causes irreversible effects on mental development at low concentrations, with 
the US Environmental Protection Agency (EPA) proposing drinking water standards of 15 µg L-1 
and with stricter existing water regulations in California and Massachusetts (6 and 2 µg L-1, 
respectively).15-17 The best available technologies for perchlorate currently include whole-cell 
biological reduction and ion exchange.16, 96 However, these technologies are hampered by the 
low concentration of perchlorate and the low ratios of perchlorate to co-contaminating 
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compounds (often 1:1,000 to 1:10,000), as well as the costs and environmental impacts 
associated with resin regeneration and/or disposal. Reverse osmosis was excluded from this 
analysis due to its high costs and impacts.19, 152 Considering new technologies, palladium-
rhenium catalysts have been proposed for perchlorate removal.29 Biocatalytic treatment using 
perchlorate reductase and chlorite dismutase has also recently been demonstrated to selectively 
reduce perchlorate in groundwater samples.64, 150  
A fundamental understanding of the parameters governing sustainability tradeoffs in 
biocatalytic processes is critical to prioritize research and development and to protect both public 
health and our environment. To this end, we integrated performance models with techno-
economic analysis (TEA) and life cycle assessment (LCA) in a Monte Carlo framework to 
elucidate the economic and environmental implications of biocatalysis for drinking water 
treatment, using perchlorate as a model contaminant. Costs and impacts were compared to four 
alternative technologies at different stages of development and implementation, and results were 
leveraged to identify technology development pathways for biocatalytic processes. 
4.3. Methods 
4.3.1. Water Characteristics Distribution 
Data for anion concentrations were obtained from the United States Geological Survey 
(USGS) based on well samplings from ten states.153 Empirical distributions were created based 
on the five anions: perchlorate, nitrate, sulfate, bicarbonate, and chloride from wells with 
detectable perchlorate. Wells with more than 44 mg L-1 nitrate (<11.3% of wells) were excluded. 
For most technologies, these distributions were used to generate 10,000 random data sets using 
Latin Hypercube Sampling. For non-selective ion exchange, due to the use of high-throughput 
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computing, Monte Carlo was done to generate the distribution of 2,000 random data sets for 
influent anions. Ratios of water quality characteristics were analyzed using the two-sample 
Komolgorov-Smirnov test. Groundwater temperatures were assumed to have a uniform 
distribution from 5°C to 25°C. 
4.3.2. Perchlorate Treatment Models 
Perchlorate treatment models were developed in MATLAB 2015a for a biocatalytic 
perchlorate reduction process as well as one emerging (catalytic reduction) and three current 
(whole-cell biological reduction, non-selective ion exchange, and selective ion exchange) 
perchlorate treatment technologies. The basis for each model is summarized in Table 4.1 and 
described below, with additional details available in Sections C.1.1 - C.1.6 and model parameters 
in Table C.1 and Table C.2. Only the biocatalytic technology performance model incorporated 
the effect of temperature, as other technologies lacked sufficient data in the literature. After 
perchlorate removal, for technologies requiring re-aeration of the water (biocatalysis, catalysis, 
and whole-cell degradation), a target dissolved oxygen value of 6 mg L-1 was assumed.  
The biocatalysts were modeled kinetically, using the integrated form of the Michaelis-
Menten equation154 and assuming a reaction time of two hours, to determine the required dosing 
to achieve the designated effluent target. Kinetic parameters were from soluble protein fractions 
from the perchlorate-reducing bacterium Azospira oryzae strain PS (ATCC number BAA-33) and 
incorporated the effects of real-world groundwater components.150 Specifically, temperature 
effects were modeled using the Arrhenius equation (Equation 3.2) based on previous 
experiments,150 and the effects of competition from nitrate were modeled as non-competitive 
inhibition.64, 150 Other groundwater components have negligible effects.150 Substrate inhibition 
and product inhibition are also negligible, as detailed in Section C.1.2.76, 150 
64 
 
Table 4.1: Performance models for perchlorate removal technologies 
Technology Performance Equationa Impacts Considered 
    
Biocatalyst 𝑟𝑟𝑒𝑎𝑐𝑡𝑜𝑟 ∗ 𝛥𝑡 = 𝐾𝑚 ∗ (ln[𝑆𝑜] − 𝑙𝑛[𝑆1])
+ ([𝑆0] − [𝑆1]) 
Substrate (Equation C.8), 
Temperature (Equation 





ln[𝑆1] − ln[𝑆0] = −𝑟𝑅𝐸𝐴𝐶𝑇𝑂𝑅_𝐶𝐴𝑇 ∗ 𝛥𝑡 Substrate (Equation C.20), 
Inhibitorsb 
















Substrate (Equation C.25), 
Inhibitors (Equation C.25, 
Equation C.26, Equation 
C.27, Equation C.28) 
 
Selective IX [𝑆0] − [𝑆1]
𝑙𝑜𝑎𝑑𝑖𝑛𝑔 𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦
= 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑟𝑒𝑠𝑖𝑛 
Substrate (C.1.6)  
aVariable definitions: rreactor = maximum activity of the reactor, Δt = hydraulic retention time, 
Km = half saturation constant, S0 = perchlorate influent concentration, S1 = perchlorate 
regulatory limit, rreactor_cat = rate constant for chemical catalysts, TED = total electron donor, 
FED = fraction of electron donor, fe = fraction of electrons, K = equilibrium constant, RClO4 
= perchlorate sorbed to resin, RCl = chloride sorbed to resin, ClO4
− = bulk perchlorate 
concentration, Cl− = bulk chloride concentration. bThe impact of oxygen and nitrate were 
accounted for in the electron donor demand without modeling the mechanism for removal. 
cThe amount of electron donor was accounted for in the reduction of perchlorate but the 
kinetic effects of perchlorate concentration were not. 
 
For chemical catalysts, the performance model used first-order reaction rate kinetics to 
estimate catalyst dosing for the reactor.146 Oxygen and nitrate poison the chemical catalysts and 
must be removed.33 This was accounted for by increasing the amount of electron donor, without 
modeling the technology required to remove the oxygen and nitrate. The required pH adjustment 
before and after treatment was included in the costs and impacts. The catalyst was assumed to 
have a five-year life, for consistency with a previous LCA25 and to account for expected 
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improvements resulting from technology development, although to our knowledge this life span 
has not yet been demonstrated experimentally.  
The whole-cell bacterial reduction model was based on the stoichiometry for facultative 
perchlorate/nitrate-reducing bacteria,64 with acetic acid as the electron donor. The electron donor 
demand included the reduction of preferred electron acceptors oxygen and nitrate,45 in addition 
to perchlorate, with corresponding cell synthesis requirements for all three electron acceptors. As 
with temperature, the effects of perchlorate concentration on kinetics were neglected due to 
insufficient data in the literature.  
Performance of the non-selective ion exchange systems was modeled according to 
Guter20, 155 with published selectivity coefficients for perchlorate, nitrate, bicarbonate, and sulfate 
to chloride (Table C.1). The model assumed plug flow and instantaneous equilibrium of sorbed 
and aqueous phases156 and calculated the number of treatable bed volumes of drinking water. 
Because nitrate desorption from the resin could result in effluent nitrate concentrations greater 
than influent, the model terminated treatment and initiated regeneration as needed to prevent 
violation of regulatory limits (44 mg NO3
- L-1 or perchlorate).157 The computational intensity of 
the non-selective ion exchange performance model required the use of high-throughput 
computing using the Open Science Grid as detailed in Section C.1.5.  
The selective ion exchange system was modeled with perfect selectivity for perchlorate 
and complete saturation of the resin with perchlorate of 1,000 meq L-1. The assumption of perfect 
selectivity was required due to the computational intensity of the performance model. This 
assumption results in approximately an order of magnitude greater bed volume treatment 
compared to actual perchlorate-selective resins (again, presenting an optimistic scenario against 
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which to compare biocatalytic technology).158  
4.3.3. Sustainability Analysis 
TEA and LCA were used to determine net present value and life cycle environmental 
impacts of produced water, with LCA following ISO 14040/14044 standards.159, 160 Perchlorate 
treatment was analyzed assuming a 1,000,000 gallon per day (3,790 m3 day-1) drinking water 
treatment system and a functional unit of 1 m3 of drinking water of perchlorate removal to a 
designated treatment level of 15, 10, 6, or 2 µg L-1. In all scenarios, perchlorate was the only 
contaminant exceeding regulations, so costs and impacts were directly attributed to perchlorate 
removal. The system boundary included production and operation of the perchlorate treatment 
technology, with the manufacture of the treatment material, transportation, chemical inputs for 
operation, electricity, and waste disposal taken into account. Construction and demolition of the 
facility were excluded because their contributions accounted for less than 1% of total 
environmental impacts and due to the high degree of uncertainty associated with final treatment 
design for new technologies (biocatalysts and chemical catalysts). The Life Cycle Impact 
Assessment, including life cycle emissions, were quantified using the ecoinvent database 
accessed via SimaPro (v8; PRé Consultants) using unit default allocation. Normalization was 
performed using the Tool for the Reduction and Assessment of Chemical and Other 
Environmental Impacts (TRACI) version 2.1 to determine the environmental impact of raw 
materials and direct emissions,161 and the impacts were imported into MATLAB. No other 
normalization was performed.  
Monte Carlo with Latin Hypercube Sampling was used to address uncertainty in 84 
parameters across the performance and technology landscape. This analysis was conducted using 
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10,000 trials for biocatalytic reduction, chemical reduction, whole-cell biological reduction, and 
selective ion exchange. For the non-selective ion exchange technology, 2,000 trials were 
conducted, in consideration of the computational intensity of the performance model. For the 2 
ppb regulatory limit, representativeness of the results from 2,000 trials was confirmed by 
comparison to results from 4,000 trials. The sensitivity of the technologies to inputs was 
determined by Spearman’s Rank-Order Correlation.162, 163 Median values are presented, unless 
otherwise noted, and were analyzed using Mood’s Median test. 
4.3.4. Materials Flow Analysis  
When evaluating the feasibility of new technologies, it is important to ensure that the raw 
materials could be available. Material flow analysis was therefore also considered for metals 
used in biocatalytic and catalytic perchlorate removal.164 Total amounts of the molybdenum, 
rhenium, and palladium were determined by extrapolating to 4% of drinking water treatment in 
the United States,165 based on the 2010 estimate for waters requiring perchlorate treatment to 4 
µg L-1.165, 166 Required amounts were compared to 2013 US production levels of molybdenum167 
for biocatalysts, and rhenium168 and palladium169 for chemical catalysts.  
4.4. Results and Discussion 
4.4.1. Water Quality Distributions 
Perchlorate removal technologies differ in their sensitivity to the concentration of 
competing anions; thus it was important for our analysis to have realistic distributions for anion 
concentrations. We therefore derived our groundwater compositions from USGS data,153 
focusing on groundwaters with perchlorate contamination and nitrate below the EPA limit for 
nitrate (<44 mg L-1 as nitrate). Our dataset included 88.7 % of the perchlorate-contaminated 
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wells, 72.9% with nitrate below the regulatory limit and another 15.7% for which no nitrate 
measurements were reported. These restrictions allowed us to directly compare the costs and 
impacts associated with perchlorate removal for different technologies.  
Empirical anion distributions from the USGS data were used to generate larger data sets 
for chloride, bicarbonate, sulfate, nitrate, and perchlorate concentrations in groundwater sources. 
The generated distributions were in good agreement with anion distributions from well data (p > 
0.05). The ratios of anions to perchlorate were also in good agreement with the empirical data 
(Figure C.1). Although only ten states are included in the USGS’s groundwater sampling for 
perchlorate,153 this approach is likely to provide a better representation of real contamination 
scenarios than the alternative approach of assuming a uniform distribution.  
4.4.2. Biocatalytic Treatment – State of Technology 
To assess the potential of biocatalytic water treatment, an initial assessment of the 
biocatalysts was performed assuming a worst case scenario with no reuse of the biocatalysts. In 
this scenario, cell extracts were used in a batch system, with the addition of electron donor and 
electron shuttle. This treatment process would not require substantial technology development 
beyond current capabilities and thus was chosen as the baseline scenario. The costs and 
environmental impacts of the biocatalytic treatment were determined for an effluent water 
quality of 2 µg L-1 – the strictest state standard currently in effect. The effects of different 
regulatory limits are considered later.  
Under this single-use scenario, the total cost for biocatalytic treatment had a median 
value of $1.92 m-3, nearly four times the average price to the consumer for drinking water in the 
United States ($0.53 m-3).157 However, the average price to the consumer does not represent the 
69 
 
additional costs associated with the specialized treatment of micropollutants on a wide scale. 
Non-selective ion exchange treatment of perchlorate to below 6 µg L-1 had estimated operation 
and maintenance costs of $0.267 m-3.103 In its current, relatively undeveloped state, the 
biocatalytic treatment is therefore nearly one order of magnitude more expensive than a current 
technology. Biocatalytic costs were primarily driven by the production of the biocatalysts (61.3% 
of total cost) (Figure 4.1a), which stemmed largely from components of the production media. 
Specifically, buffer (32.2%), acetic acid (18.1%), and perchlorate (13.3%) were the top three 
contributors. Electricity also played a role in the cost of producing the biocatalysts, contributing 
13.2% of the production cost. For operating costs, the electron shuttle represented the bulk of the 




Figure 4.1: Factors contributing to costs (a and b) and global warming potential (GWP) impacts 
(c and d) of the baseline scenario for biocatalytic technology (Table C.2). (a) Median cost per m3 
of produced drinking water for each component. (b) Spearman’s rank correlation coefficients for 
each component and total cost. (c) Median GWP of each component represented as kg CO2
 eq m-
3 of drinking water (additional environmental impacts shown in Figure C.2). (d) The correlation 
of components’ GWP impacts to the total GWP. Factors are classified within the categories of 
biocatalyst production (red), technology operation (blue), biocatalyst parameter (green), or 
influent water characteristics (orange). Positive correlations in (b) and (d) indicate that increasing 
the component correlates with increases in the total cost or total GWP, respectively. *Individual 
media components were aggregated into a representative media term. 
The dominant sources of costs were well correlated with the total cost of the biocatalytic 
technology. Positive correlations indicate that changes in a particular component correspond with 
changes in the same direction for the cost or GWP. Conversely, a negative correlation indicates 
that changes in a particular component correspond with changes in the opposite direction for the 
cost or GWP. For example, in this study, the cost data showed strong and positive correlations 
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with the production process (0.948), including the media (.947), electricity consumption (.916), 
and material transportation (.902) (Figure 4.1b), indicating that increasing the materials in the 
production process generally resulted in an increase in the cost or GWP. For correlation data, 
individual media components were aggregated into the representative media term, as no 
uncertainty was placed on individual media components, and all media components had strong, 
positive correlations with the total cost of the biocatalytic technology.  
The operation of the biocatalytic process showed less of a correlation (0.318), except for 
transportation of materials to the treatment site (0.756). Parameters connected to the biocatalysts 
and influent water characteristics behaved as expected. For example, the kinetic parameter 
maximum velocity (Vmax) had a negative correlation with total cost (-0.572); an increase in 
activity of the biocatalysts would decrease the required dosing for a given hydraulic retention 
time, thereby decreasing costs. Positive correlations with total cost were observed with 
perchlorate-associated electron donor consumption (0.722) and nitrate-associated electron donor 
consumption (0.420).  
Considering the environmental impacts of biocatalytic treatment under the same single-
use scenario, the global warming potential (GWP) of the biocatalysts had a median value of 3.72 
kg CO2 eq m
-3 of produced drinking water (results for nine additional LCA impact categories are 
presented in Figure C.2). For comparison, conventional groundwater treatment, without 
perchlorate removal, has been estimated to produce 0.698 kg CO2 eq m
-3, while the high purity 
water produced by reverse osmosis has correspondingly higher impacts: 2.47 to 5.6 kg CO2 eq 
m-3.152 As with cost, production of the biocatalysts contributed most of the GWP, with a median 
value of 3.42 kg CO2 eq m
-3 of drinking water (Figure 4.1c). Components of the production 
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media made up 83.7% of these impacts, with electricity consumption (15.8%) and material 
transportation (0.488%) making up the remaining impacts. Operation of the biocatalytic 
perchlorate treatment process contributed 0.291 kg CO2 eq m
-3, with the electron shuttle (79.5%) 
and electricity consumption (14.4%) comprising a majority of these impacts. The correlation data 
for GWP (Figure 4.1d) showed similar trends as those described above for cost.  
In this initial assessment, the biocatalytic technology had costs and impacts greater than 
standard groundwater treatment without micropollutant removal, but in both cases, these values 
were less than an order of magnitude higher. These results are promising for a technology at such 
an early stage of development. Further reduction in costs and impacts are expected as the 
technology progresses: a trend not uncommon in the development of drinking water treatment 
technologies. For example, over forty years of development in reverse osmosis has decreased 
electricity consumption by an order of magnitude.86 With further work, biocatalytic technology 
experience curves for high volume processes may be developed and allow predictions of cost 
reductions.170 Furthermore, the results of this initial assessment suggest specific directions for 
technology development, beginning with the production of the biocatalysts. 
4.4.3. Biocatalytic Treatment – Research and Development Prioritization 
To evaluate and prioritize potential technology innovation pathways for biocatalytic 
treatment, we focused on system components driving costs and GWP impacts. Since biocatalyst 
production was the dominant economic and environmental burden of the baseline scenario, it 
was prioritized as the first pathway for improvement. This could be accomplished by increasing 
yield, implementing reuse, or utilizing both methods. 
Biocatalyst yields vary significantly depending on the cultivation method, carbon source, 
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and medium. The medium and growth condition used in this analysis were based on laboratory-
scale production and have not been optimized, so improvements are likely. For example, yield 
improvements of 7.5 to 35 fold have been obtained for other enzymes by varying the medium 
and/or strain.171, 172 Two different perchlorate-reducing strains also showed a four-fold difference 
in the yield of perchlorate reductase activity per liter of culture media,64, 70 suggesting that 
improvements can be obtained. Based on these values, and on additional examples included in 
Section C.2.3, we analyzed the potential impacts of a ten-fold increase in biocatalyst yield per 
liter of media. Realizing this improvement would reduce the total cost from $1.92 to $0.71 m-3 
and GWP from 3.72 to 0.627 kg CO2 eq m
-3 (Figure 4.2). Reuse of biocatalysts is an alternative 
approach to reduce costs and impacts associated with production. Several methods of possible 
immobilization for biocatalysts are available,49 and have in some cases also been used to 
improve upon biocatalytic efficiency and stability,173 although the effects of immobilization vary 
for different enzymes and immobilization methods. As detailed in Section C.2.2, considering the 
available literature and known characteristics of the perchlorate-reducing biocatalysts, it appears 
likely that catalytic inactivation of chlorite dismutase will be the limiting factor for reuse. We, 
therefore, considered the impacts of reusing the biocatalysts for no more than 1,000 bed volumes 
based on this constraint. Given the considerable uncertainty around the effects of immobilization 
and the variety of options available for implementing reuse, and to facilitate comparisons, the 





Figure 4.2: Effects of biocatalytic technology improvements on the cost and GWP impacts per 
m3 of drinking water. Improvements examined included increasing the biocatalytic yield (a five-
fold yield would be 500% more biocatalysts relative to the base scenario of 1) (x-axis, 
logarithmic scale), reusing the biocatalysts for multiple bed volumes (y-axis, logarithmic scale), 
and elimination of the electron shuttle (b, d). (a) Decreasing costs as the biocatalysts are reused 
in treatment and the biocatalytic yield is improved. (b) Elimination of the electron shuttle 
decreases costs further. Reference lines of $0.80 m-3,19 $0.36 m-3,103 and $0.06 m-3 are shown as 
high-end cost of reverse osmosis (RO), a previous estimate of the cost to remove perchlorate 
using ion exchange technology (IX), and the estimated cost of the improved biocatalyst 
technology, respectively. (c) The decreasing GWP impacts associated with improvements to the 
use and production of the biocatalysts. (d) The GWP impacts with biocatalyst improvements and 
the elimination of the electron shuttle. The reference lines of 2.47 kg CO2 eq m
-3, 0.7 kg CO2 eq 
m-3, 152 and 0.05 kg CO2 eq m
-3 indicate emissions from reverse osmosis (RO) treatment, 
standard groundwater treatment (GW), and with the improved biocatalysts evaluated in this 
study, respectively. 
Retaining and reusing the biocatalysts up to 1,000 bed volumes, without increased yield, 
would reduce the costs from $1.92 m-3 to $0.595 m-3 and GWP impacts from 3.72 to 0.287 kg 
CO2 eq m
-3. These values do not take into account the support material or other additional 
materials, due to the high uncertainty regarding the specific immobilization method, but low 
impact immobilization methods could likely be developed.49 Mass transfer limitations may also 
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be significant (depending on the implementation), but the lack of experimental data from 
immobilized perchlorate-reducing biocatalysts and the wide range of immobilization options 
presented too much uncertainty for productive consideration of those impacts here. It is worth 
noting that these results suggest realizing the full potential of only one improvement – increasing 
yield or achieving reuse – would be needed to improve the sustainability of biocatalytic 
perchlorate treatment. Because yield improvements and biocatalyst reuse both impact production 
costs, combining them does not offer substantial additional benefits, achieving costs of $0.593 m-
3 (Figure 4.2a) and GWP impacts of 0.284 kg CO2 eq m
-3 (Figure 4.2c). 
As the target improvements in either production yield or biocatalyst reuse are 
approached, operational impacts begin to govern technology sustainability. In its current 
implementation, an organic electron donor such as ascorbic acid or acetate supplies electrons for 
biocatalytic perchlorate reduction. However, an electron shuttle is required for this process. In 
addition to incurring costs and impacts from their synthesis, the electron shuttles known to be 
effective are also oxygen sensitive, requiring removal of oxygen from the water before 
perchlorate removal and then re-aeration before distribution to the population. Identifying 
oxygen-stable electron donors that interact directly with the biocatalysts would eliminate the 
shuttle and the oxygen sensitivity, significantly reducing costs and environmental impacts. 
Identification of a safe and effective direct electron donor, in combination with the yield and/or 
reuse improvements detailed above, could decrease total cost to $0.0343 m-3 (Figure 4.2b) and 
GWP to 0.0511 kg CO2 eq m
-3 (Figure 4.2d), representing 6.5% and 7.3% of the cost and GWP of 




4.4.4. The Technology Landscape 
To fully evaluate the feasibility of biocatalytic perchlorate removal, this novel technology 
was compared to one emerging and three existing perchlorate removal technologies for removal 
of perchlorate to 2 µg L-1 (Figure 4.3). The emerging technology was palladium/rhenium 
catalysis,29 a new field for large-scale water treatment despite the established use of transition 
metal catalysis in chemical synthesis.174 The existing technologies included whole-cell bacterial 
perchlorate reduction, non-selective ion exchange, and perchlorate-selective ion exchange. 
Because our primary aim was to evaluate the feasibility of biocatalytic treatment, we generally 
chose optimistic or best-case scenarios for the competing technologies, resulting in a more 
conservative analysis. For example, the effects of temperature were only considered for the 
biocatalytic technology, not any of the other technologies. 
For the chemical catalysts, a five-year life span was assumed to bring costs and impacts 
into the range of the other technologies being considered. To our knowledge, this target has not 
yet been achieved experimentally. With this assumption, the median values for the chemical 
catalysts were $0.108 m-3 and 0.119 kg CO2 eq m
-3. For the whole-cell technology, effects of 
substrate affinity were not included. The median values for the whole-cell system were lower, 
$0.0399 m-3 and 0.0649 kg CO2 eq m
-3. This GWP is comparable to an earlier study value of 0.03 
kg CO2 eq m
-3 that examined perchlorate removal at concentrations of 50 µg L-1 down to 6 µg L-1 
with 20 mg L-1 nitrate.25 Slight differences could be accounted for by the inclusion of a wider 




Figure 4.3: Comparison of the biocatalytic technology (A, grey) and the improvements of 
increasing biocatalyst yield (B, blue), reusing the biocatalysts up to 1,000 bed volumes (C, 
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Figure 4.3 (cont.) green), and eliminating the electron shuttle (D, pink). The biocatalytic 
technology in its current state (A) and with targeted improvements (B to D, moving top to 
bottom in each impact category) was compared to rhenium/palladium catalysis (CR), whole-cell 
biological reduction (BR), non-selective ion exchange (NS), and perchlorate-selective ion 
exchange (IS). Scales in the figure are normalized to m3 of drinking water. The technologies 
were compared using their costs ($ m-3) and ten environmental impacts. These impacts include 
global warming potential (GWP, kg CO2 eq m
-3), ozone depletion (Oz, kg CFC-11 eq m-3), smog 
(Sm, kg O3 eq m
-3), acidification (kg SO2 eq m
-3), eutrophication (Eu, kg N eq m-3), carcinogens 
(Car, CTUh m-3), non-carcinogens (N-Car, CTUh m-3), respiratory effects (R. Effects, kg PM 2.5 
eq m-3), ecotoxicity (Eco, CTUe m-3), and fossil fuel depletion (FF Depletion, MJ surplus m-3). 
Double bar on graph lines indicates a change in scale. 
Non-selective ion exchange is widely used by drinking water utilities, so existing data are 
more likely to reflect the technology’s potential and fewer assumptions were required. We did 
use optimistic parameters for regeneration, assuming a 6% brine solution with only 2.5 bed 
volumes of solution achieved complete regeneration of the resin, although we did not consider 
options for regeneration and reuse of the brine.103, 175 Under this scenario, the median values for 
non-selective ion exchange were $0.111 m-3 and 0.164 kg CO2 eq m
-3. For the perchlorate-
selective ion exchange system, we assumed a best-case scenario of perfect selectivity. We also 
considered modeling currently achievable selectivities and including regeneration,139, 176 but that 
approach is likely to give lower performance and therefore not provide the most rigorous 
comparison. The computational intensity of that model would also have prevented us from 
conducting uncertainty analysis and from evaluating different regulatory limits. Under the 
assumption of perfect selectivity, the selective system had median values were $0.0261 m-3 and 
0.0434 kg CO2 eq m
-3. The GWP values in this study are similar to a previous study of 0.011 kg 
CO2 eq m
-3;25 the electrical requirements included in this study account for the majority of the 
difference. 
Across the five technologies, the current state of biocatalytic treatment had the highest 
costs or impacts in most categories, as expected, whereas selective ion exchange had the lowest 
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(Figure 4.3). Non-selective ion exchange had the highest impacts in ozone depletion, and 
chemical catalysis had the highest impacts in the non-carcinogens and ecotoxicity categories. 
With targeted innovation focusing on yield and/or reuse, as well as the electron shuttle, 
biocatalytic technology could match the economic and environmental sustainability of even the 
best competing technologies (selective ion exchange under optimistic performance predictions) 
for perchlorate removal (Figure 4.3). 
4.4.5. Effect of Regulatory Levels 
To understand the effects of different regulatory limits, USGS data on perchlorate in 
groundwater153 were first used to evaluate how many wells would require treatment at 
perchlorate standards as low as 1 µg L-1, a public health goal in California.89 Increasingly 
stringent regulations exponentially increased the number of wells requiring perchlorate treatment 
(Figure C.7, R2=0.998). The increase in wells under more stringent regulatory limits was due to 
the added treatment of wells with low influent concentrations, which lowered the median influent 
perchlorate concentration in drinking water sources requiring perchlorate removal (Figure C.7). 
This effect of different regulatory limits on the median influent perchlorate concentration is an 
important consideration in understanding how the technologies respond to different regulatory 
limits. 
For biocatalysts, due to non-linear change in activity with perchlorate concentration and 
the favorable kinetics of starting at higher influent perchlorate concentrations, the required 
dosing was actually lower at treatment targets of 10 and 15 µg L-1 than at 2 or 6 µg L-1. In 
addition, the electron donor requirements were lower for effluent targets of 6, 10, and 15 µg L-1. 
No statistically significant difference was observed between effluent targets of 2 and 6 µg L-1 for 
80 
 
the cost medians (P=0.89) and the GWP impact medians (P=0.55). However, a significant drop 
in costs and GWP impacts was observed for effluent targets of 10 and 15 µg L-1 (P<0.001) 
compared to the 2 µg L-1 values (Table 4.2).  
Table 4.2: Median cost and GWP for different regulatory limits of perchlorate 
Technology Cost ($ per m3)  GWP (kg CO2 eq. per m
3) 
     
Regulatory Limit 
(µg L-1) 
2a 6 10 15 2a 6 10 15 








0.0343 0.0343 0.0337 0.0330 0.0511 0.0491 0.0478 0.0476 
Chemical Catalyst 
 









0.111 0.117 0.121 0.120 0.164 0.172 0.181 0.177 
Selective Ion 
Exchange 
0.0261 0.0285 0.0296 0.0307 0.0434 0.0444 0.0450 0.0457 
a Values from Figure 4.3 
 
For chemical catalysts, the costs and impacts also decreased slightly with less stringent 
regulatory limits. This decrease is rooted in the relationship of the favorable kinetics of starting 
at higher perchlorate concentrations, despite the increasing median perchlorate removal required 
at higher regulatory limits (Figure C.7). In contrast to biocatalysts, electron donor requirements 
held steady for the chemical catalysts, as the change in perchlorate treatment was small 
compared to the concentrations of nitrate and oxygen.  
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For both ion exchange technologies, less stringent regulatory limits resulted in higher 
costs and environmental impacts (Figure C.5 and Figure C.6), reflecting the higher median 
influent perchlorate concentrations under these scenarios (Figure C.7). The higher median 
influent reduced the performance as measured in bed volumes of the non-selective ion exchange 
(Figure C.8), requiring more ion exchange resin. Overall, less stringent regulatory limits resulted 
in lower median costs and environmental impacts for catalytic technologies, but higher median 
costs and environmental impacts for ion exchange technologies. However, the additional wells 
from increasingly stringent limits would increase the total cost to the country for perchlorate 
treatment.  
4.4.6. Rare Material Flow Analysis 
In addition to competitiveness in terms of performance and cost, adoption of a new 
technology requires that the materials be available on the appropriate scale. For the two emerging 
technologies, biocatalytic and catalytic reduction, we assessed the feasibility from a material 
flow perspective,164 determining the required quantity of rare metals and comparing that to 
current production levels. For biocatalytic treatment, the estimated amount of molybdenum 
required for perchlorate treatment was 160 kg per year, less than 0.00027% of domestic 
production (Figure C.9). Realizing the improvements assessed in this study would decrease 
consumption further. These values suggest molybdenum availability would not restrict the use of 
biocatalytic perchlorate removal. Again assuming the proposed five year lifetime of the catalysts 
can be achieved,25 the chemical catalyst approach would require 1,950 kg of both rhenium and 
palladium. This corresponds to 27.5% of rhenium and 15.5% of palladium of 2013 U.S. 
production, which presents a feasibility concern. Shorter catalyst lifetimes would exacerbate this 
concern. Palladium and rhenium also both score higher than molybdenum in the criticality space: 
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supply risk, vulnerability to supply restriction, and environmental implications.164 
4.5. Implications  
This study demonstrated that biocatalytic perchlorate degradation has the potential to be 
competitive, in terms of both costs and environmental impacts, with existing methods for 
perchlorate removal. Furthermore, it identified specific targets for technology development: 
increasing the biocatalysts’ production yield and/or achieving biocatalyst reuse, as well as 
eliminating the oxygen-sensitive electron shuttle. With the improvements identified here, the 
estimated costs and environmental impacts were less than non-selective ion exchange and on par 
with perchlorate-selective ion exchange.  
Four important points should be noted about this study. First, in contrast to ion exchange, 
biocatalytic, chemical, and whole-cell bacterial perchlorate reduction convert the contaminant 
into innocuous compounds, preventing reintroduction into the environment. This advantage is 
difficult to quantify, because the reintroduction of perchlorate from water treatment processes has 
not been studied, and was not included in our work. However, perchlorate contamination has 
been detected in the Colorado River and could indicate contamination of and cycling in 
municipal treatment.18 Second, as with any new material, the safety of biocatalysts has not been 
tested directly and would need to be verified. A complete risk assessment for the performance of 
the biocatalytic technology would also need to be performed prior to widespread and large-scale 
implementation, incorporating the specific characteristics of the treatment configuration(s). 
Third, because our aim was to rigorously evaluate the potential for biocatalytic treatment to 
compete with alternative technologies and to prioritize research and development needs, some 
optimistic assumptions were made for competing technologies. The results shown here for the 
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competing technologies reflect those optimistic assumptions and may not be directly applicable 
to other research questions. Fourth, the approach applied here did not consider scenarios 
requiring removal of multiple contaminants. While not ideal for targeted perchlorate removal, 
processes such as non-selective ion exchange and reverse osmosis may offer advantages for 
source water compositions requiring the removal of multiple contaminants.  
Overall, these results suggest that the application of biocatalytic technologies in water 
and wastewater treatment could provide environmental engineering with a new toolbox to 
remove contaminants and enable more deliberate water reuse.  
4.6.  Supporting Information 
Additional supporting information for this chapter is located in Appendix C and includes 
equations and parameters used in production and performance models, water quality 
distributions, additional correlation data, additional environmental impact category data, and the 
effects of regulatory limits on wells requiring treatment, performance of non-selective ion 
exchange, and metal consumption.  
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CHAPTER 5: ACTIVITY MEASUREMENTS AND PERFORMANCE MODELING OF 
AN IMMOBILIZED BIOCATALYST  
Yihan Zhang assisted with the construction of the Strep-tagged Cld from Ideonella 
dechloratans and initial work for incorporation of PcrA in pBAD. Indran Kamalanathan assisted 
with the collection of the preliminary activity data for the Strep-tagged Cld column activity and 
collected the data for the free and attached biocatalyst batch activities. I developed and fit the 
activity, mass transfer, and combined models. 
5.1. Introduction 
Traditional drinking water treatment technologies are unable to target micropollutants 
such as perchlorate in complex environmental matrices. To advance targeted destruction of 
micropollutants, biocatalytic technologies have been proposed and are characterized by rapid, 
targeted destruction.64, 150 However, a recent technoeconomic and life cycle analysis found that 
improvements to the biocatalyst’s sustainability are required before the technology is 
competitive with current drinking water treatment technologies (Chapter 4).179 One suggested 
improvement was achieving reuse of the biocatalysts, and this improvement is the focus of this 
study. To achieve reuse, three general immobilization strategies are available. These include 
support,49 covalent binding, and entrapment.180 However, none of the specific biocatalyst 
examples have been developed for drinking water treatment.  
Immobilization to support materials is achieved by adsorption and affinity attachment. 
Adsorption of the biocatalysts is maintained by hydrophilic/hydrophobic interactions. This 
method has been utilized for biocatalyst purification and attachment in sensors. For biocatalyst 
purification, chlorite dismutase76 and perchlorate reductase69 were able to sorb to hydroxyapatite. 
In theory, this approach could be ideal for environmental applications due to its low cost. 
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However, these attachments can be reversed using simple salt solutions. This facile reversibility 
is a significant drawback, as the biocatalysts would leach.173 In a sensor, perchlorate reductase 
was immobilized to the surface of an electrode.115 Using a Nafion-treated glassy carbon 
electrode, perchlorate reductase was applied to the surface and air dried. To assure that the 
perchlorate reductase did not desorb from the electrode, a dialysis membrane was used to hold 
the perchlorate reductase in place. However, this process introduced mass transfer limitations 
and is unsuitable for water treatment applications. The second support-immobilization strategy is 
affinity attachment. Like adsorption, affinity attachment is maintained by 
hydrophilic/hydrophobic interaction but the biocatalysts and support material have been designed 
to enhance the bonds. For biocatalyst purification, chlorite dismutase from Nitrobacter 
winogradskyi,116 Candidatus Nitrospira defluvii,117 and Ideonella dechloratans77 have been 
modified to include a His-affinity tag.77 This tag has a strong affinity for nickel(II) metal as well 
as other metals. The His-tag could be used in environmental applications as long as the 
concentration of metals such as nickel was low. For this study, the Strep-tag was used. However, 
the materials for resin beads used for tagged proteins are expensive.  
Covalent binding includes the covalent attachment of the biocatalysts to a surface or the 
covalent linking in aggregates. Examples of this approach are the use of spores and cross-linked 
enzyme aggregates (CLEAs). Spores are specialized cells used in spore display. These cells are 
synthesized in a mother cell and then released. Spore display involves engineering 
microorganisms to produce the desired biocatalyst and localize it on the surface of the spores 
(reviewed in 181, 182). Spore display is considered a covalent attachment mechanism for this 
dissertation as the biocatalysts are covalently attached to a spore-coat protein. Microorganisms 
from the genera Bacillus and Saccharomyces have been used in spore display. The benefit of the 
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spore-displayed approach is that the organism immobilizes the biocatalysts, and the spore cells 
are dormant and remarkably stable.183, 184 However, the spores are still small (diameter of ~1µm) 
and would require further immobilization or recapture mechanisms for environmental 
applications. The construction of CLEAs is performed by cross-linking the biocatalysts. Initial 
CLEAs were formed with glutaraldehyde;185 however, in certain cases, the cross-linking agent 
caused damage to the biocatalysts. This was potentially due to the small size of the cross-linking 
agent penetrating individual biocatalyst’s structure and crosslinking within a biocatalyst rather 
than across biocatalysts. To resolve this problem, larger cross-linking agents have been 
utilized.186 For environmental applications, CLEAs are appealing as they do not require external 
support material; the biocatalysts are the support material. However, like spore display, the 
aggregates are small and would require additional immobilization or recapture strategies.187 To 
my knowledge, no known examples of this immobilization strategy have been utilized for 
perchlorate reductase and chlorite dismutase.  
Entrapment is the third immobilization strategy.113 Biocatalysts can be entrapped in 
materials such as gelatin, alginate, and solgel (reviewed in 173, 188, 189) or encapsulated in lipids 
and synthetic polymers.64 For perchlorate reductase and chlorite dismutase, I achieved 
encapsulation of the biocatalysts in vesicles using synthetic polymer membranes (Chapter 2).64 
The benefit to this immobilization approach is that it is a generalized method suitable for most 
biocatalysts. However, the entrapment of the biocatalysts can introduce significant mass transfer 
limitations. These limitations can be alleviated by proper selection of entrapment material49 or 
the incorporation of pores for encapsulation.121 
Attachment and entrapment can result in a decrease in the observed activity at low 
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substrate concentrations due to mass transfer limitations.49 To explore the decreased activity, data 
was used to develop and calibrate models incorporating kinetic and mass transfer parameters. 
Several studies have developed models for activity and mass transport. The activity of the 
biocatalysts has been well modeled by the Michaelis-Menten equation190 (translation191). Under 
the assumption of steady-state, the activities are determined from an initial, short time interval of 
the reaction. These conditions minimize the impact of changes in the substrate concentration and 
the potential of product inhibition. Using a plot of biocatalytic activity versus substrate 
concentration, the kinetic parameters of the biocatalysts, maximum activity (Vmax) and the half-
saturation constant (Km), can be determined. The kinetic parameter, Vmax, is comprised of the 
biocatalytic rate constant, kcat, and the biocatalyst concentration. This often results in a Vmax with 
units corresponding to a change in substrate concentration over time (moles L-1 s-1), with the 
understanding that a specific amount of biocatalysts has been added to the system. Recent work 
for perchlorate reductase150, 192 and chlorite dismutase83 have reported Vmax  normalized to their 
respective metal content, molybdenum and iron (heme). However, collecting the data points 
required to fit kinetic parameters is time consuming. Later research efforts focused on creating an 
integrated form of the Michaelis-Menten equation so that the kinetic parameters, Vmax and Km, 
could be determined from longer observations of a single experiment.154 Using predetermined 
kinetic parameters, the integrated form of the equation was used to model performance of 
perchlorate-reducing biocatalysts in a batch system.179 The required biocatalytic dosing was 
calculated to achieve reduction of perchlorate.179 Another study used this integrated form to 
model the performance of packed-bed columns, but the model could not account for mass 
transfer limitations.193  
Mass transfer limitations are another critical component when modeling immobilized 
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biocatalysts. Fick’s First Law of Diffusion has been used to model the diffusion of a substrate to 
the biocatalysts on an immobilized surface.194 The authors concluded that the activity of the 
biocatalysts could be determined by using either the Michaelis-Menten equation or the mass 
transfer equation. This required the assumption that the substrate concentration at the 
immobilized surface was equivalent in both equations, and the Michaelis-Menten and mass 
transfer equations were set equal. While it is difficult to measure substrate at the surface, 
simplifications have been made assuming very large or small substrate concentrations.194  
To advance biocatalytic technologies, development of immobilization mechanisms 
suitable for drinking water treatment are required. To that end, molecular techniques were 
utilized to create modified biocatalysts facilitating affinity attachment. Using a chlorite 
dismutase capable of affinity attachment, preliminary activity data was collected for 1) free 
biocatalysts in a batch reaction (free biocatalyst), 2) resin bead-attached biocatalysts in a batch 
reaction (attached biocatalyst), and 3) resin bead-attached biocatalysts packed into a column 
(column-packed biocatalyst). Efforts to create an affinity attached perchlorate reductase and a 
spore-displayed chlorite dismutase were not successful (Appendix D). To understand the 
tradeoffs in activity and attachment, models were developed and fit to quantify the impact of 
immobilization on the activity of chlorite dismutase. Utilizing the Michaelis-Menten and mass 
transfer equations, modeling of the biocatalysts was performed in the three scenarios. Additional 
efforts were made to combine the Michaelis-Menten and mass transfer equations into a single 
model. The second Damköhler numbers, a unitless ratio comparing the kinetic and mass transfer 
limitations, were calculated to determine when the activity of the biocatalysts was limited by 
kinetics or mass transfer. Using these models based on first-principle concepts, an understanding 
of the system mass transfer limitations was gained. This information could be used for 
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optimizing the system and promoting the sustainability of biocatalytic applications.  
5.2. Materials and Methods 
5.2.1. Chemicals, Media, and Buffers 
A summary of the media types and recipes are included in Table D.1. Unless noted 
otherwise, chemicals came from Thermo-Fisher Scientific (Waltham, MA). A summary of 
buffers and recipes is included in Table D.2. Media was sterilized for 30 minutes in an autoclave. 
When cells requiring ampicillin selection were grown on LB agar, carbenicillin (50 mg L-1) was 
used.  
5.2.2. Strains, Primers, and Vectors 
Strains used in this study are listed in Table 5.1. Strains were grown at 37ºC in LB media 
unless noted otherwise and stored at -80ºC as 20% glycerol stocks. A summary list of vectors 
used in this dissertation is included in Table 5.2. 
Table 5.1: Strain summary 
Strain Source Used In 
   
Azospira oryzae PS 
 
ATCCb BAA-33 All Experiments 
E. coli BL21a  NEBc All Experiments 
 
E. coli BL21 (DE3)a NEB Strep-tag Experiments 
 
a Competent cells were provided by the manufacturer for chemical/physical transformations. 
b American Type Culture Collection (atcc.org) 








Table 5.2: Plasmid summary 
Plasmid Origin of Gene AntibioticR 
(Concentration) 
Source 
    
pET3a-IdCld Ideonella dechloratans Ampicillin (50 mg L-1) Dr. Rova83, 195 
 
pET51b(+) -- Ampicillin (50 mg L-1) NEBa 
 
pUC19 -- Ampicillin (50 mg L-1) NEB 
 
a New England Biolabs (neb.com) 
 
5.2.3. DNA Extraction, Gel Electrophoresis, and Quantification Protocol 
Initial efforts to extract DNA from A. oryzae PS using a FastDNATM Kit (MP 
Biomedicals, Santa Ana, CA) failed. Template DNA from A. oryzae PS was therefore extracted 
using a standard phenol/chloroform method. Approximately 1.5mL of overnight cell growth was 
pelleted at 10,000xg for 5 minutes. The supernatant was decanted, and cells were resuspended to 
a final volume of 0.5mL using 1x TE buffer. Lysozyme (Millipore Sigma, Darmstadt, Germany) 
was added to a final concentration of 50mg L-1, and the sample was incubated at 37ºC for 1 hour. 
After incubation, 3µL of 20mg mL-1 proteinase K (Millipore Sigma) and 30µL freshly prepared 
20% sodium dodecyl sulfate was added. The sample was incubated at 37ºC for 1 hour with 
gentle, intermittent mixing.  
Following this protein digestion, the sample was spun down at 10,000xg for 5 minutes. 
The supernatant was transferred to a fresh, 1.5mL Eppendorf tube. An equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1, Millipore Sigma) was added, and the sample was 
gently inverted to mix. The sample was spun down at 10,000xg for 5 minutes, and the 
supernatant was saved. An additional round of extraction was generally performed.  
After the phenol-chloroform extraction, 0.05 volumes of 3M sodium acetate (pH 5.2) and 
1 volume of cold ethanol were added. The sample was mixed gently by inverting. A final 
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incubation was performed at -20ºC overnight. The following day, the sample was centrifuged at 
14,000xg for 10 minutes. The supernatant was removed, and the DNA pellet was gently washed 
using 3x200µL of cold, 70% ethanol. The pellet was allowed to air dry for up to 30 minutes, 
dissolved in 50µL of Elution Buffer (Qiagen), and stored at -20ºC.  
DNA size was confirmed using a 1% TAE agarose gel at 60V for 2 hours unless noted 
otherwise. Gels were stained after electrophoresis using TAE buffer and 2x of GelRed (10,000x 
DMSO, Biotium, INC, Fremont, CA). Gels were gently shaken (25rpm) for 10 minutes and 
visualized using UV absorption in a Gel Doc XR+ (Biorad, Hercules, CA). DNA quantification 
was performed using Qubit Fluorimeter. The double-stranded DNA, broad-spectrum assay was 
used according to the manufacturer’s protocol.  
5.2.4. Polymerase Chain Reaction (PCR) 
Primers used in the amplification of the target genes are included in Table D.5, and 
primers used for control experiments and the verification of the DNA insertion into plasmids are 
included in Table D.6. Primers were ordered from IDT-DNA (Iowa City, IA). All primers were 
redissolved in TE buffer (Qiagen, Hilden, Germany) to a final concentration of 0.1 mM. PCR 
experiments were performed using the GoTaq® Green Master Mix (Promega, Madison, WI) 
following the manufacturer’s instructions. In general, a 25 µL reaction contained 12.5 µL of the 
master mix, 1 µL of template DNA, 1 µL of the forward primer, 1 µL of the reverse primer, and 
9.5 µL of nuclease-free water. Larger volumes of this reaction were carried out using the same 
ratio of each component unless noted otherwise. Samples were amplified using the appropriate 
protocol for Strep-tagged chlorite dismutase (Table D.9). A negative control using all the primers 
from that experiment and water in place of DNA was included. The positive control was 
92 
 
amplification of the 16S rRNA gene using the appropriate primers. The reactions were performed 
in a MyCyclerTM Thermal Cycler System (Biorad). A final incubation at 4ºC overnight was 
performed for all PCR reactions. Appendix D contains the DNA image from the successful PCR 
experiment (Figure D.19).  
5.2.5. Molecular Techniques 
After PCR experiments, digestions, and ligations, DNA was cleaned. In general, the 
QIAquick PCR Purification Kit (Qiagen) was used to clean up DNA after PCR and ligation 
experiments. DNA digestion experiments were run on a gel, and the DNA bands were purified 
using the QIAquick Gel Extraction Kit (Qiagen). The standard gel electrophoresis method was 
used. 
DNA segments were digested with the appropriate restriction enzymes according to the 
manufacturer’s protocol. All restriction enzymes were purchased from New England Biolabs 
(NEB, Ipswich, MA) in either the standard or high fidelity versions. In most cases, the CutSmart 
buffer was compatible for all double-digests. Ligation experiments were carried out using the T4 
DNA Ligase (NEB) according to the manufacturer’s instructions. In most ligation experiments, a 
molar ratio of insert to plasmid was 3:1. 
Chemical/physical transformation experiments were performed using manufacturer’s 
competent cells and according to the manufacturer’s instructions (Table 5.1). Transformation 
experiments were plated on LB agar plates with the appropriate antibiotic using 100 µL of a 1:10 
cell dilution (10 µL of cells were added to 90 µL of SOC media), undiluted cells, and 
concentrated cells. One hundred µL of concentrated cells were produced by centrifuging the 
remaining transformants at 5,000xg for 2 minutes. The supernatant was removed except for 
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approximately 90 µL. This remaining volume was used to resuspend the cells. A negative 
transformation control of no DNA and a positive transformation control of 1 µL of pUC19 
plasmid were included. 
Successful transformants were grown and plasmids extracted using QIAquick MiniPrep 
(Qiagen) for further analysis. Digested and undigested plasmids were run on DNA gels. To 
confirm the correct DNA segment was inserted, the plasmid was sequenced with services 
provided by the University of Illinois Core Sequencing Facility.  
5.2.6. Protein Visualization 
Proteins were visualized using pre-prepared 10% polyacrylamide gels (Biorad). Samples 
were mixed to a final concentration of at least 50% cracking buffer. Five to 10 µL were loaded 
into a well. Gels were run at 40V for 3 hours. After the run, gels were stained with Coomassie 
and microwaved for approximately 3 minutes. Gels were allowed to cool at room temperature 
and shaken (30 rpm) for 10 minutes. The stain was decanted, and destain was added. The gel was 
microwaved for 3 minutes and allowed to cool with shaking at room temperature for 10 minutes. 
Another round of destaining was performed followed by overnight incubation in distilled water. 
Gels were imaged using a Gel Doc XR+ (Biorad). 
5.2.7. Construction of Tagged Chlorite Dismutase 
A schematic of the construction of a Strep-tagged chlorite dismutase is included in Figure 
5.1. The cld gene from I. dechloratans was amplified using 3 µL of pET3a-IdCld195 in a 50 µL 
PCR reaction. To add the Strep-tag, the amplified PCR gene segment was incorporated into the 
pET51b(+). A ligation experiment using a ratio of 1:1 inset to plasmid was also performed. 




Figure 5.1: Schematic showing the construct for the Strep-tagged chlorite dismutase using 
pET51b(+). Definition of terms: amp – encodes for penicillin β-lactamase, Strep-tag II – 
sequence corresponding to the Strep-tag, cld – encodes for chlorite dismutase. 
5.2.8. Expression and Testing of Tagged Chlorite Dismutase 
To test activity of the Strep-tagged chlorite dismutase, the biocatalyst was expressed in E. 
coli BL21 (DE3). The growth, production of SPF, purification of chlorite dismutase, and 
characterization of chlorite dismutase were performed as previously reported.83 This included 
freezing the cell pellets after growth at -80ºC. Two notable modifications to the previous 
methods involved the quantification of chlorite dismutase. First, the elution buffer (buffer E) 
interfered with the bicinchoninic acid assay (Pierce, Thermo-Fisher Scientific, Waltham, MA). 
As a result, total protein concentration for the purified biocatalyst was measured using the 
Bradford protein assay. Second, in heme quantification, a small amount (~25 mg) of solid 
sodium dithionite was used as the reducing agent. All chlorite dismutase activity data was 
normalized to heme content, an indirect measurement of the total, active chlorite dismutase.  
The activity of the tagged chlorite dismutase was confirmed in a batch reaction. In 
addition, the tagged biocatalyst was attached to resin beads (IBA, Göttingen, Germany) and 
tested in batch and column setups. When preparing the attached biocatalysts, the final elution 
step of the purification protocol was omitted. For the batch tests, a dissolved oxygen probe 
(083005MD) was used to measure the end product, oxygen, in 50 mL of 10 mM phosphate 
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buffer at pH 7.0. Various concentrations of 80% sodium chlorite (0-20mM) was tested with 5-10 
µL of purified biocatalyst or measured amount of biocatalyst-attached resin beads. The activity 
of the chlorite dismutase was calculated using the slope of the initial linear portion of oxygen 
formation. 
For the column tests, chlorite concentrations were fed into a prepacked column loaded 
with 5-10 µL of SPF using a syringe pump at 1mL min-1. The effluent from the column was 
allowed to degas to the atmosphere in a 250 µL container to remove supersaturated oxygen. The 
solution was drawn into a flow cuvette using an additional syringe at the same flow rate. 
Breakthrough of chlorite was measured using a spectrophotometer at 260 nm. The absorption 
value was converted to a chlorite concentration using an extinction coefficient of 155 M-1 s-1.80  
5.2.9. Equation Development 
Free biocatalytic activity was used to fit kinetic parameters to the single substrate 
Michaelis-Menten equation,  




where, v is the activity of the biocatalyst in substrate concentration over time normalized to heme 
concentration. Heme was used as an indirect measure of the total chlorite dismutase content. 
Vmax is the maximum activity of the biocatalysts measured in the same units as v, Km is the half 
saturation constant, and [S] is the substrate concentration. For free biocatalysts, [S] is the bulk 
substrate concentration. For attached biocatalysts, [S] is the concentration at the immobilized 
surface, and v and Vmax have units normalized to the surface area of resin beads. The conversion 
between heme concentration and surface area was made by tracking the amount of biocatalyst 
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loaded on to a measured mass of resin. Using the bead density (1 g cm-3) and the average 
diameter (110 µm), the concentration of heme was converted to reactive surface area of resin.  
Using large particles for biocatalyst attachment imposes a diffusion layer. To account for 
this mass transfer limitation, a mass transfer equation based on Fick’s First Law (Equation 5.2) 
was utilized, 
Equation 5.2  𝑣 = 𝑘𝐿 ∗ 𝑑[𝑆] 
where, v is the activity of the attached biocatalyst with similar units described above, kL is a mass 
transfer coefficient in units of distance over time, and d[S] is the change in substrate 
concentration across the diffusion layer. The transfer coefficient is calculated from, 
Equation 5.3  𝑘𝐿 = −𝐷𝑆/𝑑𝑥 
where, DS is the diffusivity of the substrate (chlorite) and dx is the diffusion distance between the 
bulk substrate concentration and the surface substrate concentration.  
However, Equation 5.1 and Equation 5.2 require knowledge of the substrate 
concentration at the immobilized surface, a parameter that is difficult to measure. To eliminate 
this unknown variable, both Michaelis-Menten and mass transfer equation were solved for the 
substrate concentration at the surface. Both equations were set equal to one another to remove 
the surface substrate concentration under the assumption of steady state (Equation 5.4),  
Equation 5.4  
𝑣∗𝐾𝑀
𝑉𝑚𝑎𝑥−𝑣




where, [So] is the bulk substrate concentration and all other variables are as previously defined. 
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The quadratic is rearranged to solve for the biocatalytic activity (v, Equation 5.5), 




The activity in this equation was normalized to the surface area of the resin beads, and for 
these models, it was assumed that the distribution of the biocatalysts was uniform across the 
surface of the resin beads and the boundary layer was fixed and stagnant. This equation was used 
to determine activity of the biocatalysts in batch reactions under the assumption that the change 
in bulk substrate concentration was nominal. Equation 5.5 was also used to determine the activity 
of the biocatalysts attached to resin beads packed into columns. This assumed that the column 
was at steady state, dispersion was negligible compared to advection, and the biocatalysts’ 
concentration remained unchanged.  
5.2.10. Model Fit 
Data from experiments were used to fit models of activity from purified chlorite 
dismutase. For the free and attached biocatalysts, experiments included batch reactions with 
measurements of the end products taken by an oxygen probe. The column-packed biocatalyst 
experiments were performed in one mL columns measuring breakthrough of chlorite using a 
spectrophotometer.  
To fit model parameters, the Excel 2013 solver function was used to minimize the sum of 
squared residues between the model activity and the observed activity. Kinetic parameters for the 
free biocatalysts were determined from the data fit to the single-substrate Michaelis-Menten 
equation. For the immobilized biocatalysts, Equation 5.5 was used. For the attached biocatalysts, 
Vmax and Km were fixed under the assumption that these values were unchanged compared to the 
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free biocatalysts, and kL was fit. To compare the model, kL and Km were fit. As a starting point 
for the solver, initial values for kL and Km were used. The initial mass transfer coefficient, kL, 
was based on the diffusivity of perchlorate (1.79e-5 cm2 s-1)196 and a diffusion length 
approximated by the radius of the resin bead (55µm). The initial half-saturation constant, Km, 
was assumed to be the same as the free biocatalysts. For column-packed biocatalysts, the Vmax 
and Km were fixed at the value for the free biocatalysts or the attached biocatalysts. Only the 
mass transfer coefficient was fit to the column data. 
5.2.11. Damköhler Number 
The second Damköhler number (Da) was calculated using Equation 5.6,197  





where, V’max is the activity of the biocatalysts, kL is the mass transfer coefficient, and [So] is the 
bulk substrate concentration. The number was calculated using two different V’max. The first 
value was the normalized maximum activity, and the second value was the activity of the free 
biocatalysts at the respective bulk substrate concentration. 
5.3. Results and Discussion 
5.3.1. Strain Construction 
The approach to constructing a Strep-tagged chlorite dismutase (Figure 5.1) was 
successful. Colony counts (Table D.16) and PCR amplification (Figure D.22) and sequencing 
(Section D.2.5.3) of the gene in the plasmid were used to confirm this result. The growth of E. 
coli BL21 DE3 and expression of the chlorite dismutase was as expected. Anecdotally, freezing 
the cell pellets at -80ºC after growth seemed to enhance the activity of the purified biocatalyst, 
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but this observation was not tested robustly. The SPF was a red hue, typical of SPF containing 
the chlorite dismutase.83 The SPF contained an average of 24,020 ± 2270 mg L-1 of protein and 
104 ± 22 µM of heme. The ratio of heme to total protein suggests an active Cld content of 
11.7%. Purified biocatalyst had a protein concentration of 2,270 mg L-1 (84.1 µM) and a heme 
content of 17.2 µM. This indicated that only approximately 20.5% of the Cld had the metal 
cofactor required for activity. The size of Cld was as expected (27 kDa, Figure 5.2). 
 
Figure 5.2: Protein gel of Cld. Lanes 1 and 10 are protein ladders. Lanes 2 is a 1:2 dilution of 
pure Cld. Lane 3 is a 1:2 dilution of the soluble protein fraction. Lane 4 is a 1:2 dilution of the 
flow through from the purification column. Lane 5 is a 1:2 dilution of the wash buffer used to 
clean the pure Cld. Lanes 6-9 are repeats of the previous four samples in undiluted form. The Cld 
band corresponds closely with the expected size of 27 kDa. 
5.3.2. Preliminary Activity 
The activity of the free biocatalyst was tested over a range of chlorite concentrations and 
followed an expected biocatalytic kinetic profile (Michaelis-Menten). A kinetic profile for the 
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biocatalysts attached to resin beads was also obtained (Figure 5.3). For the columns, activity was 
determined by extrapolation. This was required due to the inactivation of Cld protein as well as 
the delay in complete chlorite breakthrough in the column (Figure D.23). Using the extrapolated 
concentration, the activity of the biocatalytic column was determined (Figure 5.3). 
 
Figure 5.3: Activity from a single replicate of purified, free (red circles), attached (blue, open 
circles), and column-packed (green squares) biocatalysts tested at various chlorite 
concentrations. Activities are normalized to heme content, an indirect measure of Cld. The 
Michaelis-Menten model fit (black line) and the combined mass transfer, activity model for the 
attached biocatalysts (Km and kL fit, blue, dashed line) and the column-packed biocatalysts 
(green, dotted line) are included.  
As chlorite dismutase undergoes catalytic inactivation,83 it was important to measure and 
confirm the rate of inactivation. This rate, given as active protein loss over time, was 
exponentially related to the chlorite concentration. However, at environmentally relevant 
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Figure 5.4: Cld inactivation rates measured as protein loss per minute with respect to chlorite 
concentration.  
For the I. dechloratans Strep-tagged Cld heterologously expressed in E. coli BL21(DE3), 
the maximum activity and half-saturation constant were comparable to previous reports.83 The 
activity decreased when the attached biocatalysts were tested in batch and column reactions. 
With respect to the production of the biocatalyst, future efforts should focus on better 
incorporation of the heme into Cld. The total amount of active Cld expressed was quite high at 
11.7%. If it is assumed that the ratio of heme-containing Cld and non-heme Cld is consistent 
between the purified protein and the SPF, this would suggest that greater than 50% of the total 
protein content in the SPF is comprised of Cld. This level of expression is greater than the 
observed yield for codon-optimized constructs where levels can vary between 10 to 20% of the 
SPF protein content.198 However, the amount of active protein as measured by the heme content 
was relatively low, comprising only 20.5% of the purified, total Cld content. Future efforts 








































should focus on optimizing the incorporation of heme into Cld.  
To achieve increased incorporation of heme, two methods could be utilized. The first is a 
systematic approach to the preparation of the SPF, specifically focusing on the -80ºC storage and 
the probe sonication steps. As noted, freezing cell pellets prior to SPF preparation anecdotally 
increased the yield of active protein. During the probe sonication step, cell pellets are converted 
from a white color to a red-colored soluble protein fraction. As the red color is generally 
associated with the iron-containing Cld,85 it would suggest that the sonication step plays another 
important role in the incorporation of the heme. 
The second approach supplies heme rather than hemin for expression of Cld. Hemin was 
incubated in excess of the protein requirements. Approximately 5 µM of hemin was required, 
and 19 µM of hemin was provided. However, it is important to note that hemin was supplied, 
which is a non-functional, oxidized version of heme. It is possible that the step of reducing 
hemin to heme may be rate limiting for the proper formation of Cld. This could be alleviated by 
the addition of sodium dithionite and anaerobic storage of the hemin stock solution.199 
5.3.3. Model Fits 
To obtain kinetic and mass transfer parameter values, data (Figure 5.3) was used to fit the 
equations highlighted in the Methods. Three scenarios were modeled: free biocatalysts in batch 
reactions (free biocatalysts), resin-attached biocatalysts in batch reactions (attached biocatalysts), 
and resin-attached biocatalysts packed into columns (column-packed biocatalysts).  
 Free Biocatalyst Activity in Batch Reactions 
The activity of the free biocatalyst followed traditional single-substrate Michaelis-
Menten kinetics. The data was used to fit two parameters: Vmax and Km (Figure 5.3). Vmax is a 
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parameter that measures the maximum activity of the biocatalysts and is approximated by the 
plateau in the figure. Km is the substrate concentration at half of Vmax. Vmax was 39,300 µmol 
min-1 µmolheme
-1 and a Km of 115 µM (R
2=0.80). These values are consistent with previously 
published reports of Cld from Ideonella dechloratans (Vmax = 42,000 µmol min
-1 µmolheme
-1, Km 
= 260µM,200 and Vmax = 46,000 µmol min
-1 µmolheme
-1, Km = 320 µM
83).  
 Attached Biocatalyst Activity in Batch Reactions 
When the biocatalysts are attached to resin beads, mass transfer limitations are introduced 
into the system. Accurate modeling of the activity, therefore, requires not only the kinetic 
parameters but the inclusion of parameters that account for mass transfer limitations. For the 
model fit of the attached biocatalysts, Vmax was assumed to be unchanged compared to the free 
biocatalysts. This assumption appears to hold true as in Figure 5.3, the activity of the attached 
biocatalysts approaches a similar Vmax at high substrate concentrations. However, this 
assumption should be tested by determining activity of the attached biocatalysts at higher 
substrate concentrations and performing robust statistical analysis. The fitted kL
 was 3.3 x 10-3 
cm s-1 (R2=0.9766). When fitting for both Km and kL, the Km increased and the kL remained 
unchanged. However, this did not result in much improvement in the goodness of fit value 
(R2=0.9768). Subjectively, when Km and kL
 were fit, the model appeared to better capture the 
curve up to the activity plateau. Again, this should be confirmed with additional replicates and 
statistical analysis. For this analysis, both fitting scenarios were retained for the column-packed 
biocatalyst. The following places the attached-biocatalyst fitted values of Km and kL in context of 
the literature.  
When the Km was fit to the model, it shifted higher, to 965µM. Two possible explanations 
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may account for the change in Km: 1) changes in the biocatalyst’s substrate affinity and 2) 
inclusion of Km as a fitting parameter. Considering the first explanation, there is precedent for 
unexpected impacts with respect to kinetic parameters, including increasing, decreasing, and 
unchanged values, when biocatalysts are immobilized. For example immobilization of acid 
phosphatase increased Km while no change was observed for laccase and peroxidase.
201 The 
change in Km could be accounted for by a change in the structure of the biocatalyst or the 
introduction of steric hindrance. For steric hindrance, the biocatalyst’s chlorite entry site may be 
partially blocked by the attachment matrix. The second explanation, allowing Km to vary, could 
have been erroneous. In this case, the Km parameter should be held constant in the model fit. 
Confirming whether the Km changed could be determined experimentally. This could be tested 
by attaching the biocatalysts to a resin bead with a smaller diameter. Streptavidin magnetic beads 
(e.g. P/N S1420S from NEB) have a diameter of approximately 1µm. This diameter is small 
enough to potentially move mass transfer limitations below the substrate concentration for the 
half-saturation constant. In this case, the Km could be measured. If the value matches the fitted 
value, then a change in substrate affinity or blockage due to steric hindrance occurred. If the Km 
value matches the free biocatalyst value, Km should be fixed for the model.  
The second fitting parameter, the mass transfer coefficient, combines the diffusion 
distance and the diffusivity of chlorite. Using Equation 5.3, the model-fit kL value, and the initial 
assumption of chlorite diffusivity,196 the diffusion distance was calculated and found to be 
approximately 80µm, slightly larger than the originally assumed 55µm. When Km was included 
as a fit value, the diffusion distance remained the same. Looking to the literature for context, the 
diffusion distance in experimental systems varies. One report suggests that in a well-mixed 
system as simulated in these experiments, the diffusion distance should be approximated by the 
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radius of the particle.202 Another report suggests that this diffusion distance would only be 
observed in a stagnant, low to no-flow system.203  
In addition to the diffusion distance, the assumed value for diffusivity could be revisited. 
The diffusivity of chlorite could be determined experimentally.196 Alternatively, a mathematical 
approach could be utilized, which includes analytical or empirical calculations. The analytical 
approach is called the Stokes-Einstein equation.204 Empirical approaches include the Wilke-
Chang,205 the Scheibel,206 and the Reddy-Doraiswamy207 equations. Another important factor to 
consider with respect to mass transfer limitations is the effect temperature can play on diffusivity. 
For the calculations in this chapter, the referenced diffusivity was determined at 25ºC, slightly 
warmer than the average room temperature at which the activity experiments were conducted 
(~21ºC). This temperature difference could introduce an error in the diffusivity of up to 10%. To 
account for temperature, especially over a larger range relevant to drinking water treatment, the 
dependence could be experimentally determined and used in the Arrhenius equation. Using a 
theoretical approach, the empirical formulas mentioned above can also take into account 
temperature. In general, the kL fit obtained for the attached biocatalysts suggests that the assumed 
diffusion distance and the diffusivity were acceptable. 
 Attached Biocatalyst Activity Packed in Columns 
A technology format convenient for drinking water treatment is the column. However, the 
column activity was lower than the free and attached biocatalysts (Figure 5.3). When modeling 
this experimental setup, the Vmax was assumed to be the same as the free biocatalysts. Under 
fitting scenarios where the Km was the value from the free biocatalysts, the fitted diffusion 
distance increased to 384 µm. For the model where Km and kL were fitted, the diffusion distance 
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was 380 µm (Figure 5.3). The goodness of fit for the column model was not calculated due to the 
small number of experimental measurements. This diffusion distance was larger than the 
previous report where the diffusion layer is approximated by the radius of the particle in 
stagnant, low to no-flow system.203  
5.3.4. Implications of the Damköhler Number 
To determine when mass transfer or kinetics was limiting over a range of substrate 
concentration, the second Damköhler number was calculated (Figure 5.5). Traditional 
approaches to calculating the Damköhler number use the maximum velocity of the biocatalysts. 
However, this approach does not take into account the impact substrate concentration has on 
biocatalytic activity. To better incorporate this impact, the activity of the biocatalysts at the given 
bulk substrate concentration was also included in the Damköhler number calculation. For both 
scenarios, the Damköhler number was much greater than one, especially over the 
environmentally relevant ranges of chlorite concentrations (e.g., regulatory limit of 0.015 
mM157). For the column-packed biocatalysts, the Damköhler number was greater than one for the 
tested chlorite concentrations (data not shown). These data suggest that the biocatalytic system 




Figure 5.5: Damköhler number (y-axis, logarithmic) calculated assuming the maximum activity 
(orange) and the relative activity of the free biocatalysts (blue). The activities were normalized to 
surface area. When the Damköhler number is one (black horizontal line), the system has no 
activity or mass transfer limitation.  
To optimize the attached and column-packed biocatalytic system with respect to the 
Damköhler number, two approaches could be implemented. First, improvements to mass transfer 
limitations could be achieved by decreasing the diffusion layer surrounding the resin beads. 
Smaller resin bead diameters would decrease the diffusion layer. However, for the batch system, 
the trade-offs of retaining or recapturing the smaller particles would need to be examined. 
Another method of compressing the diffusion layer is increasing the mixing speed for the batch 
system or the flow rate for the column system.  
Second, the Damköhler number could be interpreted as more biocatalysts having been 
loaded than necessary. The inefficient, high biocatalyst loading results in a system that has more 
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Damköhler number over the range of environmentally relevant chlorite concentrations.  
5.3.5. Catalytic Inactivation 
If optimizing the biocatalyst loading is seen as the most efficient method of balancing the 
system’s kinetics and mass transfer, then the inactivation of the biocatalyst must be taken into 
account. As described in Section 1.5.2, Cld undergoes catalytic inactivation. As discussed in 
4.4.3, biocatalytic immobilization methods must achieve 1,000 or greater bed volumes of 
treatment to promote the sustainability of biocatalytic technologies. In order for the column-
packed biocatalysts to achieve a 1,000 bed volume reuse target, the system required a high 
biocatalyst loading (Section 5.2.8). To decrease the biocatalyst loading while maintaining the 
required treatment bed volumes, chlorite dismutase’s resistance to catalytic inactivation must be 
improved. Lower catalytic inactivation would require less biocatalyst loading to treat the 
required number of bed volumes while helping to optimize the Damköhler number.  
Quantification of the catalytic inactivation also plays a critical role in the development of 
biocatalytic performance models. The change in protein concentration was determined as 
described in Section 5.3.1. The rate of this change with respect to substrate concentration was 
determined from fitting the data using an exponential equation (Figure 5.4, R2=0.995). To 
include the impact of catalytic inactivation in the model, the change in biocatalyst concentration 
could be incorporated into the Vmax term. By including the changing biocatalyst concentration 
with respect to time, the models developed in this chapter could take into account catalytic 
inactivation.   
5.3.6. Modeling Performance of the Batch and Column Systems 
The equations developed in this chapter aim to predict the activity of the biocatalysts at a 
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given substrate concentration. However, to accurately predict the performance of the attached or 
column-packed biocatalysts requires the integration of Equation 5.5. A similar process was 
performed for the free biocatalysts with the Michaelis-Menten equation in Section C.1.2. While a 
solution to this integration with respect to substrate concentration was identified, the analytical 
solution was complicated and would not converge due to division by zero. To circumvent this 
problem, discretization of Equation 5.5 is recommended. This approach will require greater 
computational time to perform than an analytical solution, but such a model could predict 
performance and handle more complex biocatalytic scenarios including catalytic inactivation.  
5.4. Conclusions 
This chapter demonstrates the successful construction of the Strep-tagged Cld for affinity 
attachment. This construct was used to test Cld in batch and column reactions. Catalytic 
inactivation of Cld was still observed when packed into columns. Models developed based on 
first principles of kinetics and mass transfer showed good fit with experimental data (R2>0.80).  
From the Damköhler numbers, the attached and column-packed biocatalysts were mass 
transfer limited over the environmentally relevant concentrations of chlorite. Two approaches 
may be used to optimize the system with respect to the Damköhler number: 1) decreasing the 
diffusion layer surrounding the bead and 2) lowering the biocatalyst loading. However, for the 
second option, an increase in the resistance to catalytic inactivation must be achieved to maintain 
the required number of treated bed volumes.  
5.5. Supporting Information 
Additional supporting information for this chapter is located in Appendix D. This 
appendix includes efforts to construct an affinity-attached perchlorate reductase and a spore-
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displayed Cld. For the affinity-attached Cld, the appendix includes primers; PCR conditions; gels 





CHAPTER 6: BIOCATALYTIC REMOVAL OF PERCHLORATE AND NITRATE IN 
ION EXCHANGE WASTE BRINE 
The results described in this chapter are currently in press at Environmental Science: 
Water Research and Technology. As author, I retain copyright of this work. Brittany Webb 
assisted with the activity data profile with respect to sodium chloride concentration. I performed 
all the other experiments.  
6.1. Abstract 
Biocatalytic technologies are characterized by targeted, rapid degradation of 
contaminants over a range of environmentally relevant conditions representative of groundwater, 
but have not yet been integrated into drinking water treatment processes. This work investigated 
the potential for a hybrid ion-exchange/biocatalytic process, where biocatalysis is used to treat 
ion-exchange waste brine, allowing reuse of the brine. The reduction rates and the fate of the 
regulated anions perchlorate and nitrate were tested in synthetic brines and a real-world waste 
brine. Biocatalysts were applied as soluble protein fractions from Azospira oryzae for perchlorate 
reduction and Paracoccus denitrificans and Haloferax denitrificans for nitrate reduction. In 
synthetic 12% brine, the biocatalysts retained activity, with rates of 32.3 ± 6.1 U (µg Mo)-1 for 
perchlorate (A. oryzae) and 16.1 ± 7.1 U (µg Mo)-1 for nitrate (P. denitrificans). In real-world 
waste brine, activities were slightly lower (20.3 ± 6.5 U (µg Mo)-1 for perchlorate and 14.3 ± 3.8 
U (µg Mo)-1 for nitrate). The difference in perchlorate reduction was due to higher concentrations 
of nitrate, bicarbonate, and sulfate in the waste brine. The predominant end products of nitrate 
reduction were nitrous oxide or dinitrogen gas, depending on the source of the biocatalysts and 
the salt concentration. These results demonstrate biocatalytic reduction of regulated anions in a 
real-world waste brine, which could facilitate brine reuse for the regeneration of ion-exchange 
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technologies and prevent reintroduction of these anions and their intermediates into the 
environment. 
6.2. Introduction 
Ion-exchange technologies are effective at removing a range of charged contaminants in 
drinking water treatment and serve as the best available technology for many inorganic anions, 
radionuclides, and metalloids.208 However, regenerating ion-exchange resins produces a 
contaminated brine waste, which is principally disposed of through dilution and municipal 
wastewater treatment.3 The brine and its disposal result in three negative consequences: i) 
increasing the financial costs of treatment, ii) contributing a significant portion of the 
environmental impacts, and iii) reintroducing the contaminants into the environment.103, 156 This 
work seeks to minimize those consequences by developing a biocatalytic treatment process for 
ion-exchange waste brines, focusing on the regulated anions perchlorate17 and nitrate.208  
Brine regeneration for perchlorate and nitrate contamination has been investigated 
previously using chemical reduction, chemical catalysts, or whole-cell biological technologies.33, 
103, 209, 210 Chemical reduction produces ammonium, which must then be removed.210 Chemical 
catalysts rely on hydrogen as the source of the electrons.33 Whole-cell biological reduction has 
been tested using a variety of electron donors, including hydrogen211, 212 and acetic acid.103 
Whether chemical or biological, processes that use hydrogen as an electron donor can minimize 
the growth of excess biomass since no additional carbon is added to the system. However, this 
electron donor can be volatile (if supplied as liquid hydrogen), corrosive, and explosive. An 
acetic acid-based whole-cell process was tested at the pilot scale, where it had effective nitrate 
and perchlorate reduction in waste brines.103 While capital costs would be approximately 14.3% 
higher per 1000 gallons of treated water for whole-cell brine treatment, the operation and 
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maintenance were predicted to yield a significant cost reduction of 29.7% per 1000 gallons of 
treated water. Whole-cell biological reduction has also been tested with direct contact between 
the ion-exchange resin and the bacterial cells, both in the absence and presence of sodium 
chloride.138, 213 In these systems, biological degradation of perchlorate without brine resulted in 
incomplete regeneration of the resin (greater than 40% resin-bound perchlorate remaining after 8 
days of incubation).138, 213 To avoid the effects of biofouling, another study proposed combined 
brine and resin regeneration by separating the resin and the bacterial cells with a membrane; this 
study reported better resin capacity than the previous study over six regeneration cycles.214 In the 
whole-cell biological regeneration systems, to the best of our knowledge, the fate of the 
contaminants, especially nitrate, has not been thoroughly evaluated. Furthermore, although these 
prior reports support the potential benefits of brine treatments, to our knowledge, no such process 
has been implemented at full-scale.  
Recent work has demonstrated the reduction of perchlorate using cell-free enzymes as 
biocatalysts in drinking water sources64, 150 and described the required technology improvements 
that would allow this approach to be competitive financially and environmentally.179 Compared 
to chemical catalysts, the biocatalysts have the advantages of performing well under typical 
groundwater pHs and of having faster reduction rates.33, 150 Compared to whole-cell processes, 
the biocatalysts have the advantages of being less sensitive to nitrate, having no observed activity 
for sulfate, and having no effects from sulfate on perchlorate-reducing activity.64 The biocatalysts 
themselves are inert and therefore do not require supplemental nutrients.64 This inert state 
reduces the amount of electron donor that is required, because none is going towards biomass 
production. The lower electron donor concentration also reduces the potential for growth of other 
microorganisms, which might include pathogens. However, to our knowledge, the response of 
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perchlorate-reducing biocatalysts to salt concentration has not previously been reported. 
One focus of this work was to investigate the effects of synthetic and real-world waste 
brine on the perchlorate-reducing activity of biocatalysts. Since nitrate is also an important 
contaminant in waste brines, we also sought to develop a biocatalytic approach for nitrate 
reduction (Figure 6.1) and test its response to brine conditions. The fates of both contaminants 
were also evaluated. This characterization of the activity and contaminant fate was designed to 
provide an assessment of the technical feasibility of biocatalytic treatment for ion-exchange 
waste brines. The long-term motivation of this work includes minimizing contaminant 
reintroduction into the environment, converting contaminants into innocuous end products, and 
improving ion-exchange treatment’s economic and environmental sustainability. 
 
Figure 6.1: Biocatalytic reduction of perchlorate and nitrate. Pcr – perchlorate reductase, Cld – 
chlorite dismutase, Nar – nitrate reductase, Nir – nitrite reductase, Nor – nitric oxide reductase, 
Nos – nitrous oxide reductase. 
6.3. Materials and Methods 
6.3.1. Biocatalyst Preparation, Media, and Chemicals 
Laboratory solutions were prepared with Nanopure water (18 MΩ cm) from deionized 
water (EMD Millipore Milli-Q System, Billerica, MA). Unless otherwise specified, chemicals 
were purchased from Fisher Scientific (Pittsburgh, PA). Anaerobic solutions were degassed with 
N2 with CO2 for 30 minutes, and headspace was degassed with the same mixture for 5 minutes. 
The target ratio of N2 to CO2 was 80:20. Experiments were performed in triplicate from 
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independent growths (biological replicates) and reported with standard deviation unless noted 
otherwise. Open anaerobic solutions were handled in an anaerobic glovebox chamber (95% N2, 
5% H2) and used within an hour. 
Biocatalysts were obtained from the perchlorate-reducing Azospira oryzae strain PS 
(ATCC number BAA-33), the nitrate-reducing Paracoccus denitrificans (ATCC number 19367), 
and the marine nitrate-reducing Haloferax denitrificans (ATCC 35960). A. oryzae was grown 
anaerobically on perchlorate (7mM), harvested by centrifugation, lysed by sonication, and 
centrifuged to separate the soluble protein fraction (SPF), all as described previously.64, 150 
Similar procedures were followed for the other two strains, with the following modifications. For 
P. denitrificans, 11.8 mM sodium nitrate was used for growth instead of perchlorate. H. 
denitrificans was initially grown aerobically in YH medium as previously described.215 The 
anaerobic growth media for H. denitrificans again contained nitrate instead of perchlorate and 
was also supplemented with 175.2 g sodium chloride, 1.9 g potassium chloride, 0.1 g calcium 
chloride dihydrate, and 19.8 g magnesium chloride hexahydrate per L of media. Throughout the 
preparation of the SPF from H. denitrificans, 12% sodium chloride was included in the buffers.  
To compare across independent preparations and strains, perchlorate, chlorate, and 
nitrate-reducing activities were normalized to the molybdenum concentration, an indirect 
measure of perchlorate reductase and nitrate reductase concentration. Molybdenum concentration 
was measured using inductively coupled plasma-optical emission spectrometry (ICP-OES) 
(PerkinElmer Optima 2000DV, Waltham, MA). The impact of increasing the sodium chloride 
concentration on the solubility of the perchlorate-reducing SPF from A. oryzae was determined 
for a single biological replicate. The SPF was incubated in five sodium chloride concentrations 
(SPF buffer with 0%, 3%, 6%, 9% and 12% NaCl) for 15 minutes. Samples were then 
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centrifuged at 140,000xg for 60 minutes. The soluble fractions were analyzed for their 
molybdenum content. Total protein in each SPF was also measured using the Bicinchoninic acid 
(BCA) assay (Pierce, Rockford, IL). 
6.3.2. Brine Characterization 
The waste ion-exchange brine was obtained from a California utility and was 
characterized before use by previously reported methods.64, 150 Additional analyses included 
chemical oxygen demand (COD), ammonium, and anions. COD was determined using a 
digestion solution (Hach digestion solution). For high (>0.36 mM) ammonia, samples were 
analyzed by colorimetric analysis (Hach salicylate kit). Perchlorate, chlorate, nitrate, sulfate, 
bromate, and iodate were analyzed by ion chromatography (IC) as previously described.64 
Including 1:10 sample dilutions due to the high chloride concentration, detection limits for the 
anions are listed in Table 6.1.  
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Table 6.1: Waste brine composition 
Component Units Brinea % NaCl eq 
    
pH  7.04  
Alkalinity mM 122  
Calcium mM 12.8  
Iron µM 0.04  
Potassium mM 26.9  
Magnesium mM 15.3  
Manganese µM 0.2  
Molybdenum mM 0.7  
Sodium mM 2,000 11.7% NaCl 
Phosphorus µM 12.9  
Sulfur mM 11.3  
Ammonia µM <18.3  
Fluoride mM 3.8  
Chloride mM 2,100 12.3% NaCl 
Bromide µM 250  
Iodide µM 23.6  
Perchlorate µM NDb  
Chlorate µM ND  
Nitrate mM 151  
Bromate mM ND  
Iodate mM ND  
Sulfate mM 25.5  
COD ppm 407  
a  Detection Limits – Nitrate (0.16 mM), Chlorate (95.8 µM), 
Perchlorate (0.5 µM), Iodate (0.5 mM), Bromate (0.4 mM), Sulfate 
(70.8 µM) 
b ND – Not Detected 
 
6.3.3. Colorimetric Biocatalytic Assays 
Perchlorate- and nitrate-reducing activities were analyzed colorimetrically using methyl 
viologen as the electron donor64, 70, 216 in stoppered anaerobic cuvettes with 20 µL of SPF at room 
temperature. Perchlorate and chlorate was added to a final concentration of 1 mM. Nitrate 
experiments typically had a final concentration of 10 mM. In tests mimicking the nitrate 
concentration in the waste brine, 151 mM nitrate was included. Assays were conducted over 
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sodium chloride concentrations ranging from 0 to 12% (w/v) and in waste brine. For reactions 
testing the effects of other anions on the biocatalyst activity, the anions were included in the 
synthetic brine at concentrations identical to the waste brine before degassing. All anions were 
sodium form. Chlorite150 and nitrite could not be tested in this assay due to background activity 
caused by their reactivity with methyl viologen. 
6.3.4. Perchlorate-End Product Analysis 
While perchlorate was measured using the IC, the fate of perchlorate, as determined by 
measuring the formation of chloride, could not be tested through a typical mass balance 
approach. This was due to the high concentration of sodium chloride in brine experiments 
prevented quantification of chloride. Specifically, for chloride, full reduction of 1 mM 
perchlorate added to the kinetic reactions would only contribute 0.05% change in the chloride 
concentration at 12% sodium chloride conditions. Due to the small concentration difference, 
combined with the sample dilutions required to obtain integrable peaks for chloride, we were 
unable to distinguish the small chloride contribution from perchlorate reduction in the IC data. 
The other end product, oxygen, reacts with the electron donors required for perchlorate reductase 
activity. Instead, perchlorate and chlorate degradation was monitored based on quantification of 
perchlorate and chlorate in endpoint assays with IC measurements. These endpoint assays 
contained 100 µL of SPF, electron donor (nicotinamide adenine dinucleotide (NADH), 250 µM), 
electron shuttle (phenazine methosulfate (PMS), 100 µM), and 50 µM of sodium perchlorate in 
100 mL 50 mM MOPS buffer, pH 7.0. or 100 mL of waste brine in 160 mL stoppered serum 
bottles. Assays were incubated at room temperature (approximately 21.7C) overnight.118, 150 After 
incubation, 3 mL samples were taken and passed through 0.22 µm PES syringe filters for IC 
analysis. Controls containing perchlorate and chlorate without the SPF were included.  
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The last step in the perchlorate-reducing pathway, chlorite decomposition, was directly 
tested in experiments where chlorite was supplied and dissolved oxygen was measured. 
Dissolved oxygen was measured at room temperature using a DO probe (08005MD, Thermo 
Fisher Scientific, Waltham, MA), and the probe was calibrated each time with air saturated DI 
water. Twenty µL of SPF was added to 10mL of 50mM Tris-Cl- buffer (pH 7.5) in a 25mL beaker 
with 0 to 12% sodium chloride, or to 10mL of waste brine, with constant stirring. Sodium 
chlorite was added to a final concentration of 0.18 mM to initiate the reaction. The experiment 
was monitored until the oxygen values leveled off. A salt correction factor based on temperature 
and barometric pressure was used to account for the salinity effects on the probe217 according to 
manufacturer’s instructions. No oxygen formation was observed in buffer-only, buffer plus SPF, 
or buffer plus sodium chlorite controls. The amount of oxygen formed was compared 
stoichiometrically with the amount of chlorite added to the reaction. Oxygen formation rates are 
reported as mg O2 per second per liter of reaction. 
6.3.5. Nitrate-End Product Analysis 
To determine the fate of nitrate, additional endpoint assays were conducted. In these 
assays, 100 µL of A. oryzae, P. denitrificans, or H. denitrificans SPF was incubated as described 
above, except that isotopically-enriched nitrate (98% Na15NO3, Sigma Aldrich, St Louis, MO, 
25µM) was included instead of perchlorate.118 Sodium chloride concentrations were varied from 
0% to 12%. Assays were incubated overnight at room temperature (approximately 21.7 °C). 
Controls using sodium nitrate and sodium nitrite with no SPF were conducted.  
For ammonium analysis, ten mL of aqueous samples were filtered through 0.22 µm 
acetate filters and stored at -80°C until analysis. Ammonium was quantified using the standard 
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phenate method.218  
For nitrous oxide analysis, fifteen mL of gas from the headspace was transferred to a 
vacuumed (-20 in. Hg) 10 mL vial for analysis. Nitrous oxide was measured using gas 
chromatography (GC, Shimadzu GC-2014 with Auto Sampler AOC 5000 Plus) with electron 
capture detector, with a detection limit of 0.1 ppmv.  
To quantify 15N2, one mL of gas from the assay bottle headspace was transferred directly 
to the instrument for gas chromatography-isotope ratio mass spectroscopy (GC-IRMS, Isoprime 
100 and Isoprime Trace Gas Analyzer, Isoprime Ltd, Cheadle Hulme, UK) analysis. The setup 
included modifications to the Isoprime Trace Gas Analyzer, and the instrument drift was 
accounted for by applying k-factor corrections as previously reported.219 Instrument precision 
was 2 x 10-6 % 15N. The measured ratio of mass 30 was used to estimate the amount of dinitrogen 
formed from nitrate reduction by multiplying the ratio and the amount of total nitrogen in the 
headspace (80% at 5psi).219 
6.3.6. Statistical Analysis 
Statistical analysis was performed in OriginPro 2017. A standard linear curve fit was used 
for anions except chlorate. A. oryzae SPF activity with chlorate was fit using a non-linear 
exponential fit. Curve fits are reported with coefficient of determination (R2). Normality was 
tested using Shapiro-Wilks test. A Kruskal-Wallis test was initially performed to determine 
significant differences in data groups. Subsequent differences were tested using the Mann 
Whitney U Test. Significance was determined at an alpha less than 0.05. 
6.4. Results 
6.4.1. Characterization of Brine 
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Waste brine was obtained from a full-scale drinking water treatment plant that uses ion 
exchange to remove nitrate. The sodium chloride concentration in the waste brine was similar to 
a synthetic 12% brine. The brine had background concentrations of nitrate (151 mM) but no 
detectable levels of perchlorate (Table 6.1). Other anions in the perchlorate and nitrate-reducing 
pathways were not detected. Sulfate and bicarbonate levels were 25.5 mM and 122 mM, higher 
than concentrations previously tested for the perchlorate-reducing biocatalysts.64 
6.4.2. Characterization of SPF  
As in previous reports, biocatalysts were used as SPFs; they were not purified.64 
Throughout this work, the activities of the SPF were normalized to molybdenum, as the subunit 
α of perchlorate reductase and subunit NarG of nitrate reductase each contain one molecule of 
molybdenum.70, 220 SPFs produced in this work contained an average of 17.6 ± 0.4 mg protein 
mL−1 and 383 ± 47 μg Mo L−1 for A.oryzae and 11.5 ± 1.0 mg protein mL−1 and 418 ± 17 μg Mo 
L−1 for P. denitrificans. For the stable isotope experiments, data from a single SPF from 
Haloferax denitrificans is reported. This SPF had a protein concentration of 14.1 ± 0.8 mg 
protein mL−1. 
6.4.3. Biocatalytic Activity in Synthetic and Waste Brine 
Due to the structural similarity between perchlorate reductase and nitrate reductase,67 
SPFs from perchlorate-reducing and denitrifying bacteria were both tested with perchlorate and 
with nitrate. Considering perchlorate-reducing activity first, no activity was detected with P. 
denitrificans SPF, regardless of the sodium chloride concentration. The A. oryzae SPF had the 
highest perchlorate-reducing activity in the absence of sodium chloride, 146.7±21.8 U (µg Mo)-1, 
which was consistent with previously reported values of 162.5±8.4 U (µg Mo)-1.150. With 
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increasing salt concentration, the activity decreased linearly, with an R2 fit value of 0.999 (Figure 
6.2). However, even at 12% sodium chloride, the A. oryzae SPF retained a perchlorate-reducing 
activity of 32.3±6.1 U (µg Mo)-1. The A. oryzae SPF had higher activity with chlorate compared 
to perchlorate (Figure 6.2). Chlorate reduction decreased exponentially (R2=0.983), suggesting 
the activity is more sensitive to the initial increase in sodium chloride concentrations. However, 
chlorate-reducing activity maintained a factor of at least 1.8 times greater activity than 
perchlorate-reducing activity across all tested sodium chloride concentrations and was sustained 
even at 12% sodium chloride. The observed inhibition on perchlorate-reducing activity was not 
specific to sodium chloride for perchlorate reduction. In a mixture of 6% sodium chloride and 
3.7% sodium sulfate, the biocatalytic activity decreased to 42.8 ± 3.6 U (µg Mo)-1.  This activity 
is slightly less than the observed activity at 9% sodium chloride. 
 
Figure 6.2: Biocatalytic activity of A. oryzae SPF (squares) and P. denitrificans SPF (triangles) 
with perchlorate, nitrate, and chlorate. Results of MV activity assays conducted in increasing 
sodium chloride concentration (0-12% sodium chloride). Activity is given in Units (U), defined 
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Figure 6.2 (cont.) of perchlorate reductase or nitrate reductase. Double slash on y-axis indicates 
a change in scale. Solid line indicates regression fit from data. Error bars are standard deviation 
from triplicate biological replicates. 
Nitrate reduction decreased linearly with increasing sodium chloride concentration for 
both A. oryzae and P. denitrificans SPFs, but again was sustained even at 12% sodium chloride 
(Figure 6.2). In buffered solution without sodium chloride added, the A. oryzae SPF had a 
nitrate-reducing activity of 105.6±18.7 U (µg Mo)-1, and the activity decreased linearly with an 
R2 fit value of 0.998, to 28.7±3.2 U (µg Mo)-1 in 12% sodium chloride. With the P. denitrificans 
SPF, nitrate-reducing activity started at 188.9±8.1 U (µg Mo)-1for the buffered solution, similar 
to a previously published value for pure nitrate reductase of 285 U (µg Mo)-1.221 The activity 
decreased linearly with increasing sodium chloride (R2 fit of 0.991),with a nitrate-reducing 
activity of 16.1±7.1 U (µg Mo)-1 in buffered 12% sodium chloride solution. For SPF from A. 
oryzae, incubation under high sodium chloride concentrations did not cause a change in the 
concentration of molybdenum in solution (data not shown), which suggests that the biocatalysts 
remained soluble. 
Building on these promising results, perchlorate reduction was then tested using a real-
world waste brine spiked with 1 mM perchlorate (Figure 6.3). The A. oryzae SPF had a 37.1% 
decrease in activity in the waste brine (20.3±6.5 U (µg Mo)-1 in the waste brine versus 32.3±6.1 
U (µg Mo)-1 in the synthetic brine). Interpretation of this activity was however complicated by 
the presence of nitrate in the waste brine and the activity of A. oryzae SPF with nitrate; without 
spiking perchlorate, this SPF already had an activity of 17.4±2.7 U (µg Mo)-1. 
To better understand the effects of other anions present in the waste brine, the 
composition of the synthetic brine was systematically varied with the A. oryzae SPF (Figure 6.3). 
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Bicarbonate caused a slight but not statistically significant decrease in perchlorate-reducing 
activity. Sulfate also caused a slight decrease; in this case, the decrease was statistically 
significant. In a synthetic brine with no sulfate and bicarbonate, but where nitrate concentrations 
mimicked those in the waste brine (151mM), the perchlorate-reducing activity decreased to 
11.5±1.3 U (µg Mo)-1. A synthetic brine containing similar bicarbonate, sulfate, and nitrate 
concentrations to the waste brine showed good agreement with the real-world brine experiments. 
For nitrate reduction, this combination had 16.9±0.6 U (µg Mo)-1, as compared to 17.4±2.7 U (µg 
Mo)-1 in the waste brine (P = 0.28). For perchlorate reduction, the activity was 17.4 ± 1.0 U (µg 
Mo)-1, compared to 20.3 ± 6.5 U (µg Mo)-1 in the waste brine (P = 0.33). 
 
 
Figure 6.3: Biocatalytic activity of A. oryzae SPF (panel A) and P. denitrificans SPF (Panel B) 
in synthetic (12% sodium chloride) and waste brine for perchlorate, nitrate, and perchlorate and 










































































Figure 6.3 (cont.) mimicking the waste brine: 122 mM bicarbonate (B), 25.5 mM sulfate (S), 
and 151 mM nitrate (N). The exception is the N only experiment, which had 10mM nitrate. 
Activity is given in Units (U), defined as 1 µmol MV oxidized per minute, and normalized to µg 
of molybdenum, an indirect measure of perchlorate reductase and nitrate reductase. Error bars 
are standard deviation from triplicate biological replicates. 
The nitrate-reducing SPF from P. denitrificans was also tested with the waste brine, 
which contained 151 mM nitrate (Figure 6.3). Compared to the simplified synthetic system with 
10 mM nitrate, a slight decrease in activity was observed in the waste brine, to 14.3±3.8 U (µg 
Mo)-1. However, increasing the nitrate concentration in a synthetic brine to 151mM, to mimic the 
waste brine, resulted in an activity of 13.9±3.6 U (µg Mo)-1, not significantly different from the 
waste brine (P = 0.67). 
6.4.4. Perchlorate Fate 
Technical constraints prevented a direct analysis of all substrates, intermediates, and 
products in a single experiment, as detailed in the methods section. Since activity for perchlorate 
and chlorate was demonstrated (Figure 6.2) and no perchlorate was detected in the end-point 
assays at high salt concentrations, experiments focused on testing the activity of chlorite 
dismutase at varying salt concentrations, measuring oxygen formation from chlorite. The chlorite 
dismutase activity was more robust then the overall perchlorate activity in the methyl viologen 
assay, as no statistically significant decrease in activity was detected up to 9% sodium chloride (P 
= 0.09, 0.55 ± 0.04 mg O2 L
-1 s-1) (Figure 6.4). At the highest sodium chloride concentration, the 
average chlorite dismutase activity had a statistically significant decrease to 0.51 ± 0.05 mg O2 
L-1 s-1 at 12% sodium chloride. The average activity of chlorite dismutase in the waste brine was 





Figure 6.4: Biocatalytic formation of oxygen from chlorite using A. oryzae SPF in synthetic and 
waste brines. Total oxygen formed (bars) is reported in µmoles, with the red line indicating the 
theoretical maximum determined from chlorite added (1.8 µmoles). Oxygen formation rate 
(squares) from the decomposition of chlorite is given in mg O2 L
-1 s-1. Error bars are standard 
deviation from triplicate biological replicates.  
The total amount of oxygen formed was tracked, and this mass corresponded well with 
the mass of chlorite added to the system. Greater than 90% of the expected oxygen was 
measured for reactions containing up to 6% sodium chloride. At higher sodium chloride 
concentrations, the mass of oxygen captured was 89.0% for 9% sodium chloride, 86.3% for 12% 
sodium chloride, and 69.0% for waste brine. The decrease in the mass balance closure could be 
accounted for by decreased activity under the latter conditions, which allowed more time for 
oxygen to diffuse out of the open system.  
6.4.5. Nitrate Fate 
The fate of nitrate was tracked by measuring potential products after biocatalytic 






















































treatment. Nitrous oxide and dinitrogen were measured as gaseous end products, using stable 
isotope analysis for the dinitrogen, and ammonium as an aqueous end product. Mass balance 
calculations suggest there was no accumulation of nitrite or nitric oxide in the synthetic brine 
system. The stable isotope experiments were conducted in synthetic, buffered systems, and 
results are based on a single biological replicate with duplicate analytical replicates, unless 
accompanied by a standard deviation. In control experiments, abiotic conversion of nitrite was 
observed via direct reaction with the electron shuttle PMS or electron donor NADH. The 
predominant product of this chemical reaction was ammonium, comprising 75.5% of the total N 
mass balance. The formation of nitrous oxide was also observed but constituted less than 1% of 
the total N mass. 
The A. oryzae SPF yielded nitrous oxide as the dominant product, with 85.5% of the 
nitrogen recovered as nitrous oxide in 0% sodium chloride and 96.4% in 12% sodium chloride. 
In both conditions, no 15N2 or ammonium was detected from the reaction. These results suggest 
that while these perchlorate-reducing biocatalysts have activity for nitrate, the A. oryzae SPF is 
unable to reduce nitrous oxide into dinitrogen. 
In contrast, the P. denitrificans SPF was able to completely reduce the labeled nitrate into 
dinitrogen at 0% sodium chloride. Under these conditions, no nitrous oxide was detected, and 
99.4% ± 4.0% dinitrogen was recovered. However, sodium chloride concentrations of 3% or 
more prevented dinitrogen production; instead, nitrous oxide was formed. Recoveries of nitrous 
oxide ranged from 83.3% to 99.0% for sodium chloride concentrations from 3% to 12%. Stable 
isotope detection of dinitrogen gas was not possible with the waste brine, because of its high 
nitrate concentration, but nitrous oxide was detected after waste brine experiments with SPF 
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from both A. oryzae and P. denitrificans. 
As a preliminary attempt to achieve complete reduction of nitrate at elevated brine 
concentrations, SPF from a salt tolerant denitrifier, H. denitrificans, was also tested in stable 
isotope experiments. The H. denitrificans SPF performed worse than P. denitrificans at 0% 
sodium chloride, with only 4.6% of the original nitrate reduced to dinitrogen. However, the H. 
denitrificans SPF was the only one to show any dinitrogen formation in 12% sodium chloride 
(1.4%). The remaining nitrogen was in nitrous oxide, ammonium, and nitrate. Adding both P. 
denitrificans and H. denitrificans SPF simultaneously (100 µL each) increased the total gaseous 
nitrogen to 84.3% of the total mass. The dinitrogen yield increased to 25.1% and nitrous oxide 
comprised 59.2% of the total nitrogen content in 12% sodium chloride. For the combined SPFs, 
the formation of ammonium was below detection.  
6.5. Discussion 
This work demonstrates biocatalytic reduction of the contaminants perchlorate and nitrate 
in concentrated synthetic and real-world waste brines containing up to 12% sodium chloride. To 
our knowledge, it is the first report on the impact of sodium chloride concentration on these 
enzymes, as well as the first report of biocatalytic nitrate reduction. Differences in the activity for 
a real-world waste brine compared to synthetic, buffered, laboratory brine were due to the 
elevated concentrations of bicarbonate, sulfate, and nitrate in the waste brine. Perchlorate was 
completely degraded to innocuous end products: chloride and oxygen, while the end products 
from the reduction of nitrate depended on the source of the biocatalysts and the reaction 
conditions. 
At sodium chloride concentrations relevant to brines used in ion-exchange regeneration, 
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the activities of the enzymes decreased, but substantial activity was retained even at 12% sodium 
chloride. One possible mechanism for the decrease in perchlorate-reducing activity is product 
inhibition, since chloride is a product of perchlorate reduction. In the current work, however, the 
chlorite dismutase in the A. oryzae SPF had no apparent inhibition at concentrations up to 9% 
sodium chloride. Studies on purified enzymes from other organisms have given conflicting 
results, suggesting that this property varies among isozymes.85 78 Furthermore, in the current 
work, the impact of anions on the biocatalytic activity was not unique to perchlorate reduction or 
to sodium chloride, suggesting a more general mechanism of inhibition. While anion and cation 
effects from the Hofmeister series may result in the biocatalysts salting out of solution, this 
explanation was not supported by molybdenum analysis. This would effectively decrease the 
biocatalysts available for perchlorate and nitrate reduction.222 Ions can also play a role in the 
stabilization of particular biocatalysts, as previously shown for purified chlorite dismutase.78  
Compared to other approaches for perchlorate degradation, the biocatalysts have 
advantages in effective range, efficient use of the electron donor, and/or reaction rates. In whole-
cell systems, some perchlorate-reducing strains were inhibited with the addition of only 2.5 or 
5% sodium chloride.223 A salt-tolerant culture was able to reduce nitrate and perchlorate in real-
world 6% waste brine, when amended with magnesium, calcium, and potassium, but was 
apparently not tested at higher concentrations.103, 224 In another system, perchlorate and nitrate 
were reduced in 10% sodium chloride but required acclimation, excess acetate addition, and a 15 
hour empty bed contact time to achieve complete reduction.225 In contrast, the biocatalysts used 
here showed immediate activity even at 12% sodium chloride. In our assays, the amount of 
electron donor required to achieve perchlorate and nitrate reduction had a 4 molar excess ratio 
versus 10 for whole-cell biological reduction.225 Unfortunately, the units used in previous 
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publications on whole-cell processes do not permit a direct comparison of the reaction rates with 
biocatalysis. Both the chemical reduction and existing chemical catalysts are most effective at 
acidic pH, while the biocatalysts function well under a typical range of pHs for water treatment. 
Compared to bi-metallic chemical catalysts,33 the biocatalysts have reaction rates that are three or 
four orders-of-magnitude faster for perchlorate and nitrate, respectively, when both activities are 
normalized to the relevant metal content.  
The fate of the contaminants is another important consideration. The complete 
perchlorate reduction pathway was functional even at 12% sodium chloride, and its end products 
of oxygen and chloride are innocuous. The fate of nitrate in biocatalytic reduction is more 
complicated, due to its longer pathway and the confounding effect of abiotic ammonium 
formation between nitrite and the electron donor or shuttle. In brines, the SPF from A. oryzae 
reduced nitrate into nitrous oxide. The reduction of nitrate could have been catalyzed either by 
perchlorate reductase67 or by a putative nitrate reductase encoded in the A. oryzae genome.119 
There are also putative nitrite and nitric oxide reductases in its genome, which could account for 
the subsequent conversion to nitrous oxide. P. denitrificans has the full denitrifying pathway, and 
its SPF produced dinitrogen when sodium chloride was not added. However, in brines, the P. 
denitrificans SPF produced nitrous oxide rather than dinitrogen gas, suggesting that the nitrous 
oxide reductase may be sensitive to the salt concentration. Ammonium formation occurred only 
with the H. denitrificans SPF alone. Based on control experiments, we attribute this to abiotic 
formation from nitrite and suggest that biological nitrite reduction may be slower in this 
organism. Interestingly, although the H. denitrificans SPF on its own converted only a small 
fraction of the nitrate to dinitrogen gas, when the two denitrifying SPFs were added together, 
approximately a quarter of the nitrate was completely reduced even at 12% sodium chloride. For 
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comparison, chemical reduction produces ammonium, thus requiring an additional treatment 
process to remove the ammonium.210 Chemical catalytic reduction converts 30% of the nitrate 
mass balance to ammonium and 3% to nitrite;156 both are undesirable end products. To our 
knowledge, no end product analysis has been reported for whole-cell biological reduction of 
nitrate in waste brine.   
These results suggest that the end products of biocatalytic nitrate reduction could be 
controlled by the selection of biocatalysts and reactor design. With the large diversity of nitrate-
reducing organisms, there may exist biocatalysts better suited for high nitrate concentrations and 
salinity, and genetic engineering techniques provide additional options for improving the 
biocatalysts. To decrease production of nitrous oxide, optimization of nitrous oxide reductase 
would be recommended. Designing a reactor with minimal head space would also help retain 
nitrous oxide in the aqueous phase, allowing more time for its reduction. Alternatively, the 
process could be designed for recovery of nitrous oxide. Nitrous oxide has been proposed to 
enhance the power output of biogas in wastewater treatment,226 but it is unlikely that water 
treatment facilities would have access to biogas. However, with a possible mass balance yield of 
3.3 g of high purity nitrous oxide from a liter of waste brine, it could be feasible to recover 
nitrous oxide for use as an aerosol propellant or an oxidizer in fuel.  
The catalytic life of the biocatalysts and their reuse potential are important considerations 
for process design that were not addressed in this initial investigation. For the perchlorate-
reducing biocatalysts, robust activity was observed up to 23 days without any optimization of 
storage conditions.64 It is likely that chlorite dismutase would be the limiting component, since it 
is subject to catalytic inactivation.83 However, recent efforts to identify an optimal chlorite 
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dismutase for water treatment application already yielded a biocatalyst with a catalytic life up to 
six times greater than the one used in this study.83 To our knowledge, no corresponding 
information is available on the nitrate-reducing biocatalysts, but the structural similarities 
between perchlorate reductase and nitrate reductase67 suggest that at least the first step will be 
similarly long-lived. A variety of options are available to retain or recover biocatalysts, based on 
previous applications in industrial syntheses, but additional research is needed to identify the 
options most appropriate for these particular biocatalysts and their large-scale applications in 
water treatment. 
6.6. Conclusions 
To our knowledge, this is the first investigation of biocatalysts to treat real-world waste 
brine; the long-term goal is to improve the sustainability of ion-exchange processes. This is also 
the first demonstration of nitrate-reducing biocatalysts for water treatment. Biocatalytic 
treatment of waste brines would serve two purposes: it would prevent reintroduction of the 
contaminants into the environment and it would allow reuse of the brine. The impact of the first 
of these is difficult to quantify, as there is little information currently available on the 
contributions of these brines to nitrate and perchlorate in the environment. For the second, some 
estimates are possible. Regeneration of ion-exchange resins with a 6% sodium chloride solution 
represented 10.9% of the median cost and 44.8% of the median global warming potential of ion-
exchange treatment,179 suggesting the potential for substantial benefits. Application of whole-cell 
brine regeneration for perchlorate and nitrate at the pilot scale resulted in estimated cost 
reductions of 18.4%.103 With effective removal of nitrate and perchlorate, brine reuse could be 
achieved. Limitations on the number of reuse cycles would likely depend on other constituents of 
the source water, such as radiohalides.103  
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Biocatalysis is a new approach for environmental engineering, and further development is 
required to make it economically viable, particularly in the areas of biocatalyst reuse and supply 
of electron donors.179 However, as brine regeneration occurs in a significantly smaller volume 
than drinking water treatment and is not feeding directly into distribution systems and 
subsequent human consumption, brine regeneration appears to be both a good potential 
application for biocatalytic treatment and a route to promote the technology development that 
could form the basis for a wide range of biocatalytic treatment processes. 
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CHAPTER 7: CONCLUSIONS AND FUTURE WORK 
This work demonstrates the promising application of biocatalysts for drinking water 
treatment and highlights methods to swiftly advance and implement new drinking water 
treatment technologies. The biocatalysts maintained robust activity in real-world groundwaters 
with selectivity for perchlorate over co-competing contaminants such as nitrate. They operated 
over a range of environmentally relevant temperatures, pH, and environmental matrices. To 
further advance perchlorate biocatalytic technologies, I used an economic and environmental 
assessment to identify three improvement targets for the biocatalysts. These include achieving 
increases in biocatalytic yield or reuse of the biocatalysts in the drinking water treatment system 
and eliminating the electron shuttle.  
Improvements to the yield of the biocatalyst, chlorite dismutase, were not expected to 
deliver the required advancements. Efforts, therefore, were focused on achieving reuse by 
immobilizing the biocatalysts. Three mechanisms of immobilization (encapsulation in Chapter 2, 
affinity attachment in Chapter 5, and spore display in Appendix D) were studied. Entrapment and 
affinity attachment were accomplished. For affinity-attached chlorite dismutase, the decrease in 
activity was well modeled using parameters from mass transfer and kinetic equations. For 
operational improvements, the potential of electrobiocatalytic reduction of perchlorate was 
explored but still required the presence of the electron shuttle (Appendix E).   
Even with advancement, the adoption of a new drinking water treatment technology can 
be a slow process. To accelerate this process, the biocatalysts can be integrated with established 
drinking water technologies such as ion exchange. The benefit for ion exchange is the potential 
reduction of costs and environmental impacts. For the novel technology, this approach offers a 
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path for implementation while providing exposure to treatment operators and evidence of the 
robust nature of biocatalysis. While this dissertation demonstrated the potential of biocatalysis, 
additional research steps are required. The following section highlights additional objectives 
following the outline of the dissertation. These objectives are broadly classified into further 
advancing the sustainability of the biocatalysts (Sections 7.1.1, 7.1.2, and 7.1.3) and exploring 
additional approaches to combining the biocatalysis with traditional drinking water treatment 
(Section 7.1.4).  
7.1. Next Steps 
7.1.1. Surveying Diversity of Perchlorate Reductase 
Perchlorate reductase has some activity for nitrate. However, even this low nitrate 
activity contributes to the cost and environmental impacts of the technology. Using an approach 
similar to our study that identified a chlorite dismutase more resistant to catalytic inactivation,83 
surveying the natural diversity of perchlorate reductase may yield an isozyme with better 
characteristics. To reduce the costs and impacts associated with the required electron donor for 
nitrate reduction, an isozyme that demonstrates greater selectivity for perchlorate in the presence 
of nitrate could be identified.  
7.1.2. Assessing the Costs and Environmental Impacts of the Immobilization Methods 
The economic and environmental assessment performed in Chapter 4 excluded the costs 
and environmental impacts associated with the biocatalytic immobilization support material. 
Several of the support materials used in this study were convenient for demonstrating 
immobilization strategies. However, these materials bear considerable cost (e.g., $37.96 g-1 for 
the Strep-Tactin resin beads). These materials should be evaluated for their costs and 
environmental impacts. If these materials are deemed cost prohibitive and not environmentally 
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sustainable, efforts should focus on optimizing material production or identifying other suitable 
immobilization materials.  
7.1.3. Improving Activity of Electrobiocatalytic Reduction of Perchlorate  
To utilize alternative electron donors, an electrochemical system was explored (Appendix 
E); however, the current electrobiocatalytic setup does not have the required activity to treat 
perchlorate in drinking water. Two approaches could be used to explore these limitations. First, 
attaching the biocatalysts directly to the surface of the electrode while eliminating the electron 
shuttle could reduce the number of electron transfers and minimize diffusion distances. Second, 
increasing the mixing rate of the reactor could compress the diffusion distance. Concerning the 
quality of the electrodes, the material exhibited high resistance. Better materials could lower this 
barrier and increase the rate of perchlorate reduction.  
7.1.4. Directly Regenerating Ion Exchange Resins 
Chapter 6 provided evidence for combining biocatalysis with traditional treatment 
technologies. The motivation is the potential benefit of minimizing costs and environmental 
impacts. For example, the sodium chloride utilized in the regeneration of ion-exchange resins 
represents significant costs and environmental impacts. Even with brine-regeneration 
technologies, further advancements are possible. The next step in the hybrid approach is the 
complete elimination of the brine solution. Because of their small size, biocatalysts could 
potentially reduce the contaminants on the surface of the resin without a brine solution. 
7.2. Contributions to Environmental Engineering 
This dissertation includes two significant contributions to the field of Environmental 
Engineering. The first contribution is the unlocking of a powerful new toolbox for targeted 
drinking water treatment applications. The second is the articulation of an iterative methodology 
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incorporating experimentation, modeling, sustainability analysis, and technology comparison to 
rapidly advance the novel technology’s development.  
Perceptions, such as high costs, have been a barrier to implementation of biocatalytic 
technologies in water treatment. When I started this work, no examples of contaminant-specific 
biocatalysis were available. To the best of my knowledge, this continues to be the case. However, 
through my efforts, these technologies have potential applications in environmental processes. 
These applications could include targeting many human-made environmental contaminants that 
persist in the environment. Through evolution and under specific environmental conditions, 
microorganisms have provided the biocatalytic tools to address these long-lived contaminants. 
This includes degradation of plastics,227, perfluorinated compounds,228 and synthetic 
hormones.229  
By bringing biocatalysis to the field of Environmental Engineering, the impact of the 
technology is not limited to the development of a new toolbox. Biocatalytic technologies can 
inspire the development of new materials as well as inform the optimization of microbial 
processes in engineered systems. Biocatalysts provide a boundless supply of inspiration to 
inform the development of biomimetic materials. Accelerated discovery of materials with 
unique, desired properties could be based on biological phenomena by applying our fundamental 
understanding of biocatalytic technologies. For example, the water selectivity of aquaporin 
proteins has provided potential inspiration for the surface modification of carbon nanotubes.230 
The next link is connecting our fundamental knowledge of biocatalysts to biologically 
engineered systems. The biocatalysts’ response to environmental conditions is indicative of the 
performance of biological systems. We can use our observations to design selective pressures to 
optimize biological treatment systems.  
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Finally, I hope the methodology used in this dissertation provides a framework to rapidly 
advance new technologies. Drinking water treatment technologies have a long development 
phase before implementation. For example, reverse osmosis required nearly 40 years of 
development to bring costs down to thermodynamic limits.86 By identifying research objectives 
and optimizing the use of research resources, I hope to bring down the costs and environmental 





The following is a detailed recipe of the anaerobic growth media, RST, used throughout 
this dissertation.  
 
Ralph S. Tanner (RST) Basal Media for Azospira oryzae (ATTC BAA-33) Growth 
 
RST Basal Medium                  (L-1) 
RST Mineral Stock Solution   20 ml 
RST Trace Metal Stock Solution  10 ml 
RST Vitamin Stock Solution   10 ml 
TES buffer     4.6 g 
NaHCO3     1.0 g 
Yeast extract     1.0 g 
NaCH3COOH     2.0 g 
NaClO4     1.0 g 
 
Adjust pH to 7.2 with 10N NaOH 
 
To degas the samples, follow these instructions based on the volume of media being prepared. 
 
Volumes less than 100 ml: 
 
Cap and crimp seal bottles 
Exchange headspace 3 times with UHP N2 (10 psi) 
Autoclave 120°C 15 min 
 
Volumes greater than 100 ml: 
 
Autoclave 120°C 20 min uncapped 
Cap and crimp seal bottles while hot 
Using sterile cotton filters, exchange headspace 3 times with UHP N2 (5 psi) while hot 
 
The larger the volume the longer a vacuum should be applied to the media: 
 Less than 100 ml use three cycles of 30 min, 15 min and 5 min 
 Greater than 100 ml use three cycles of 1hr, 30 min, and 15 min (while hot) 
 





RST Stock Solutions – The stock solutions were filter sterilized (0.22 µm). 
 
RST Mineral Stock Solution  (L-1) 
NaCl      40 g 
NH4Cl      50 g 
KCl      5.0 g 
KH2PO4     5.0 g 
MgSO4 • 7H2O    10 g 
CaCl2 • 2H2O     1.0 g 
 
RST Trace Metal Stock Solution  (L-1) 
Nitrilotriacetic acid (pH 6.0 w/ KOH) 2.0 g 
MnSO4 • 2H2O    1.0 g 
Fe(NH4)2(SO4)2 • 6H2O   0.8 g 
CoCl2 • 6H2O     0.2 g 
ZnSO4 • 6H2O     0.2 g 
CuCl2 • 2H2O     20 mg 
NiCl2 • 6H2O      20 mg 
Na2SeO4     20 mg 
Na2WO4 • 2H2O    20 mg 
Na2MoO4 • 2H2O    20 mg 
 
RST Vitamin Stock Solution  (L-1) 
Pyridoxine HCl    10 mg 
Riboflavin     5.0 mg 
Calcium pantothenate    5.0 mg 
PABA      5.0 mg 
Thioctic acid     5.0 mg 
Niacinamide     5.0 mg 
Biotin      2.0 mg 
Folic acid     2.0 mg 






This supporting information was published with Chapter 2. The citation is Hutchison, J. 
M.; Poust, S.K.; Kumar, M.; Cropek, D.M.; MacAllister, I.E.; Arnett, C.M.; Zilles, J. L., 
Perchlorate reduction using free and encapsulated Azospira oryzae enzymes. Environmental 
Science and Technology 2013, 47, (17), 9934-9941. Explicit copyright permission is not required 
as I am the author of this work. For ease of access to relevant information, this section has been 
included as an Appendix. The content of this section is based on my Master’s Thesis found at 
http://hdl.handle.net/2142/34559 except for Section B.2.6 and Figure B.3.   
B.1. Methods 
B.1.1. Vesicle Preparation  
Vesicles were formed using the previously published method of film rehydration 126. 
Twenty mg of lipid (9:1 ratio of soy asolectin and cholesterol (Sigma-Aldrich, St. Louis, MO)) or 
12 mg of polymer (poly-(2-methyloxazoline)-poly-(dimethylsiloxane)-poly-(2-methyloxazoline) 
PMOXA15-PDMS110-PMOXA15) 
231 was dissolved in a 100 mL round bottom flask with 2 mL of 
chloroform and evaporated to form a thin film. For rehydration, 2 mL of Azospira oryzae soluble 
protein fraction, 1:200 molar ratio of purified OmpF where specified, and 0.3% n-octyl-oligo-
oxyethylene (Enzo Life Sciences, Ann Arbor, MI) were added to the round-bottom flask. The 
solution was mixed by alternating 30 s bath sonication and vortexing for 5 minutes. The mixture 
was stored at 4°C with stirring for 12 hours, sonicated and vortexed for an additional 5 minutes, 
and stored at 4°C with stirring for an additional 24 hours. This treatment resulted in a cloudy, red 
mixture that was extruded through a 1μm track-etched filter (Nucleopore, Whatman, GE 
Healthcare, Piscataway, NJ) in a LIPEX extruder (Northern Lipids, Burnaby, British Columbia, 
Canada). To produce unilamellar vesicles, the solution was extruded an additional ten times 
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through a 0.4 μm pore-sized track-etched filter. To break up protein aggregates, the extruded 
vesicles were treated with 5% (v/v) of 20 mg mL-1 Proteinase K (Roche Applied Science, 
Indianapolis, IN) for one hour at room temperature. Size exclusion chromatography was used to 
separate non-inserted OmpF, non-encapsulated protein and vesicles, on a Tricorn 10/300 filled 
column with Sephacryl 500-HR (GE Life Sciences, Piscataway, NJ) and an ÄKTAprime plus 
system (GE Life Sciences, Piscataway, NJ) using a maximum column pressure of 0.38 mPa and a 
flow rate of 0.5 ml min-1.  
B.1.2. Dynamic Light Scattering (DLS)  
Lipid and polymer vesicle sizes (diameter) and size distribution (polydispersity index – 
PDI) were analyzed by dynamic light scattering (DLS) on a Zetasizer Nano ZS90 (Malvern 
Instruments Ltd., Malvern, UK) using a 632.8 nm He-Ne gas laser at 12.8° and 90°. Samples 
were analyzed at room temperature using a refractive index of 1.47 and an absorption value of 
0.10.  
B.1.3. Transmission Electron Microscopy (TEM)  
To confirm the formation of polymer vesicles, images were captured using a JEM-2100F 
TEM with LaB6 emitter (JEOL USA, Inc., Peabody, MA) located at the University of Illinois 
Material Research Laboratories (Urbana, IL.) Ultrathin holey carbon grids supported on a gold 
mesh (Ted Pella, Inc., Redding, CA) were prepared by charging for 45 s under a Denton DPG-1 
glow-discharge system (Denton Vacuum Inc., Moorestown, NJ) at 200 mA. Vesicle dilutions of 
1:2 by volume in 50 mM phosphate buffer at pH 6.0 were incubated on the charged carbon grids 
for 2 min, blotted, stained with 1% uranyl acetate dye (SPI, West Chester, PA), and immediately 
blotted again. Grids were stained a final time for 1 min, blotted, and air dried for 5 min. Grids 
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were viewed at 200 kV and 110 μA e-beam current, and several images were acquired per grid. 
B.1.4. Verification of Incorporation of OmpF  
Incorporation of OmpF was confirmed by measuring retention of encapsulated 
fluorescence in polymer vesicles. During vesicle formation, 2.5 mM of 5,6-carboxyfluorescein 
dye (Life Technologies Molecular Probes, Carlsbad, CA) was included. Following separation of 
vesicles from unencapsulated dye by size exclusion chromatography as detailed under vesicle 
preparation, fluorescence was measured with excitation at 492 nm and emission at 517 nm using 
a SPECTRAmax PLUS microplate spectrophotometer (Molecular Devices Corporation, 
Sunnyvale, CA). Leakage of carboxyfluorescein through the lipid membrane prevented similar 
analysis in lipid vesicles. 
B.2. Results 
B.2.1. Characterization of Vesicles  
The average size and PDI, a measure of size distribution, of the vesicles were measured 
by dynamic light scattering (Table B.1). For lipids, the average size of OmpF vesicles was not 
statistically different from vesicles without OmpF (Table B.1, n=3 P=0.254). The PDI was 
relatively high in these preparations. This is due to the limited number of extrusions and the use 
of a 0.4 μm pore size for extrusion; these decisions were designed to minimize vesicle lysis and 
the accompanying release of the perchlorate-reducing enzymes. The PDI for the two sets is 
significantly different (OmpF = 0.452, No OmpF = 0.268, n=3 P=.018). For polymer vesicles, 
the size and PDI were similar with and without OmpF. Transmission electron microscope 
imaging also indicates the formation of polymer vesicles (Figure B.1). As reported previously, 




Table B.1: Diameter and size 
distribution for lipid and polymer 




   
Lipid OmpF 371.6 0.45 
Lipid 320.3 0.27 
Polymer OmpF 185.2 0.15 




Figure B.1: Examination of polymer vesicles using transmission electron microscopy. (a) 
Micrograph of the No OmpF vesicles (Scale bar: 50nm) (b) Micrograph of the OmpF vesicles 
(Scale bar: 100nm), 
B.2.2. Incorporation of OmpF  
The incorporation of OmpF in the polymer vesicles was confirmed by testing retention of 
carboxyfluorescein in vesicles with and without OmpF. The low fluorescence signal observed in 
vesicles with OmpF, compared to vesicles without OmpF, supports the functional incorporation 




absence of OmpF.  
 
 
Figure B.2: Incorporation of OmpF prevents retention of the fluorescence dye, 
carboxyfluorescein, as shown by the decrease in fluorescence in the presence of OmpF for 
polymer vesicles, illustrated here visually and through fluorescence measurements taken at 
517nm emission wavelength. The negative control was buffer. 
B.2.3. Calculations of the Volume Limitations Imposed by the Polymer Vesicles  
Encapsulation should lower the perchlorate-reducing activity due to the volume 
limitations imposed by the vesicles, and might also introduce diffusion limitations. To predict the 
encapsulated activity, the total volume activity (TVA) restriction of the vesicle, as determined by 
the encapsulation volume of the perchlorate-reducing vesicles, and 2) the diffusion-limited 
activity (DLA), as determined by the perchlorate diffusion across OmpF in the polymer 
membrane, were calculated as follows.  
B.2.4. Encapsulation Volume Restriction on Activity 
The total volume activity (TVA) was calculated using Equation B.1: the volume 









The theoretical total volume activity (TVA) was calculated using the total vesicle 
encapsulation volume (TEV), the activity of the soluble protein fraction (APF), and the total 
suspension volume of the vesicle (TVV) after preparation using size exclusion chromatography. 
The TEV was calculated by determining the total number of vesicles (TNV) and the 
encapsulation volume of one vesicle (EV). The TNV was difficult to determine from dynamic 
light scattering results due to their small size. So, the TNV was calculated using the mass of 
polymer, the surface area (SA) of a polymer molecule estimated at 350 Å2 233, 234, and the surface 
area of a vesicle using a radius of 90 nm. This calculation assumed that all polymer molecules 
were incorporated into vesicles. This value was converted to the total number of polymer 
molecules using the molecular weight of 11,048 mg mmol-1. 
The EV of a vesicle was determined from the geometrical equation of volume for a 
sphere.  The inner diameter of the vesicle was used. The inner diameter of the vesicle was 
determined from light scattering and the thickness of the polymer, 15 nm. The inner diameter 
used in these calculations was 150 nm.  For the activity of the soluble protein fraction (APF), the 
average of activities from soluble protein fraction was used. These calculations resulted in a TVA 
of approximately 95 U L-1. 
B.2.5. Perchlorate Diffusion Restriction on Activity 
The diffusion limiting activity (DLA) was calculated using Equation B.2.  






The diffusion limiting activity was determined using Fick’s First Law of diffusion (F), 
the surface area of the vesicles (SAV), and the total volume of the vesicle suspension (TVV). 




The flux of perchlorate was determined from the diffusion coefficient (D), the porosity of 
the vesicles (n), and the perchlorate concentration gradient (dC/dx). 
For perchlorate, the published diffusion coefficient (D) 2.25 X 10-5 cm2 s-1 was used.196 
The equations were adapted to account for the pore structure of the vesicles. Perchlorate was 
assumed to diffuse into the vesicles only through the pores, and the flux of perchlorate into the 
pore was assumed not to be hindered by steric effects. The calculations also assumed 100% 
insertion efficiency of the 1:200 molar ratio of OmpF to polymer. The porosity of the vesicle, a 
dimensionless number, was therefore determined from the ratio of OmpF surface area to vesicle 
surface area and molar ratio. The dimensions of the pore were given as 7Å by 11Å 129. The 
surface area of the elliptical OmpF was 60.5 Å2. The concentration gradient (dC/dx) was 
determined by the perchlorate concentration used in the experiments (0.83 µmole cm3) over the 
radius of the vesicle.  The vesicle radius was used as the diffusion length to approximate the 
boundary layer thickness. The flux of perchlorate was converted to µmoles of methyl viologen 
(MV) consumed per minute for comparison with activity measurements by applying the known 
reaction stoichiometry (complete reduction of perchlorate consumes eight moles of MV).  
Having determined the flux of perchlorate (F), the total surface area of the vesicles (SAV) 
was calculated using the surface area of one vesicle and the total number of vesicles as 
previously calculated. The diffusion-limited activity was determined to be 4,940,000 U L-1. As 
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the DLA value is much greater than the TVA, diffusion was not found to be limiting under 
experimental conditions. However, at lower perchlorate concentrations, diffusion could become 
limiting. 
B.2.6. Activity Limitation of Vesicles 
To demonstrate that the vesicles are activity limited rather than mass transfer limited, 
vesicles were formed with three ratios of OmpF to polymer subunit: 0:1 (No OmpF), 1:4000 
(OmpF 1X) and 1:2000 (OmpF 2X) (Figure B.3). The perchlorate-reducing activity was 
normalized to molybdenum, a transition metal found in the metal cofactor of perchlorate 
reductase. The vesicle activity was compared to the activity of free biocatalysts in the soluble 
protein fraction.  
The vesicle activity is mass transfer limited when no OmpF is included in the vesicles, 
limiting perchlorate diffusion. Some activity is still observed and may be explained by two 
hypotheses. The first is pores from the A. oryzae carried over in the soluble protein fraction 
during preparation. These pores integrated into the vesicles. The second explanation is the 
diffusion of perchlorate through the vesicle wall. While carboxyfluorescein did not diffuse 
through the vesicle walls (Figure B.2), it is possible that perchlorate, a much smaller molecule, 




Figure B.3: Activity limitation of perchlorate-reducing vesicles. Activity of four preparations 
was compared including soluble protein fraction (SPF), vesicles without OmpF (No OmpF), 
vesicles with a 1:4000 ratio of OmpF to polymer (OmpF 1X), and vesicles with a 1:2000 ratio of 
OmpF to polymer (OmpF 2X). Activity was normalized to molybdenum, an indirect 



























This supporting information was published with Chapter 4. The citation is Hutchison, J. 
M.; Guest, J.S.; Zilles, J. L., Evaluating the development of biocatalytic technology for the 
targeted removal of perchlorate from drinking water. Environmental Science and Technology 
2017, 51, (12), 7178-7186. Explicit copyright permission is not required as I am the author of 
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C.1. Methods 
This environmental and economic assessment examined five technologies to address 
perchlorate removal in drinking water treatment. Production and operation parameters and 
distributions are presented in Table C.1. General and technology-specific equations are presented 
below. Materials for the production of the biocatalyst and chemical catalysts are included in 
Table C.2. 




Table C.1 Model parameters and distributions  
Parameters Value Units Distribution  Reference 
Biocatalysts     
Maximum Activity (Vmax) 20.31±1.81 (µmol min-1 µg 
Mo-1) 
Normal 150 
Half-Saturation Constant (Km) 92±32 (µM) Normal 150 
PreExponential Constant (A) e21.3676 (µmol min-1 µg 
Mo-1) 
±10% 150 
Activation Energy (Ea) 45630.78±221
5.46 
(J mol-1) Normal 150 
Catalysts     
Rate Constants 0.0005, 
0.0043, 0.083 
g L-1 min-1 Triangular 25, 29, 146, 235 
Whole-Cell     
Yield on Oxygen 15.9±0.6 gDWb (mol)-1 Normal 236 
Yield on Nitrate 11.9±0.4 gDWb (mol)-1 Normal 236 
Yield on Perchlorate 14.4±2.2 gDWb (mol)-1 Normal 236 
Non-Selective Ion Exchange     
Selectivity Coefficient – Chloride 1.0   20, 155  
Selectivity Coefficient – Nitrate 3.0   20, 155  
Selectivity Coefficient – 
Perchlorate 
50.0   20, 155  
Selectivity Coefficient – 
Bicarbonate 
0.3   155  
Selectivity Coefficient – Sulfate 0.2   20, 155  
General Parameters     
Heat Exchanger Efficiency 70–90%  Uniform a  
Pump Efficiency 60–80%  Uniform a 237 
Pump Motor Efficiency 60–80%  Uniform a 237 
Transportation Distance - 
Production 
10, 50, 500 km Triangular  a 
Transportation Distance – 
Operation 
10, 50, 500 km Triangular a 
Cleanings  1-12 yr-1 Uniform a 
Oxygen Concentration Influent 0, 4.8, 8 mg L-1 Triangular a 
Temperature Influent 5–25 °C Uniform 142 
Mixing Speed 50-180 s-1 Uniform a 
Piping Length 10-30 ft Uniform a 
Fluid Velocity 6-10 ft s-1 Uniform a 
Diameter of Pipes 0.333-0.833 ft Uniform a 
Standard Aeration Efficiency 0.5-4.5 kgO2 kW-1 hr-1 Uniform 25, 238 
Cleaning Thickness  0.001-0.003 m Uniform a 
Technology Production Parameters     
Volume of Reactor 500 m3 N/A a 
Height of Reactor 10–30 ft Uniform a 
Incubation Time 44-52 hr Uniform 64 
Influent Water Temperature 5-20 °C Uniform 142 
Operating Temperature of Reactor 30 °C  64 
Ambient Temperature of Facility 15, 20, 25 °C Triangular a239 
Thickness of Insulation 0.1, 0.3, 0.6 m Triangular a 
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Table C.1 Continued - Model parameters and distributions   
Thermal Conductivity of 
Insulation 
0.02, 0.04, 0.1 W m-1 C-1 Triangular a 
Transmembrane Pressure 5-20 ft Uniform 237 
Biocatalyst Yield 0.0018-0.0022 L L-1 Uniform 150 
Biocatalyst Concentration 357±39 µg Mo L-1 Normal 150 
Maximum Nitrate Inhibition 1, 3 mM Uniform 64, 150 
Nitrate Activity Reduction 0.279±0.011  Normal 64 
Electron Shuttle Dosing 0.01, 0.129, 
0.2 
g L-1 Triangular 64 
Pd AC Production Time 0.067, 0.083, 
0.1 
hr Triangular 240 
Reactor Temperature  70, 80, 90 °C Triangular 240 
Pd AC Drying – 1 100, 110, 120 °C Triangular 240 
Pd AC Dry Time – 1 0.9, 1.0, 1.1  hr Triangular 240 
Pd AC Drying – 2 225, 250, 275 °C Triangular 240 
Pd AC Dry Time – 2 0.9, 1.0, 1.1 hr Triangular 240 
Pd AC Yield 0.0706, 
0.0784, 
0.0862 
kg L-1 Triangular 240 
RePd AC Production Time 4.5,5,5.5 hr Triangular 235 
RePd AC Drying  100, 105, 110 °C Triangular 235 
RePd AC Drying Time 0.9, 1.0, 1.1 hr Triangular 235 
Yield RePd AC 0.0019, 0.002, 
0.0021 
kg L-1 Triangular 25 
a Assumed  
b gram dry weight 






Table C.2 Materials and cost 





Biocatalyst Production (Appendix A) 
TES Buffer 4.6e-3 kg L-1  Sodium 
Phosphate 
0.00285  64 
Sodium Bicarbonate 1e-3 kg L-1  Soda Ash 0.00126  64 
Yeast Extract 1e-3 kg L-1 Protein Feed 0.001  64 
Sodium Acetate 2e-3 kg L-1 Acetic Acid 0.00146  64 
Sodium Perchlorate 
Monohydrate 
1e-3 kg L-1 Sodium 
Perchlorate 
0.00087  64 
Water 1 kg L-1 c 1  64 
Sodium Chloride 8e-4 kg L-1 c 0.0008  64 
Ammonium Chloride 1e-3 kg L-1 c 0.00051  64 
Potassium Chloride 1e-4 kg L-1 c 1.27e-5  64 
Potassium Phosphate 
Monobasic 
1e-4 kg L-1 Sodium 
Phosphate 
1e-4  64 
Magnesium Sulfate 
Heptahydrate 
2e-4 kg L-1 Magnesium 
Sulfate 
9.77e-5  64 
Calcium Chloride 
Dihydrate 
2e-5 kg L-1 Calcium 
Chloride 
1.51e-5  64 
Nitrilotriacetic Acid 2e-5 kg L-1 EDTA 3.06e-5  64 
Potassium Hydroxide 1e-5 kg L-1 c 1e-5  64 
Ferrous Ammonium 
Sulfate Hexahydrate 
8e-6 kg L-1 Iron Sulfate 3.1e-6  64 
Cobaltous Dichloride 
Hexahydrate 
2e-6 kg L-1 Cobalt 5e-7  64 
Zinc Sulfate 
Heptahydrate 
2e-6 kg L-1 Zinc 
Monosulfate 
1.1e-6  64 
Cuprous Dichloride 
Dihydrate 
2e-7 kg L-1 Copper 
Concentrate 
7.5e-8  64 
Nickelous Dichloride 
Hexahydrate 
2e-7 kg L-1 Nickel (99.5%) 4.9e-8  64 
Sodium Selenate 2e-7 kg L-1 Selenium 9.1e-8  64 
Sodium Tungstate 2e-7 kg L-1 d   64 
Sodium Molybdenate 
Dihydrate 
2e-7 kg L-1 Molybdenum 9.3e-8  64 
Pyridoxine HCl 1e-7 kg L-1 d   64 
Riboflavin 5e-8 kg L-1 d   64 
Calcium Pantothenate 5e-8 kg L-1 d   64 
4-Aminobenzoic Acid 
(PABA) 
5e-8 kg L-1 d   64 
Thioctic Acid 5e-8 kg L-1 d   64 
Nicotinic Acid 5e-8 kg L-1 d   64 
Biotin 2e-8 kg L-1 d   64 
Folic Acid 2e-8 kg L-1 d   64 
Vitamin B12 5e-8 kg L-1 d   64 
Palladium Carbon Catalyst Production    
Nitric Acid 0.112 kg L-1 c   240 
Darco G-60 Activated 
Carbon 
0.074 kg L-1 Activated 
Carbone 
  240 
Palladium Chloride 0.007 kg L-1 Palladium   240 
Hydrochloric Acid 0.007 kg L-1 c   240 
Formaldehyde 0.002 kg L-1 c   240 
Sodium Hydroxide 0.004 kg L-1 c   240 
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Table C.2 Continued – Materials and Cost    
Potassium Hydroxide 0.072 kg L-1 c   240 
Rhenium Palladium Carbon Catalyst Production    
Water 1 kg L-1 c   29 
5% Palladium Catalyst 0.002 kg L-1 f   29 
Hydrochloric Acid 0.0001 kg L-1 c   29 
Ammonium Perrhenate 0.00014 kg L-1 Molybdenumg   29 





  Uniform 241, 242 
Transportation 0.2278h $ (tkm)-1   Uniform 243 
Sodium Phosphate 0.766, 
2.00 
$ (kg)-1   Uniform 244, 245 
Acetate 1.499h $ (kg)-1   Uniform 244, 245 
Soda Ash 0.162, 
0.767 
$ (kg)-1   Uniform 244-246 
Protein Feed 0.0697, 
0.0705 
$ (kg)-1   Uniform 246 
Sodium Perchlorate 1.86h $ (kg)-1   Uniform 244, 245 
Water 0.000525, 
0.00136 
$ (kg)-1   Uniform 246, 247 
Sodium Chloride 0.197, 
0.271 
$ (kg)-1   Uniform 244, 245 
Ammonium Chloride 0.2264, 
0.2362 
$ (kg)-1   Uniform 244-246 
Potassium Chloride 0.103, 
0.123 
$ (kg)-1   Uniform 244, 245 
Magnesium Sulfate 0.397, 
0.474 
$ (kg)-1   Uniform 244, 245 
Calcium Chloride 0.197, 
0.271 
$ (kg)-1   Uniform 244-246 
EDTA 1.008h $ (kg)-1   Uniform 246 
Potassium Hydroxide 0.301, 
0.344 
$ (kg)-1   Uniform 246 
Iron Sulfate 1.157, 
2.337 
$ (kg)-1   Uniform 244, 245 
Cobalt 27.49, 
44.0 
$ (kg)-1   Uniform 248, 249 
Zinc Monosulfate 0.472, 
0.671 
$ (kg)-1   Uniform 244, 245 
Copper Concentrate 1.036, 
1.653 
$ (kg)-1   Uniform 248, 249 
Nickel 10.384h $ (kg)-1   Uniform 248 
Selenium 22.046h $ (kg)-1   Uniform 250, 251 
Molybdenum Trioxide 10.49h $ (kg)-1   Uniform 248, 250, 251 
Sodium Hypochlorite 95.197, 
142.796i 
$ (kg)-1   Uniform 244, 245 
Electron Shuttle 1.008, 10 $ (kg)-1   Uniform k 244-246 
Palladium AC 1087.5, 
5770 
$ (kg)-1   Uniform 248, 252 
Hydrochloric Acid 0.085, 
0.094 
$ (kg)-1   Uniform 244, 245 
Ammonium Perrhenate 2425.1, 
14720  
$ (kg)-1   Uniform 251, 253 
Hydrogen 1j, 3.1 $ (kg)-1   Uniform 246 
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Table C.2 Continued – Materials and cost 
Phosphoric Acid 0.937, 
1.08 
$ (kg)-1   Uniform 244, 245 
Selective Resin 14.13, 
26.49 
$ (kg)-1   Uniform 254, 255 
Non-Selective Resin 4.41, 6.36 $ (kg)-1   Uniform 254, 255 
Resin Disposal 0.954, 
1.166 
$ (kg)-1   Uniform 254 




$ (kg)-1   Triangular 254, 256 
a L-1 refers to the relevant production medium. 
b Geographical market was global unless indicated otherwise. 
c Compound identified in econinvent. 
d No suitable equivalent found in ecoinvent. Compound is a micro-nutrient. The protein feed is assumed to 
contain the required nutrient. 
e RER 
f 5% Palladium Catalysts impacts were quantified from materials in ecoinvent. 
g Multiplication factor of 0.001 used to account for the ratio of rhenium to molybdenum 25, 164. 
h Cost were estimated using a uniform distribution using ±10% of the cost. 
i Concentrated. 




Mixing: The power required to maintain a well-mixed reactor was calculated with:  




where G is the Root mean square (RMS) velocity gradient (s-1), P is the rate of work (J s-1), µw is 
the viscosity of water (kg m-1 s-1), and Vr  is the volume of water mixed (m
3).  
Pumping: The energy requirements associated with pumping were computed as 
previously described.237 In short, the Total Dynamic Head (TDH) was used to determine the 
energy required to pump the growth media or source water into the tank. For this setup, minor 
losses were assumed insignificant and ignored.  
Equation C.2  𝑇𝐷𝐻 = 𝐻𝑡𝑠 + 𝐻𝑠𝑓 + 𝐻𝑑𝑓 + 𝐻𝑚 + 𝑇𝑀𝑃 
where TDH is the total dynamic head (ft), Hts is the Total Static Head, Hsf, Hdf are the friction 
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head, Hm is minor losses, and TMP is the transmembrane pressure.   
The Hts of pumping was calculated from the Suction Static Head (Hss) (difference 
between water level in the reactor and centerline of the permeate pump) and the Discharge Static 
Head (Hds) (difference between the water level in the reactor and the centerline of the permeate 
pump). 
Equation C.3  𝐻𝑡𝑠 = 𝐻𝑑𝑠 − 𝐻𝑠𝑠 
The Hsf and the Hdf were empirically determined from the Hazen-Williams equation using 
the length of the pipe (ft), the velocity of the liquid in the pipe (ft s-1), the Hazen-Williams 
coefficient (C),242 and the inner diameter of the pipe (ft). 
Equation C.4  𝐻𝑠𝑓 = 3.02 ∗ 𝐿 ∗ 𝑉
1.85 ∗ 𝐶−1.85 ∗ 𝐷−1.17 
The TMP was determined from literature values 242. The Brake Horsepower (BHP) is the 
horsepower required to drive a pump. The flow rate (gpm), TDH (ft), and pump efficiency 
(ηpump) were used to determine the BHP. 
Equation C.5  𝐵𝐻𝑃 = 𝑄 ∗ 𝑇𝐷𝐻/(3960 ∗ 𝜂𝑝𝑢𝑚𝑝) 
The energy (kW) to power a pump for the required time was determined from the BHP 
and the motor efficiency (ηmotor).  
Equation C.6  𝐸 = 0.746 ∗ 𝐵𝐻𝑃/𝜂𝑚𝑜𝑡𝑜𝑟  
Electricity: Energy for mixing, pumping, and heating was calculated as electricity 
consumption. The characterization factors for electricity were determined by the electricity 
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generation distribution in the United States, which includes coal, natural gas, nuclear, 
hydropower, biomass, geothermal, solar, wind, petroleum, and other gases.241 Distribution of cost 
was determined from state pricing.241 
Cleaning: Tanks required for perchlorate removal were cleaned with a solution of 0.8% 
sodium hypochlorite. The volume of cleaning solution (VNaClO) (m
3) for one cleaning was given 
by the total number of tanks (n), the surface area of each tank (Atank) (m
2), and the thickness of 
the treatment solution applied (dNaClO) (m).  
Equation C.7  𝑉𝑁𝑎𝐶𝑙𝑂 = 2 ∗ 𝑛 ∗ 𝐴𝑡𝑎𝑛𝑘 ∗ 𝑑𝑁𝑎𝐶𝑙𝑂 
C.1.2. Biocatalytic Model 
The performance model for biocatalytic perchlorate reduction determined the required 
dosage of biocatalysts. The model incorporated temperature, perchlorate concentration, and the 
effects of competition from nitrate. The pH of the solution was excluded as it has no significant 
impact on performance over the pH range of 6.5 to 9.0.150 Other factors, including hardness, 
magnesium concentration, calcium concentration, and natural organic matter, were also excluded 
as they have no significant impact on the biocatalytic activity.150 Required dosing of the 
biocatalysts for the reactor was determined from an integrated form of the Michaelis-Menten 
kinetic equation (Equation C.8)257 using an HRT (Δt) of 2 hours. Kinetic parameters were 
obtained from prior experimental work150 and are included in Table C.1.  
Equation C.8  𝑟𝑟𝑒𝑎𝑐𝑡𝑜𝑟 ∗ 𝛥𝑡 = 𝐾𝑚 ∗ (ln[𝑆𝑜] − 𝑙𝑛[𝑆1]) + ([𝑆0] − [𝑆1]) 
where rreactor is the activity of the reactor required to remove influent perchlorate (S0) to a 
designated treatment level (S1) using the half-saturation constant (Km) of the biocatalysts. 
158 
 
Stoichiometrically, eight electrons from methyl viologen are required to reduce perchlorate into 
oxygen and chloride; this stoichiometry was used to adjust the reported methyl viologen activity 
into perchlorate activity. The activity in the reactor was adjusted for temperature using the 
Arrhenius equation (Equation C.9).258  




where A is the Arrhenius constant, Ea is the activation energy for the perchlorate reduction 
reaction, R is the universal gas constant, and T is the temperature.  
The inhibition of the biocatalysts with nitrate was modeled as non-competitive inhibition 
and assumed linear. The ratio of the influent nitrate concentration to the maximum inhibition 
concentration was multiplied by the maximum inhibition of perchlorate activity on the 
biocatalysts. This value was used to adjust the maximum perchlorate-reducing activity.  
Other inhibitors that could theoretically affect the biocatalytic systems were excluded due 
to their negligible impact on activity. Specifically, the product oxygen is not known to inhibit 
chlorite dismutase. For the other product, chloride, a heterologously expressed chlorite dismutase 
had a reported KI of 225mM (7,980,000 µg L-1), well above the concentrations relevant for 
groundwater treatment. 85 For perchlorate reductase, the biocatalytic system retained robust 
activity stored aerobically over a 3 week period, as long as glycerol is added, indicating that it 
was not sensitive to oxygen even at atmospheric concentrations.64 The incremental amount of 
chloride formed due to perchlorate reduction compared to background concentrations of real-
world groundwater was negligible. The intermediates of the perchlorate reduction pathway 
include chlorate and chlorite. For the intermediate chlorate, our unpurified biocatalysts had 
159 
 
higher maximum activity than for perchlorate (658.3±36.8 for chlorate versus 152.4±6.3 U (µg 
Mo)-1 for perchlorate) and lower Km 50±12 µM (4200 µg L
-1) for chlorate versus 105±16 µM 
(10,500 µg L-1) for perchlorate,150 indicating that chlorate will not accumulate. The second 
intermediate, chlorite, is degraded by chlorite dismutase. The Km for the perchlorate-reducing 
strain, GR-1, the Km of chlorite dismutase is 170 µM (11,500 µg L
-1)76 and has a much higher kcat 
of 55,800 min-1 76 versus our perchlorate-reducing system of 1,900 min-1. 150 Chlorite is not 
known to inhibit perchlorate reductase. Finally, substrate inhibition has been observed for 
perchlorate reductase. However, the KI of 7.5mM (750,000 µg L-1)67 is well above the 
concentrations found in groundwater and used in this study. Known inhibitors for chlorite 
dismutase, including azide, cyanide and EDTA,76 were excluded as they are unlikely to be found 
at relevant concentrations in groundwater. 
The combination of the factors affecting the maximum activity of the biocatalysts was 
incorporated to determine the biocatalyst dosing (BD) required to treat the influent perchlorate to 
the target treatment level. 
Equation C.10 𝐵𝐷 = 𝑟𝑟𝑒𝑎𝑐𝑡𝑜𝑟/𝑉𝑚𝑎𝑥@𝑇𝑒𝑚𝑝@𝑁𝑂3𝐼𝑛𝑓 
Biocatalyst production was based on current, laboratory scale processes.64, 150 In scaling 
up to supply the required dosage,259 sparging for anaerobic conditions was replaced with the 
addition of sufficient electron donor to remove oxygen and cells were assumed to be harvested 
by membrane filtration rather than centrifugation. The laboratory process yielded 0.002 L 
biocatalyst (L culture)-1.64, 150 The biocatalyst concentration in molybdenum equivalence (an 
indirect measure of perchlorate reductase concentration) was determined experimentally at 357 ± 
39 µg L-1,150 and this value was used to convert volume dosing into molybdenum equivalence 
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dosing. Materials and mass required for the synthesis of the biocatalysts are included in Table 
C.2, along with substitutions made for materials not represented in the ecoinvent database.  
The production of the biocatalysts required three energy components: mixing, pumping, 
and heating. Standard mixing and pumping requirements were calculated as detailed in Section 
C.1.1. The radius (r) of the production tank for the biocatalysts was a function of the tank height 
(h) and volume (V). 






Transmembrane Pressure (TMP) was included in the pumping requirement to account for 
membrane harvesting of the cells.  
For reactor heating requirements, the energy was calculated in two stages. The first stage 
calculated the energy required to bring incoming media to the desired temperature of 30°C, 
utilizing a heat exchanger to capture the heat energy from the previous batch.  
Equation C.12 𝑄 = 𝐶 ∗ 𝛥𝑇*ρ*H_Ex 
where Q is the energy required in kJ/m3, C is the specific heat of water (kJ kg-1 C-1), ΔT is the 
change in temperature required (°C), ρ is the density of water, and H_Ex is the heat exchange 
efficiency. 
The second heating component was the energy to maintain the desired temperature for the 










+ 2 ∗ 𝑇𝑡𝑎𝑛𝑘 −





where Qlost is the heat loss (W), Ttank is the required reactor temperature (K), Tamb is the ambient 
temperature (K), tins is the thickness of insulation (m), kins is the thermal conductivity of the 
insulation (W m-1*K-1), tankheight is the height of the reactor (m), rtank is the radius of the tank (m), 
routside is the radius of the tank, including the insulation.  
For the operation of the biocatalytic process, the materials were the electron donor 
(acetate), electron shuttle, biocatalysts, and cleaning agent, while the energy components 
included pumping, mixing, and aeration. The electron donor consumption per liter of treated 
water was determined from the amount of oxygen, nitrate, and perchlorate reduced in the 
reaction. 
Equation C.14 [𝐴𝑐𝑒𝑡𝑎𝑡𝑒]𝑇𝑜𝑡 = [𝐴𝑐𝑒𝑡𝑎𝑡𝑒]𝐷𝑂 + [𝐴𝑐𝑒𝑡𝑎𝑡𝑒]𝐶𝑙𝑂4− + [𝐴𝑐𝑒𝑡𝑎𝑡𝑒]𝑁𝑂3− 
The complete reduction of perchlorate (into Cl- and H2O), oxygen (into H2O), and nitrate 
(into N) requires eight, four and five electrons respectively. The required acetate for oxygen and 
perchlorate reduction was calculated based on the stoichiometry. 
























The amount of nitrate reduced was dependent on the hydraulic retention time of the 
reactor. It was shown that nitrate had up to 10% of the reduction rate of perchlorate.150 To 
determine the amount of nitrate reduced in the reactor, the equation below was solved for the 
final concentration of nitrate (S1_NO3). 




−) ∗ 𝛥𝑡 = 𝐾𝑀 ∗ (ln[𝑆0NO3] −
ln[𝑆1NO3]) + ([𝑆1 NO3] − [𝑆0NO3]) 
The Δt was set at 2 hours in the biocatalyst dosing equations, and kinetic parameters were 
known. MATLAB solver was used to solve for S1_NO3 to determine the change in nitrate 
concentration. This change was used to estimate the acetate requirement for nitrate reduction. 












The electron shuttle dosing was set as described in Table C.1. The biocatalyst dosing and 
cleaning agent calculations as well as pumping, mixing, and aeration are described above. For 
the cost and GWP analysis, trace components of the medium were combined into groups: metals, 
minerals, and nutrients. For the correlation analysis, medium components were combined to 
represent the correlation of the production medium.   
C.1.3. Chemical Catalysts 
Similar to the modeling for the biocatalysts, the modeling of chemical catalysis included 
a performance model to determine the required amount of chemical catalysts for a given set of 
conditions, with consideration of materials and electricity required for the production of the 
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chemical catalysts and operation of the chemical catalysis process. Nitrate is known to inactivate 
the chemical catalysts;33 electron donor requirements for nitrate removal were therefore 
accounted for during operation, rather than incorporating effects in the performance model. 
Rhenium is known to leach from the carbon support structure in certain conformations of the 
catalysts when exposed to oxygen.260 Electron donor requirements of oxygen removal were 
therefore included during operation as well.  
In the performance model, two chemical catalysts were analyzed in this study: (i) the 
Rhenium and Palladium, Activated Carbon catalyst at 5 weight % of Rhenium and 5 weight % of 
Palladium (Re/Pd-AC) 146 and (ii) the Rhenium hoz and Palladium, Carbon catalyst at 5 weight 
% of Rhenium and 5 weight % of Palladium (Re(hoz)2-Pd/C).235 The first catalyst represented 
the minimum value for distribution of activity. The Rhenium hoz compound was used for the 
most probable and maximum distribution of activity. The effects of temperature were not 
included in the model because no experimental data was available. A first-order reaction rate was 
used. 
Equation C.19 − (
𝑑[𝑆]
𝑑𝑡
) = 𝑘[𝑆] 
This equation was integrated by separation of variables where [S] is the concentration of 
perchlorate and k is substituted with rREACTOR_CAT.  
Equation C.20 ln[𝑆1] − ln[𝑆0] = −𝑟𝑅𝐸𝐴𝐶𝑇𝑂𝑅_𝐶𝐴𝑇 ∗ 𝛥𝑡 
where [S1] is the effluent concentration of perchlorate; S0 is the initial concentration of 
perchlorate; rREACTOR_CAT is the required activity of the reactor; and Δt is the HRT. The equation 
was used to determine the activity required to reduce perchlorate in the designated HRT of two 
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hours. The required activity was converted into a dosing rate of the catalysts using experimental 
values for kOBS_M_Norm of the catalysts.




= 𝐶ℎ𝑒𝑚𝑖𝑐𝑎𝑙 𝐶𝑎𝑡𝑎𝑙𝑦𝑠𝑡 𝐷𝑜𝑠𝑖𝑛𝑔 
Production of the chemical catalysts was based on current, laboratory scale processes. 
Materials for the production of the catalysts are included in Table C.2. The energy requirements 
for the production of the catalysts required mixing, pumping, heating, and drying. Standard 
mixing and pumping requirements were calculated as detailed in Section C.1.1. The heating 
equations used the specific heat capacity of air (c), the amount of catalyst (mass_catalyst), the 
temperature difference (ΔT) between the ambient environment and the target drying temperature, 
and a heat exchanger efficiency (H_Ex). 
Equation C.22 𝐸𝐷𝑟𝑦 = 𝑐 ∗mass_catalyst*ΔT*(1-H_Ex) 
The energy to maintain the drying temperature was determined by the following equation, 




where the heat loss from the temperature difference between the oven and the ambient 
environment (ΔT) over the oven surface area (SA) is prevented by the insulation with a thermal 
conductivity (k) and thickness (Δw) for a specified drying time (Δt). 
Operation of the process for chemical catalysis included the following materials: 
catalysts, hydrogen, hydrochloric acid, sodium hydroxide, and cleaning agent. Hydrogen 
consumption was calculated based on the stoichiometry of two electrons per molecule of 
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hydrogen for oxygen, nitrate and the required perchlorate removal. The hydrochloric acid and 
sodium hydroxide were required for drinking water pH adjustment to 3.0 for catalytic activity 
and restored to a pH 7.0 prior to distribution. The operation of the catalyst assumed a five-year 
life span25 and included pumping, mixing and aeration calculated as detailed in Section C.1.1. 
C.1.4. Whole-Cell Biological Reduction 
For bacterial reduction of perchlorate, it was assumed that cells were generated during 
treatment, not requiring a separate production process, so the model focused entirely on the 
operation. The major material required for operation of the whole-cell process was the electron 
donor, acetate, calculated based on influent water composition as detailed below. Phosphoric acid 
was supplemented at 0.01 molar ratio to acetate. Cleaning agent was included in the analysis. 
The energy requirements were due to mixing, pumping, and aeration and were calculated as 
detailed in Section C.1.1.  
For the electron donor requirement, in keeping with the typical preferences of 
perchlorate-reducing bacteria, it was assumed that all oxygen and nitrate were reduced first, 
respectively, before perchlorate was reduced. The model, therefore, reported the total amount of 
electron donor (TED) required, accounting for the reduction of preferred electron acceptors 
oxygen and nitrate,45 in addition to perchlorate, with the corresponding fraction of electron donor 
(FED) required for cell synthesis for all three electron acceptors. The acetate required to remove 
perchlorate is based on the electron equivalence required to reduce oxygen, nitrate, and 
perchlorate.  




C.1.5. Non-Selective Ion Exchange 
To model perchlorate removal for different influent water compositions and determine the 
mass of resin required for treatment, the performance of the non-selective ion exchange systems 





































where [RX] and [X] are the milliequivalents of anions for the resin phase and aqueous phase, 
respectively. The model reported the number of bed volumes that were treated keeping the 
column effluent below the indicated treatment level for perchlorate and the EPA regulation of 44 
mg L-1 for nitrate.157 The mass of resin was assumed to require double the resin to account for the 
resin down times associated with regeneration. The Type 1 resin was assumed to be regenerable 
using a 6% NaCl brine solution. Regeneration of the brine was excluded.  
The resolution of the performance model for non-selective ion exchange was determined 
between a balance of error and computational time, with columns divided into 30 equal 
segments. The model was compiled in MATLAB 2015a using the mcc command as a standalone 
application using the OS Scientific Linux. The compiled code and other required functions, 
including the Latin Hypercube Sampling script and the column solver function, were transferred 
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to the Open Science Grid177, 178 through OSG Connect.  
The results were reported as bed volumes treated. This information was used in 
MATLAB to determine the cost and impacts of the performance of the non-selective ion 
exchange. The operation of the non-selective ion exchange included anion exchange resin, the 
disposal of the anion exchange resin, brine, and cleaning agent. The resin required to treat the 
influent perchlorate was determined from the bed volumes and an HRT of 15 minutes. The 
consumption of brine was determined by a regeneration bed volume factor of 2.5. The operation 
of the non-selective ion exchange resin assumed a seven-year life span and included pumping 
and mixing calculated as detailed in Section C.1.1. 
C.1.6. Selective Ion Exchange  
Selective ion exchange was modeled assuming the technology was completely selective 
for perchlorate and was operated until fully saturated with a maximum loading of 1,000 meq L-1, 
a best-case scenario. The materials for operating included the selective resin and cleaning agent. 
The impacts and costs of resin disposal were also included in the study. The operation of the non-
selective ion exchange resin assumed a seven year life span and included pumping and mixing 
calculated as detailed in Section C.1.1. 
C.2. Results and Discussion 
C.2.1. Water Quality Distributions 
The distributions of anions in groundwater were determined from USGS groundwater 
data, considering wells with detectable perchlorate and less than 44 mg L-1 nitrate. Scatter plots 
show the comparison of perchlorate to the anions bicarbonate, sulfate, nitrate, and chloride 
(Figure C.1). In this dataset, groundwater wells with nitrate less than the US EPA regulatory limit 
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of 44 mg L-1 had a positive correlation with perchlorate (0.81). However, pairwise comparison to 
perchlorate had no strong correlations with chloride (0.00), sulfate (0.26), or bicarbonate (0.15) 
concentrations. The correlation between perchlorate and nitrate could be consistent with the 
scenario of perchlorate contamination in the United States originating from the application of 
perchlorate-laced nitrate fertilizers from Chile.261 Ratios of anions to perchlorate were consistent 
between raw data and Latin Hypercube Sampling (Figure C.1). 
 
 
Figure C.1: Comparison of anions - Scatter plot comparison of common anions in groundwater 
to the contaminant perchlorate (µg L-1). Anions include (a) bicarbonate (mg L-1), (b) sulfate (mg 
Perchlorate (µg/L)









































































































































Figure C.1 (cont.) L-1), (c) nitrate (mg L-1), and (d) chloride (mg L-1). The insets show nested 
box-and-whisker plots comparing the perchlorate to anion ratios from the raw data (red) with the 
Latin Hypercube Sampling generated data (blue). The central line is the median ratio. The box 
indicates the 25th and 75th percentiles, and the whiskers represent the 10th and 90th percentiles.  
C.2.2. Input Parameters Correlating with Cost and GWP 
The half-saturation constant (Km) had a slight positive correlation (0.212) with the total 
cost, as higher Km values would require a higher biocatalyst dosing at activities less than Vmax. 
The activation energy for the biocatalytic reaction also had a positive correlation (0.523) with the 
total cost, as a higher energy barrier would decrease the rate of the reaction. The influent 
perchlorate concentration was positively correlated with total costs (0.669); more influent 
perchlorate requires more treatment. Following the trend of previously published work,150 an 
increase in temperature resulted in an increase in biocatalytic activity, resulting in lower 
biocatalyst dosing; the influent temperature was therefore negatively correlated with cost (-
0.217). 
For GWP, the production components, including the media (0.999), electricity 
consumption (0.989), and material transportation (0.952), were strongly and positively correlated 
with impact. In contrast, the operation of the biocatalytic process showed no strong correlation 
trends, except for transportation of materials to the treatment site (0.767). Parameters connected 
to the biocatalysts and influent water characteristics had similar correlations to those observed 
for the cost. The kinetic parameter Vmax had a negative correlation (-0.590), the Km had a slight 
positive correlation (0.225), and the activation energy had a positive correlation (0.541) with 
total GWP. Perchlorate influent concentrations were positively correlated (0.722), and 




C.2.3. Support of Targeted Improvements 
In the main text, two approaches were discussed to improve the costs and impacts of 
biocatalytic production: increasing the yield of the biocatalysts and implementing biocatalyst 
reuse in the system. In this section, we present the reasoning and literature examples suggesting 
that the technology development targets considered here are feasible. 
Biocatalyst yields vary significantly depending on the cultivation method, carbon source, 
and medium. The medium and growth condition used in this analysis were based on laboratory-
scale production and have not been optimized, so improvements are likely. While yields of the 
biocatalysts used here have not been optimized, a comparison of two different perchlorate-
reducing strains showed a four-fold difference in the yield of perchlorate reductase activity per 
liter of culture media,64, 70 suggesting that improvements can be obtained. Cellulolytic enzymes 
have varying yields from 40 to 300 filter paper units g-1 of carbon source,171 and yields of 
glucose isomerase can range from 1,000 to 35,000 U L-1 depending on the organism and growth 
conditions.172 Creation of mutant strains for glucose isomerase was shown to increase yields by 
100%.172  
If, despite these examples, the ten-fold increase in yield assumed in this work proves 
difficult to accomplish by traditional means, genetic engineering would provide more certain 
increases in yield. For example, genetic modification increased production of glucose isomerase 
by a factor of 20.172 For chlorite dismutase, one of the biocatalysts in the current work, a 
heterologous overexpression system increased yield by a factor of 36.85, 200 However, the 
genetically engineered approach is likely to encounter a more difficult regulatory approval 
process for use in drinking water.262 
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The second improvement looked at immobilizing the biocatalysts for reuse. While the 
perchlorate-reducing biocatalysts, to our knowledge, have not been immobilized, other examples 
in the literature demonstrate that immobilized biocatalysts can be quite stable. For example, an 
alcohol dehydrogenase had no change in activity over thirty days of operation,263 and a 5’ 
phosphodiesterase had stable activity during 500 days of continuous operation.264 The 
perchlorate-reducing biocatalysts also have shelf lives greater than 23 days at 4°C,64 supporting 
their potential reuse.  
However, one of the biocatalysts (chlorite dismutase) is subject to catalytic inactivation.85 
In this study, the useable life of the biocatalysts was assumed to be limited by the catalytic 
inactivation of the biocatalyst, chlorite dismutase (Cld).85 After performing approximately 
17,000 chlorite decomposition reactions per heme (maximum theoretical turnover number, 
MTTN), the biocatalyst becomes inactivated, most likely due to oxidative damage.80 The total 
number of treatable bed volumes (BV) was determined by the following equation: 
Equation C.29 𝐵𝑉 = 𝑀𝑇𝑇𝑁 ∗ 𝐵𝐷 ∗ 𝐶𝐷𝐹/𝛥𝑆 
Ten percent of the biocatalyst dosage (BD) was assumed to be made up of chlorite 
dismutase (CDF).76 This chlorite dismutase concentration and the MTTN were used to determine 
the total amount of chlorite that could be decomposed in the drinking water and compared to the 
chlorite formed from perchlorate reduction in drinking water (ΔS). The maximum amount of 
chlorite decomposed divided by the chlorite concentration of drinking water provided the total 
number of treatable bed volumes. These calculations returned a limit of 1,000 bed volumes, 
which was used as the upper bound while exploring improvement scenarios. 
Towards improving the costs and impacts of the operation of the biocatalysts, we 
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identified that the electron shuttle would need to be eliminated. This could be done by reusing 
the electron shuttle, much as the biocatalysts are reused.115 Alternatively, identifying electron 
donors that interact directly with the biocatalysts would eliminate the shuttle, significantly 
reducing the environmental impact of GWP and costs. Potential candidates, such as hydrogen, 
hydrogen sulfide, and bioelectrochemical processes, would need to be evaluated for their activity 
the perchlorate biocatalysts and their potential risks. Hydrogen is explosive and may be difficult 
to handle in drinking water treatment. Hydrogen sulfide, sharing many of the concerns with 
hydrogen gas, is also corrosive and toxic. Bioelectrochemical processes have shown some 
promise; however, this process was limited to a demonstration in sensor technology.115 
C.2.4. Additional Environmental Impact Categories  
In addition to GWP, presented in the main text as a representative impact (Table 4.2), 
nine other environmental impacts were quantified in this study at perchlorate regulatory limits of 
2 µg L-1, 6 µg L-1, 10 µg L-1, and 15 µg L-1. These impacts are presented here for biocatalysts 
(Figure C.2), chemical catalysts (Figure C.3), whole-cell biological reduction (Figure C.4), non-
selective ion exchange (Figure C.5) and selective ion exchange (Figure C.6).  
The biocatalysts showed similar decreasing trends with decreasing perchlorate effluent 
requirements for all impacts, indicating that the materials had similar environmental impacts 
which minimized large variations with the tradeoff on required materials for treatment (e.g., 
biocatalysts versus electron donor requirements). The chemical catalysts also demonstrated a 
slight downward trend with decreasing perchlorate effluent requirements. However, overall, the 
chemical catalysts had the highest impacts for non-carcinogens and ecotoxicity across all the 
perchlorate regulatory limits. Upon realizing the improvements suggested in this study for the 
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biocatalysts, the chemical catalysts would have the highest impacts in another five categories: 
smog, acidification, eutrophication, carcinogens, and respiratory effects.  
Whole-cell biological reduction showed little change in impacts with different 
perchlorate effluent requirements. This was largely due small changes in acetate required to treat 
perchlorate at the various treatment levels; most of the acetate consumed in whole-cell process is 
associated with consumption of oxygen and nitrate rather than perchlorate.  
For the ion exchange technologies, the resin dominated impacts in ozone depletion. 
Across all environmental categories, the impacts increased with higher perchlorate regulatory 
limits. This was due to the larger concentration difference between the perchlorate influent and 
effluent concentrations at the higher effluent requirements, as discussed in the main text. Across 
all five technologies, non-selective ion exchange had the highest impacts with respect to ozone 
depletion. Once improvements to the biocatalytic technology were realized, non-selective ion 




Figure C.2: Additional impact categories for biocatalytic treatment technology. Box-and-
whisker plot comparison comparing different perchlorate treatment targets across nine 
environmental impact categories for the biocatalytic treatment technology. The central line is the 
median impact. The box indicates the 25th and 75th percentiles. The whiskers represent the 10th 
and 90th percentiles while the circles indicate represent the 5th and 95th percentiles. Impact 
categories include a) ozone depletion (kg CFC-11 eq m-3), b) smog (kg O3 eq m
-3), c) 
acidification (kg SO2 eq m
-3), d) eutrophication (kg N eq m-3), e) carcinogens (CTUh m-3), f) 
non-carcinogens (CTUh m-3), g) respiratory effects (kg PM 2.5 eq m-3), h) ecotoxicity (CTUe m-




Figure C.3: Additional impact categories for catalytic treatment technology. Box-and-whisker 
plot comparison comparing for different perchlorate treatment targets across nine environmental 
impact categories for the chemical catalytic treatment technology. The central line is the median 
impact. The box indicates the 25th and 75th percentiles. The whiskers represent the 10th and 
90th percentiles while the circles indicate represent the 5th and 95th percentiles. Impact 
categories include a) ozone depletion (kg CFC-11 eq m-3), b) smog (kg O3 eq m
-3), c) 
acidification (kg SO2 eq m
-3), d) eutrophication (kg N eq m-3), e) carcinogens (CTUh m-3), f) 
non-carcinogens (CTUh m-3), g) respiratory effects (kg PM 2.5 eq m-3), h) ecotoxicity (CTUe m-




Figure C.4: Additional impact categories for whole-cell biological reduction. Box-and-whisker 
plot comparison comparing different perchlorate treatment targets across nine environmental 
impact categories for the whole-cell biological reduction of perchlorate. The central line is the 
median impact. The box indicates the 25th and 75th percentiles. The whiskers represent the 10th 
and 90th percentiles while the circles indicate represent the 5th and 95th percentiles. Impact 
categories include a) ozone depletion (kg CFC-11 eq m-3), b) smog (kg O3 eq m
-3), c) 
acidification (kg SO2 eq m
-3), d) eutrophication (kg N eq m-3), e) carcinogens (CTUh m-3), f) 
non-carcinogens (CTUh m-3), g) respiratory effects (kg PM 2.5 eq m-3), h) ecotoxicity (CTUe m-




Figure C.5: Additional impact categories for non-selective ion exchange treatment. Box-and-
whisker plot comparison comparing different perchlorate treatment targets across nine 
environmental impact categories for the non-selective ion exchange treatment of perchlorate. The 
central line is the median impact. The box indicates the 25th and 75th percentiles. The whiskers 
represent the 10th and 90th percentiles while the circles indicate represent the 5th and 95th 
percentiles. Impact categories include a) ozone depletion (kg CFC-11 eq m-3), b) smog (kg O3 eq 
m-3), c) acidification (kg SO2 eq m
-3), d) eutrophication (kg N eq m-3), e) carcinogens (CTUh m-
3), f) non-carcinogens (CTUh m-3), g) respiratory effects (kg PM 2.5 eq m-3), h) ecotoxicity 




Figure C.6: Additional impact categories for selective ion exchange treatment. Box-and-whisker 
plot comparison comparing different perchlorate treatment targets across nine environmental 
impact categories for the selective ion exchange treatment of perchlorate. The central line is the 
median. The box indicates the 25th and 75th percentiles. The whiskers represent the 10th and 
90th percentiles while the circles indicate represent the 5th and 95th percentiles. Impact 
categories include a) ozone depletion (kg CFC-11 eq m-3), b) smog (kg O3 eq m
-3), c) 
acidification (kg SO2 eq m
-3), d) eutrophication (kg N eq m-3), e) carcinogens (CTUh m-3), f) 
non-carcinogens (CTUh m-3), g) respiratory effects (kg PM 2.5 eq m-3), h) ecotoxicity (CTUe m-
3), and i) fossil fuel depletion (MJ surplus m-3).  
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C.2.5. Effect of Regulatory Limit and Wells Requiring Treatment 
 
Figure C.7: Impacts of regulatory limit on the number of wells requiring treatment and the 
median perchlorate influent concentration. Wells requiring treatment in this study increase 
exponentially with increasingly stringent regulatory limits (grey diamonds, exponential fit, R2 
0.998). The median perchlorate influent (pink squares) decreases with increasingly stringent 
regulatory limits, decreasing the required median perchlorate removal (blue bars).  
 
Figure C.8: Performance of non-selective ion exchange technology. Box-and-whisker plot 
comparing the performance (in bed volumes) of Non-Selective Ion Exchange technology across 
perchlorate regulatory limits of 15, 10, 6 and 2 µg L-1.  The central line is the median. The box 
indicates the 25th and 75th percentiles. The whiskers represent the 10th and 90th percentiles 




Figure C.9: Material flow analysis for biocatalytic and catalytic technologies. Bar plots of the 
metal consumption of the technologies over an assumed technology life-time. (a) The 
molybdenum metal requirement as a percentage of US production of the biocatalysts for the 
effluent treatment targets of 2, 6, 10 and 15 µg L-1 and over assumed technology lifetimes of 1, 
100, 500 and 1,000 bed volumes. (b) The rhenium (black) and palladium (gray) requirements as 






This is supporting information for Chapter 5. This section includes efforts to construct an 
affinity-attached perchlorate reductase and a spore-displayed chlorite dismutase. Additional 
information on the construction of the affinity-attached chlorite dismutase is included. 
D.1. Materials and Methods 
  
Table D.1: Summary of media 
Ingredient Component Amount (L-1) 
  
Lennox Luria-Bertani (LB) Media 
Lennox LB 20 g 
 
Difco Sporulation Media 
Bacto Nutrient Broth 8 g 
Potassium Chloride 1 g 
Magnesium Sulfate Heptahydrate 0.12 g 
Sodium Hydroxide Adjust to pH 7.2 
Calcium Nitrate Tetrahydrate 1:1000 of 1M Stock 
Manganese Chloride Tetrahydrate 1:1000 of 0.01M Stock 
Iron Sulfate Heptahydrate 1:1000 0.001M Stock 
 
Calcium Nitrate Tetrahydrate Stock 
Calcium Nitrate Tetrahydrate 236.15 g 
 
Manganese Chloride Tetrahydrate Stock 
Manganese Chloride Tetrahydrate 1.979 g 
 
Iron Sulfate Heptahydrate Stock 
Iron Sulfate Heptahydrate 0.278 g 
 
Super Optimal broth with Catabolite repression (SOC) 
Tryptone 20 g 
Yeast Extract 5 g 
Sodium Chloride 0.584 g 
Potassium Chloride 0.186 g 
2M Glucose Stock 10 mL 
2M Mg2+ Stock 10 mL 
 
2M Glucose Stock (Filter Sterilized) 
Glucose 360.32 g 
 
2M Mg2+ Stock 
Magnesium Chloride Hexahydrate 200.33 g 
Magnesium Sulfate Heptahydrate 240.65 g 
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Table D.2: Summary of buffers 
Component Amount (L-1) 
  
50X TES Buffer 
Tris Base 242 g 
0.5M EDTA 100 mL 
Glacial Acetic Acid 57.1 mL 
 
10X TE Buffer 
Tris Base 12.1 g 
0.5M EDTA 10 mL 
 
0.5M EDTA 
EDTA 186.1 g 
Sodium Hydroxide Pellets to pH 8.0 
 
Cracking Buffer 
1 M Tris pH6.8 100 mL  
20% Fresh Sodium Dodecyl Sulfate 200 mL 
1% Bromophenol Blue 200 mL 
10% Glycerol 200 mL 
Distilled Water 280 mL 
β-Mercaptoethanol 20 mL 
 
Protein Running Buffer 
Tris Base 3 g 
Glycine 18.8 g 
20% Fresh Sodium Dodecyl Sulfate 5 mL 
Distilled Water to 1 L 
 
Coomassie Staining Solution 
Distilled Water 550 mL 
Methanol 400 mL 
Glacial Acetic Acid 50 mL 
Brilliant Blue R-250 333.5 mg 
 
Destain Solution 
Distilled Water 550 mL 
Methanol 400 mL 
Glacial Acetic Acid 50 mL 
 
10 mM Phosphate Buffer at pH 7.0 
Sodium Phosphate Monobasic 0.61 g 
Sodium Phosphate Dibasic 0.69 g 
 
25 mg mL-1  Hemin Stock 
Hemin 25 g 
Sodium Hydroxide 4 g 
Ethanol 100 mL 
Water to 1 L 
D.1.1. Molecular Techniques 
Several strains were constructed to immobilize the biocatalysts. The constructs are 
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divided into categories. The first division in the constructs is related to the approach utilized: 
Strep-tag or spore display. These categories are further divided by the target enzyme: perchlorate 
reductase or chlorite dismutase. 
 
Table D.3: Strain summary  
Strain Source Antibiotic (Concentration) Used In 
    
Azospira oryzae PS 
 
ATCCb BAA-33 -- All 
Experiments 
E. coli BL21a  NEBc -- All 
Experiments 
 
E. coli BL21 (DE3)a NEB -- Strep-Tag 
Experiments 
 
E. coli DH5α pNPTS138 
Cm 
Addgened Chloramphenicol  
(5 mg L-1) 
 
Strep-Tag of  
PcrA 
 
E. coli XL1 Blue pBAD Addgene Ampicillin  
(50 mg L-1) 
Tetracycline 





E. coli DH5α pMLK83 BGSCe ECE103 Ampicillin 
(50 mg L-1) 
Kanamycin 





E. coli MC1061pDG364 BGSC ECE46 Ampicillin 
Chloramphenicol 





E. coli NovaBluea Millipore Sigma Tetracycline 




B. subtilis 168 BGSC 1A1 -- Spore Display 
of Cld 
 
B. subtilis FBT14 BGSC 1A711 -- Spore Display 
of Cld 
 
a Competent cells were provided by the manufacturer for chemical/physical transformations. 
b American Type Culture Collection (atcc.org) 
c New England Biolabs (neb.com) 
d Addgene (addgene.org)  





Table D.4: Plasmid summary 
Plasmid Origin of Gene AntibioticR 
(Concentration) 
Source 
    
pET28b(+) -- Ampicillin (50 mg L-1) NEBc 
 
pET51b(+) -- Ampicillin (50 mg L-1) NEB 
 
pUC19 -- Ampicillin (50 mg L-1) NEB 
 
pGEM T-Vector -- Ampicillin (50 mg L-1) Promegad 
 
pDG364a -- Chloramphenicolb  




pMLK83a -- Kanamycin (5 mg L-1) 
Ampicillin (50 mg L-1) 
 
BGSC 
pBAD Strep TEV LIC 
(8R) 
-- Ampicillin (50 mg L-1) Addgenef 
a Transformants were identified using erythromycin (10 mg L-1) sensitivity. The sensitivity to erythromycin 
resulted from the interruption of the chromosomal α-amylase gene when the vector integrated into the 
chromosome. 
b The chloramphenicol resistance gene is removed during construction. 
c New England Biolabs (neb.com) 
d Promega (promega.com) 
e Bacillus Genetic Stock Center (bgsc.org) 





Table D.5: Primers used in the construction of the enzymes Cld and PcrA to facilitate 
retention of the biocatalysts in drinking water treatment 




    
Primers for construction of Strep-tagged perchlorate reductase. 
PcrA_Ao-Strep_F1 CTGGATCCGGTTCAAATGACTCGTAG Forward BamHI 
PcrA_Ao-Strep_F2 CTGACGTCGGTCGTTCAAATGACTCGTAG Forward PshAI 
PcrA_Ao-Strep_F3 CTAAGCTTGTTCAAATGACTCGTAG Forward HindIII 
PcrA_Ao-Strep_F4 CTGCGGCCGCAGTTCAAATGACTCGTAG Forward  NotI 
PcrA_Ao-Strep_R1 ATAAGCTTCTAGAAACTGATGGGCGT Reverse HindIII 
PcrA_Ao-Strep_R2 ATGCGGCCGCCTAGAAACTGATGGGCGT Reverse NotI 
PcrA_Ao-Strep_R3 ATGAGCTCACTAGAAACTGATGGGCGT Reverse SacI 
PcrA_Ao-Strep_R4 ATGGATCCCTAGAAACTGATGGGCGT Reverse BamHI 
PcrA_Ao-Strep_Bad_F1 GCTTTAAAGTTCAAATGACTCGTAG Forward DraI 
PcrA_Ao-Strep_Bad_F2b GCTTTAAAGGCTTCCTGCTAGCCTCTGGT Forward DraI 
PcrA_Ao-Strep_Bad_R1_ ATGGATCCCTAGAAACTGATGGGCGT Reverse BamHI 








PcrA_Ao_N’_DS_F1 GCCGGATCCGGCTTCCTGCTAGCCTCTGGTGC Forward BamHI 
PcrA_Ao_N’_DS_R1 GNNACTAGTCGGCAATCATGTCGAGCGGTT Reverse SpeI 
PcrA_Ao_C’_UP_F1 GCCGCATGCGTCACTCGGTTCACTCGACG Forward SphI 





PcrA_Ao_C’_DS_F1 GNNGGATCCTAGTCAGATCCGCTGATCAA Forward BamHI 
PcrA_Ao_C’_DS_R1 GNNACTAGTCCCTGATCCTCGTCCCAATT Reverse SpeI 
Primers for construction of spore-displayed chlorite dismutase 
CotG – Bacillus_1,2,3_F1 CTAGCCGGATCCCACCGGATCATCGT Forward BamHI 
CotG – Bacillus_1_R1 GCGCTAATCGATCCAGCAATTGCCGTC Reverse ClaI 
CotG – Bacillus_1_R2 GCGCTACGATCGCCAGCAATTGCCGT Reverse PvuI 
CotG – Bacillus_2_R1 GCGCTAATCGATTTTGTAGTCGTCGCA Reverse ClaI 
CotG – Bacillus_2_R2 GCGCTACGATCGTTTGTAGTCGTCGCA Reverse PvuI 
CotG – Bacillus_3_R1a GCGCTAATCGATTGGCTGCGAGATTTC Reverse ClaI 
CotG – Bacillus_3_R2a GCGCTACGATCGGTGGCTGCGAGATT Reverse PvuI 
CotG-Cld Linker_F GACATCGATGGCGGAGGCGGATCACGATCGCCA Forward ClaI/PvuI 
CotG-Cld Linker_R TGGCGATCGTGATCCGCCTCCGCCATCGATGTC Reverse ClaI/PvuI 
Cld_Ao – Spore_F CTAGCGCGATCGTCCATGACAAACAT Forward PvuI 
Cld_Ao – Spore_R GCGCTAGCATGCGTTAATCGGCTAGC Reverse SphI 
Primers for constructions of Strep-tagged chlorite dismutase 
Cld_Id – Strep_F1b CTGGATCCGGCCATGAATACCCCAGTTGA Forward BamHI 
Cld_Id – Strep_R1 ATGCGGCCGCTCAATTGCCCATCGACAGCGT Reverse NotI 




Table D.6: Other primers used in this work 
Primer Name Primer 
(5’ →3’) 
Orientation Used for 
    
16s rRNA Forward AGAGTTTGATCCTGGCTCAG Forward Controls 
16s rRNA Reverse ACGGCTACCTGGTTACGACTT Reverse Controls 
T7 Promoter TAATACGACTCACTATAGGG  Verification 
T7 Terminator GCTAGTTATTGCTCAGCGG  Verification 
SP6 Promoter GCTATTTAGGTGACACTATAG  Verification 
 
Table D.7: List of PCR thermocycler protocols for the amplification of genes for Strep-tagged 
perchlorate reductase 






















Annealing 55 0.75 
Extension 72 7 








Annealing 46 1 
Extension 72 5 
Extension 
 










Annealing 55 1 
Extension 72 5 
Extension 
 
1 55 5 




Annealing 58 1 
Extension 72 5 




Table D.8: List of PCR thermocycler protocols for the amplification of genes for spore-display chlorite 
dismutase 










CotG – Bacillus_1_F1, R1 
CotG – Bacillus_1_F1, R2 
CotG – Bacillus_2_F1, R1 
CotG – Bacillus_2_F1, R2 
CotG – Bacillus_3_F1, R1 










Annealing 54.5 0.75 
Extension 72 7 
Extension 1 72 4 
Cld_Ao – Spore_F,R 
A. oryzae 




Annealing 54.5 0.75 
Extension 72 7 
Extension 1 72 4 
 
Table D.9: List of PCR thermocycler protocols for the amplification of genes for Strep-tagged chlorite 
dismutase 








      
Cld_Id – Strep_F1,R1 
pET3a-IdCld 




Annealing 65 1 
Extension 74 1.5 
Extension 1 74 4 
 
For consistency, DNA from B. subtilis 168 was also extracted using the standard 
phenol/chloroform method. For PCR, samples were amplified using the appropriate protocol for 
Strep-tagged perchlorate reductase (Table D.7) and spore-displayed chlorite dismutase (Table 
D.8). Where appropriate, Buffer 3.1 was used in place of the CutSmart Buffer for DNA 
digestion. For ligation, initial experiments were performed using the StickyEnds Ligation Kit 
(NEB). However, the ligase used in this kit is not compatible with electroporation. No results 
from this ligase are reported. All reported ligation experiments were carried out using the T4 
DNA Ligase (NEB) according to the manufacturer’s instructions. 
Transformation of cells was performed using two methods: electroporation and 
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chemical/physical transformation. Electroporation was performed using a MicroPulser (Biorad) 
in 0.1 cm gap MicroPulser cuvettes. Manufacturer’s standard protocols for gram-negative (E. 
coli) and gram-positive (B. subtilis) bacteria were followed. Competent cells for electroporation 
were prepared according to manufacturer’s instructions. Chemical/physical transformation 
experiments were performed using manufacturer’s competent cells and according to their 
manufacturer’s instructions (Table D.3). Transformation experiments were plated on LB agar 
plates with the appropriate antibiotic using 100 µL of a 1:10 cell dilution (10 µL of cells were 
added to 90 µL of SOC media), undiluted cells, and concentrated cells. One hundred µL of 
concentrated cells were produced by centrifuging the remaining transformants at 5,000xg for 2 
minutes. The supernatant was removed except for approximately 90 µL. This remaining volume 
was used to resuspend the cells. A negative transformation control of no DNA and a positive 
transformation control of 1 µL of pUC19 plasmid were included. 
D.1.2. Construction of Tagged Perchlorate Reductase Subunit α 
To test immobilization of perchlorate reductase, the α subunit was the target for affinity 
attachment. The reference sequence used for PCR primers and sequencing was the pcrA from A. 
oryzae PS (GenBank: CP003153.1, Region 150699 to 153482).The pcrA gene was inserted into 
two Strep-tag containing plasmids (pET51b(+) and pBAD Strep TEV LIC, Figure D.1) and the 
chromosomal insertion plasmid (pNPTS138 Cm, Figure D.2). For pET51b(+), the amplified 
region of the pcrA gene included a hypothetical signaling sequence. Constructs for pBAD and 
pNPTS138 Cm did not include this sequence. Transformation experiments for pET51b(+) and 
pBAD were carried out using chemically competent BL21(DE3). To repress the leaky expression 
in the pET51b(+) vector system, additional transformation experiments were attempted using 1% 
glucose. The pGEM plasmid was used help confirm the toxicity of PcrA in E. coli. For the 
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chromosomal insertion experiments, E. coli BL21 was used as a staging strain to construct the 
gene combinations in pNPTS138 Cm. Two pcrA constructs were made to include the Strep-tag II 
at the N and C terminus of the protein. For the N terminus, the tag was included after a model-
predicted signaling sequence.  
 
Figure D.1: Schematic of the Strep-tagged perchlorate reductase using pET51(b)+ and pBAD. 
Definition of terms: amp – encodes for penicillin β-lactamase, Strep-tag II – sequence 




Figure D.2: Schematic of the chromosomal insertion constructs with Strep-tag modified pcrA in 
pNPTS138 Cm. Definition of terms: CmR – chloramphenicol resistance gene, sacB – encodes 
for levansucrase, Strep-tag II – sequence corresponding to the Strep-tag. pcrA – encodes for 
perchlorate reductase A, and upstream and downstream – segments of DNA corresponding to 
sections upstream and downstream of the pcrA gene. 
D.1.3. Construction of Spore-Displayed Chlorite Dismutase 
Spore display allows for the expression of proteins on the surface of a spore. This is 
accomplished by connecting the protein of interest to a segment of coat protein, such as CotG. In 
this work, the biocatalyst, Cld, was connected to CotG to facilitate spore-displayed Cld. A 
schematic of the 12 constructs attempted for the spore-displayed chlorite dismutase is included in 
Figure D.3. Three different reverse primers were tested to capture different lengths of the cotG 
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gene; all primers excluded the stop sequence. The cotG:cld fusion inserts were made with and 
without a separating linker sequence. These combinations were incorporated into two different 
vectors, pDG364 and pMLK83. The plasmid, pET28b(+) was also used to help create successful 
constructs at some stages. Transformations were initially carried out in E. coli Nova Blue cells. 
Successful transformants were isolated, and the plasmids were extracted. These plasmids were 
used in transformation of B. subtilis FBT14 by electroporation. In Bacillus transformants with 
the pDG364 plasmid, cells were screened for sensitivity to both erythromycin and 




Figure D.3: Schematic showing the 12 constructs for the spore-displayed chlorite dismutase 
using chromosomal insertion vectors pDG364 and pMLK83. Definition of terms: amyE – 
encodes for α-amylase, cat – encodes for chloramphenicol acetyl transferase, gusA – encodes for 
β-glucuronidase reporter, neo – encodes for 3’-glycosyl phosphotransferase, cotG – encodes for 
spore coat gene, cld – encodes for chlorite dismutase, linker – a short piece of DNA included to 
space the sequences of the cotG and cld genes. 
D.1.4. Expression and Testing of Spore-Displayed Chlorite Dismutase 
With the cld capable of spore display in Bacillus, the biocatalyst construct was expressed 
and tested for its chlorite decomposition activity. The procedure for testing putative constructs in 
B. subtilis for chlorite dismutase activity was as follows. After cultures were grown for 6 hours in 
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10mL LB broth, 100µL of 25 mg mL-1 hemin was added. Samples were allowed to grow 
overnight at 37ºC with shaking at 250rpm. The following day, cells were harvested at 5,000xg 
for 10 minutes. In addition to the LB method, transformants were grown using the Difco 
Sporulation Media (DSM). Two and a half mL samples of overnight LB cultures were transferred 
to 250mL DSM for growth overnight at 30ºC with shaking at 200rpm. The following morning, 
2.5 mL of 25 mg mL-1 hemin was added, and samples were incubated for an additional six hours. 
The chlorite activity of the samples was tested using a chloride probe as previously described.83  
D.2. Results 
D.2.1. Construction of Tagged Perchlorate Reductase Subunit α 
To achieve reuse for perchlorate reductase, affinity attachment was tested with the α 
subunit. Successful amplification of the full pcrA gene for insertion into a pET51b(+) plasmid 
with a Strep-tag was confirmed using gel electrophoresis (Figure D.4). Digestion and ligation 
experiments were confirmed (Figure D.5). Colony counts from the experimental condition and 
associated controls suggested that the transformation was successful (Table D.10). Select 
transformants were isolated for further analysis by restriction enzyme digestion and gel 
electrophoresis (Figure D.6). However, no change in the size of the plasmid was detected, 





Figure D.4: DNA gel image showing successful PCR amplification of the gene pcrA with an 
approximate size of 2783 bp. Lanes 1, 2, 9, and 10 are DNA ladders. Lanes 3-6 are replicates of 
the PCR reaction using primers PcrA_Ao-Strep_F1and PcrA_Ao-Strep_R1. Lane 7 is a positive 
control using 16S rRNA primers. Lane 8 is a negative control with all reaction primers and water 
in place of template DNA. 
 
Figure D.5: DNA gel of the digestion of pcrA and pET51b(+) with restriction enzymes BamHI 
and HindIII and ligation. Lanes 1, 2, 15, and 16 are ladders. Lane 3 is uncut pcrA. Lane 4 is 
uncut pET51b(+). Lanes 5-7 are cut versions of pcrA with the corresponding restriction 
enzyme(s). Lanes 8-10 are cut versions of pET51b(+) with the corresponding restriction 






Figure D.6: Gel electrophoresis of transformants with pcrA formed by BamHI and HindIII 
digestion. Lanes 1, 2, 10, 18, and 19 are DNA ladders. Lanes 3-8 are BamHI digested pET51b(+) 
pcrA plasmids. Lane 9 is BamHI digested pET51b(+). Lanes 11-16 are undigested pET51b(+) 
pcrA plasmids. Lane 17 is undigested pET51b(+). 
Due to the failed transformation experiment, a plasmid that would not express PcrA was 
tested (pGEM). Two pcrA segments were amplified (Figure D.7). PCR was gel purified giving 
the gel the cut appearance. Colonies from the transformation experiments were counted (Table 
D.11). Plasmids were isolated from select white colonies and sequenced using the T7 promoter 
and SP6 promoter primers. Sequencing (Section D.2.5.1) results indicated that the pcrA was 
incorporated in the pGEM plasmid.  
Table D.10: Transformation results for pcrA with BamHI and HindIII and pET51b(+) 
Sample Positive Negative 1 
(No DNA) 
Experimental (3:1) 
    
25µL Lawn 0 6 
50µL npa np 8 
100µL Lawn 0 13 
Concentrated np np Lawn 






Figure D.7: PCR amplification of pcrA segments. Lanes 1 and 5 are DNA ladders. Lane 2 is the 
pcrA segment with the restriction enzyme sites PshAI and SacI. Lane 3 is the pcrA segment with 
the restriction enzyme sites NotI and SacI. Lane 4 is a negative control incubated with all the 
primers and water. 
Table D.11: Transformation results for PcrA in pGEMa 
Sample Blue Colonies White Colonies 
   
Positive Control 81 44 
PcrA PshAI/SacI #1 42 11 
PcrA PshAI/SacI #2 71 10 
PcrA NotI/SacI #1 52 3 
PcrA NotI/SacI #2 68 8 
Negative Control 103 1 
a 50µL of transformation was plated. 
 
Glucose can minimize leaky expression of toxic proteins by repressing the lacI gene; this 
is called catabolite repression. To test if glucose could aid in the expression of the potentially 
toxic PcrA, the transformation of pcrA in the pET51b(+) plasmid was carried out in the presence 
of 1% glucose. These experiments were carried out using the PshAI/SacI and NotI/SacI 
restriction enzyme combinations. Transformation colony counts from 100µL plated onto LB with 
carbenicillin are included in Table D.12.  
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Table D.12: Transformation results for PcrA in pET51b(+) 
Sample 1:10 Dilution Undiluted Concentrated 
    
Positive Control 106 npa np 
Negative Control (No DNA) np np 0 
Negative Control (P/S Cut) np 0 0 
Negative Control (N/S Cut) np 30 144 
PcrA PshAI/SacI 0 0 2 
PcrA NotI/SacI 3 41 322 
a Indicates no sample plated 
 
 
The two colonies from the PshAI/SacI digestion and 15 colonies from the concentrated 
NotI/SacI digestion were further analyzed. While none of the NotI/SacI transformants showed 
the expected change in size, the transformants from the PshAI and SacI digestion appeared to be 
successful (Figure D.8). 
 
Figure D.8: DNA gel of plasmids isolated from the transformation of BL21(DE3) with pcrA-
pET51b(+). Lanes 1 and 20 are DNA ladders. Lane 2 is undigested pET51b(+). Lanes 3 – 17 are 
undigested plasmids from the transformation using NotI and SacI restriction enzymes. Lanes 18 




These two transformants were tested for expression of the PcrA protein and compared to 
an uninduced control (Figure D.9). The size of the expression bands corresponded closely with a 
hypothetical size of 104.9 kDa. However, sequencing of the constructs indicated an insertion 
mutation was present in the Strep-tag of both constructs (data not shown). In general, insertion 
mutations should lead to a truncated protein as these mutations result in an amino acid sequence 
with a stop codon. Unfortunately, this was not the case. The expressed protein, although not 
PcrA, had a very similar, hypothetical size of 104.5 kDa. This was likely due to the fact that there 
was just 0.3% difference in the number of amino acids between the proteins. 
 
Figure D.9: Polyacrylamide protein gel showing the expression of a putative PcrA in two 
transformants. Lanes 1 and 15 are protein ladders. Lane 2-5 are blank. Lanes 6 and 7 are 1:10 
dilutions of uninduced and induced PcrA #1. Lane 8 is blank. Lanes 9 and 10 are induced and 
uninduced PcrA #2. Lane 11 is blank. Lanes 12 and 13 are uninduced and induced PcrA #1. Lane 
14 is blank. 
To address toxicity of PcrA, two methods could be utilized. The first uses a tightly 
controlled expression plasmid in E. coli, such as the low-copy pBAD Strep TEV LIC (8R) 
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plasmid. This plasmid was obtained; however, I focused on an alternative approach, 
chromosomal insertion.  
A chromosomal insertion vector was used to introduce a tagged gene in the native 
organism, Azospira oryzae PS. Constructs were created to include the Strep-tag at the N and C 
terminus of the protein. For chromosomal insertion, two sections of DNA were ligated together 
to incorporate the Strep-tag in the middle of the gene insert. PCR amplification of these DNA 
segments is included in Figure D.10. Attempts to ligate and transform these constructs in a single 
ligation step were unsuccessful (Table D.13, Figure D.11). A stepwise ligation procedure is 
recommended for future experiments (Figure D.12).  
 
Figure D.10: DNA gel image showing the successful polymerase chain reaction amplification of 
gene fragments of pcrA and gene fragments from upstream and downstream of pcrA. DNA 
Ladder sizes indicate DNA fragments of approximately 400 base pairs. N’ and C’ correspond to 
the construct including a Strep-tag at the C’ or N’ terminus of the protein. US and DS indicate 
whether the gene fragment corresponds to upstream or downstream of the Strep-tag location. 
Two different restriction enzyme sites were created for the C’construct, SphI and HindIII.    
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Table D.13: Transformation results for PcrA-Strep in pNPTS138 Cm. 
Sample 1:10 Dilution Undiluted Concentrated 
    
Positive Control 161 1192 ---a 
Negative Control (No DNA) --- --- 0 
N’ Long 0 2 11 
N’ Short 0 3 14 
C’ SphI 0 1 15 
C’ HindIII 0 0 0 





Figure D.11: DNA gel of the transformants with pcrA in pNPTS138 Cm. Lanes 1 and 20 are 
DNA ladders. Lanes 2-17 are plasmids isolated from transformants. Lane 18 is blank. Lane 19 is 






Figure D.12: Schematic showing the step-wise incorporation of the genes to construct the Strep-
tagged pcrA in pNPTS138 Cm. 
D.2.2. Construction of Spore-Displayed Chlorite Dismutase 
To construct a strain that would display Cld on the spore surface, primers were designed 
for three different lengths of the spore coat protein, CotG. Combining these anchors with and 
without a flexible linker region and in two different plasmid vectors resulted in a total of 12 
constructs. Successful amplification of Cld for spore display is shown in Figure D.13. Successful 
DNA template purification from B. subtilis 168 and amplification of the coat proteins are shown 
in Figure D.14. For the coat protein, CotG, three lengths were tested, but only the primer pair for 
CotG-Bacillus_1 was used in the construction of modified biocatalyst. The primers for CotG-
Bacillus_3 resulted in a mixed product. Double digest of pDG364 resulted in two bands 
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approximately 5,000 and 1,200 base pairs. The 1,200 base pair segment corresponded to the 
chloramphenicol resistance gene (Figure D.3 and Figure D.15). During digestion, pDG364 lost a 
chloramphenicol resistance gene (Figure D.15). 
 
Figure D.13: Gel of PCR results for the amplification of cld from A. oryzae for spore display 
and Strep attachment. Lanes 1 and 20 are DNA ladders. Lanes 2-5 are amplification of cld for 
spore display using 4 different DNA template preps. Lanes 6-9 are amplification of cld for Strep 




Figure D.14: DNA gel of PCR product for spore coat gene, cotG. Lane 20 is the DNA ladder. 
Lanes 1-6 include amplification of the spore coat gene, cotG using the forward primer, CotG-
Bacillus_1,2,3_F1. The following reverse primers were used for Lane 1: CotG-Bacillus_1_R2, 
Lane 2: CotG-Bacillus_1_R1, Lane 3: CotG-Bacillus_2_R2, Lane 4: CotG-Bacillus_2_R1, Lane 
5: CotG-Bacillus_3_R2, Lane 6: CotG-Bacillus_3_R1. Lanes 7-11 are replicate runs of the 
amplification. Lanes 12-17 are negative controls. Lane 19, although difficult to visualize on the 
gel, includes the genomic DNA from B. subtilis 168. 
 
Figure D.15: DNA gel of digest of spore coat constructs. Lane 1 and 17 are DNA ladders. Lane 
2 is a digest of pDG364 with two bands corresponding to 5,000 and 1,200 bp. Lane 3 is 
pET28b(+) digest used in the construction of a Strep-tagged Cld. Lane 4 is the digest of the cotg 
segment used in the linker construct. Lane 5 is the digest of the linker. Lane 6 is the digest of cld 
for the spore display. Lane 7 is the cld for Strep-tagged Cld. Lane 8 is the cotg for the no-linker 
construct. Lanes 9-15 are replicate digestions. Lane 16 is uncut pET28b(+). 
Ligation of the cotG and cld with and without the linker was confirmed using gel 
electrophoresis (Figure D.16A). A combination of the two genes would create a piece of DNA 
with a size of approximately 1,600 base pairs. To confirm the combination of the cotG and cld 
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segments, the combined product was amplified using the forward primer for cotG and the reverse 
primer for cld (Figure D.16B). If the combined product was comprised of two identical genes 
(e.g., cotG-cotG or cld-cld), no amplified product would be expected. The figures have a 
construct of the correct size. However, the persistence of the smaller band was puzzling (Figure 
D.16B).   
 
Figure D.16: DNA gels confirming ligation of the cotG and cld genes. Panel A is the ligation 
experiment, and Panel B is the PCR amplification of the ligation. For Panel A, lanes 1, 2, 5, and 
6 are DNA ladders. Lane 3 is the cotG-linker-cld construct with two bands. The lower band 
corresponds to the cotg (800 bp) or cld (853bp) genes not ligated. The upper band is 
hypothesized to be a ligated construct; however, the band runs larger than the hypothetical 
combined construct estimated at 1674 bp. Lane 4 is the cotG-cld construct with two bands. The 
lower band corresponds to the cotg (800 bp) or cld (853bp) genes not ligated. The upper band is 
hypothesized to be a ligated construct; however, the band runs larger than the hypothetical 
combined construct estimated at 1653 bp. For Panel B, lanes 1 and 5 are DNA ladders. Lane 2 is 
the cotg-linker-cld construct. The upper band corresponds closely with the expected linker 
construct (1674bp). Lanes 3 and 4 are cotg-cld construct. The upper band corresponds to the 
estimated size of 1653bp. 
Despite the presence of the smaller DNA band, the cotG-linker-cld and cotG-cld 
205 
 
constructs were ligated into pDG364 and pET28b(+) plasmids. Experimental transformation 
numbers were similar to the positive ligation control (Table D.14). Individual colonies were 
selected for further analysis by plasmid isolation and PCR amplification (Figure D.17). Three 
constructs with the cotG-linker-cld were identified; however, the PCR amplification yielded 
mixed results with multiple bands (data not shown). 
 
Table D.14: Plate counts from spore display constructs 
Sample 100 (µL) 50 (µL) 25 (µL) 
    
Positive Ligation Control 80 35 14 
Positive Transformation Control ---a Lawn --- 
CotG-Cld pDG364 96 39 29 
CotG-Linker-Cld pDG364 4 0 0 
CotG-Cld pET28b(+) 16 9 --- 
CotG-Linker-Cld pET28b(+) 5 0 --- 
a Indicates no sample plated 
 
 
Figure D.17: DNA gel confirming amplification of cotG-cld constructs isolated from successful 
transformants. Lanes 1, 2, 13, and 14 are DNA ladders. Lanes 3-7 are transformants with a cotG-
cld construct in pDG364. Lanes 8-9 are transformants with a cotG-cld construct in pET28b(+). 
Lanes 10-12 are cld in pET28B(+). 
To confirm the identity of the cotG-cld constructs, sequencing was used with the forward 
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cotG and the reverse cld primers. As expected, sequencing of the forward portion of the construct 
corresponded with the cotG gene, and sequencing of the reverse portion corresponded with the 
cld gene (Section D.2.5.2). Plasmid pDG364 with the cotG-cld construct was transformed into 
Bacillus subtilis FBT14. One colony demonstrated the correct sensitivity to erythromycin and 
was selected to test for expression of Cld during sporulation. The cultures grew as expected; 
however, upon the addition of the hemin and subsequent overnight growth, the culture lost its 
opaqueness indicating the death of the bacteria. In attempt to promote sporulation prior to the 
addition of hemin, the same Bacillus transformant was grown in Difco sporulation media (DSM) 
overnight. However, upon addition of hemin, the opaqueness of the culture was reduced. No 
chlorite dismutase activity was observed. 
In order to increase the number of successful transformants and facilitate easier selection, 
the spore-displayed constructs were ligated into pMLK83. This plasmid maintained a 
neomycin/kanamycin antibiotic resistance throughout the experiment. This facilitates selection of 
a successful construct. At the time of this dissertation, only the cotG-cld construct was attempted. 
Transformation into Nova Blue was observed (Table D.15). These cultures were stored at -80ºC 
and await transformation into Bacillus.  
Table D.15: Plate counts from spore display constructs in pMLK83 
Sample 100 (µL) 50 (µL) 25 (µL) 
    
Positive Control ---a ---a Lawn 
Negative Control 1 1 ---a 
CotG-Cld #1 72 39 15 
CotG-Cld #2 3 1 2 
CotG-Cld #3 51 36 19 
CotG-Cld #4 5 1 4 
a Indicates no sample plated 
 
The construction of the cotG-linker-cld in pMLK83 are potential next steps in achieving 
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spore-displayed chlorite dismutase (Figure D.18). These experiments aim to include the cotG, 
linker, and cld fragments into the plasmid in a stepwise fashion (e.g., ligate cotG and the linker 
into the plasmid, followed by subsequent digestion and ligation to include cld). In the course of 
these experiments, it was discovered the ClaI did not cut the plasmids well. This was possibly 
due to methylation by the host bacteria blocking the cut site. In order to alleviate this problem, 
future experiments that require the ClaI restriction enzyme should use plasmids purified from 
methylation deficient strains.  
 
Figure D.18: Schematic showing the step-wise incorporation of the genes to construct the cotG-
linker-cld in pMLK83. 
D.2.3. Construction of Tagged Chlorite Dismutase 
Successful PCR of chlorite dismutase was confirmed using gel electrophoresis. As shown 
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in Figure D.19, the band corresponds closely with the hypothetical gene size of 744 basepairs. 
Following PCR, the gene was digested and ligated into the pET51b+ plasmid in order to 
incorporate the Strep-tag II. The ligated product was transformed into competent BL21 (DE3) 
and grown overnight. Colony counts yielded expected results (Table D.16). The plasmids from 
select transformants were harvested. Gel electrophoresis was run to confirm a change in the size 
of the plasmid corresponding to the addition of the 744 base pairs from cld (Figure D.20 and 
Figure D.21). Inclusion of the cld gene from I. dechloratans was further confirmed by 
amplifying the gene using PCR (Figure D.22). 
 
Figure D.19: DNA gel image showing successful PCR amplification of the Cld gene from 
Ideonella dechloratans. Size of the gene is 744 bp. The negative control included all primers 
from PCR runs in this figure. 
Table D.16: Plate counts from cld transformation experiments. 
 Positive Negative 1 
(No DNA) 




      
1:10 Dilution 71 --- --- 5 21 
No Dilution ---a --- --- 230 245 
Concentrated --- 0 8 440 520 





Figure D.20: DNA gel of the plasmids from cld transformants. The ratio at the top of the image 
corresponds to the insert to plasmid concentration ratio. The pET51b(+) is the original plasmid. 
Lanes 1 and 15 correspond to the 2-log DNA ladder. Lane 12 includes of plasmid with the 
expected size shift from the incorporation of the cld gene. 
 
Figure D.21: DNA gel of the plasmids from cld transformants. The ratio at the top of the image 
corresponds to the insert to plasmid concentration ratio. The pET51b(+) is the original plasmid. 
Lanes 1 and 18 corresponds to the 2-log DNA ladder. Lane 4 includes the plasmid with the 




Figure D.22: Gel image of PCR products from transformation experiments. Positive control 
includes amplification of the 16S rRNA gene from Azospira oryzae. Lanes 1 and 10 are 2-log 
DNA ladder.  
D.2.4. Expression and Testing of Tagged Chlorite Dismtase 
For the columns, activity was determined by extrapolation. This extrapolation was 
required due to the inactivation of Cld protein as well as the chlorite breakthrough in the column. 
Using the extrapolated absorbance, the breakthrough chlorite concentration was calculated, and 
the activity of the biocatalytic column was determined (Figure D.23). The initial, steep increase 
in absorbance (red squares) corresponds to chlorite breakthrough. The extrapolation of the slope 
from this absorbance is shown (blue circles). The gradual increase in absorbance (red squares) 
corresponds to more chlorite coming through due to biocatalyst inactivation. The extension of 
this slope was also determined (green triangles). The intersection of the extrapolated slopes gives 




Figure D.23: Extrapolation of chlorite concentration from measurements of absorbance. The 
concentration was determined by intersecting the slopes of the breakthrough and protein 
inactivation.   
D.2.5. Sequencing Information 
This section contains information on the sequences used to determine primers as well as 
DNA sequencing obtained from the University of Illinois Core Sequencing Facility. 
D.2.5.1. Sequences of pcrA  
The following are sequences of eight pGEM plasmids with pcrA incorporated. These 
were constructed to help test the toxicity of the PcrA in E.coli by incorporating the gene so that it 
could not be induced in E. coli (as described in section D.2.1). The T7 promoter was used to 
sequence the 5’ of the gene. The SP6 promoter was used to sequence the 3’ of the gene.  
pGEM-PcrA Sequence using the T7 and SP6 Promoter Primers 
 























































































































































































































































































































D.2.5.2. Sequences of Spore Coat Protein-Chlorite Dismutase 
Spore coat sequence (cotG, GenBank: CP019662.1) was used to develop primers for the 
construction of spore-displayed chlorite dismutase. The chlorite dismutase sequence from A. 
oryzae was used (CP003153.1). Sequencing of five cotG-cld constructs in pDG364 and two 
cotG-cld constructs in pET28b(+) are included below. As described in Section D.2.2, the forward 
primer for cotG (CotG – Bacillus_1,2,3_F1) was used to sequence the forward portion of the 
construct, and the reverse primer for cld (Cld_Ao – Spore_R) was used to sequence the reverse 
portion of the construct. 
cotG Sequence: 
1   cagctggcac cggatcatcg tcccatatat ccttttttaa ttcacgcaag tcttttggat 
61  gaacaaacag ctgataaagc ggtaaattgg attgattctt catccataat cctccttaca 
121 aattttaggc ttttattttt ataagatctc agcggaacac ttatacactt tttaaaaccg 
181 cgcgtactat gagggtagta aggatcttca tccttaacat atttttaaaa ggaggatttc 
241 aaattgggcc actattccca ttctgacatc gaagaagcgg tgaaatccgc aaaaaaagaa 
301 ggtttaaagg attatttata ccaagagcct catggaaaaa aacgcagtca taaaaagtcg 
361 caccgcactc acaaaaaatc tcgcagccat aaaaaatcat actgctctca caaaaaatct 
421 cgcagtcaca aaaaatcatt ctgttctcac aaaaaatctc gcagccacaa aaaatcatac 
481 tgctctcaca agaaatctcg cagccacaaa aaatcgtacc gttctcacaa aaaatctcgc 
541 agctataaaa aatcttaccg ttcttacaaa aaatctcgta gctataaaaa atcttgccgt 
601 tcttacaaaa aatctcgcag ctacaaaaag tcttactgtt ctcacaagaa aaaatctcgc 
661 agctataaga agtcatgccg cacacacaaa aaatcttatc gttcccataa gaaatactac 
721 aaaaaaccgc accaccactg cgacgactac aaaagacacg atgattatga cagcaaaaaa 
781 gaatactgga aagacggcaa ttgctgggta gtcaaaaaga aatacaaata atctaagttt 
841 tcattgtttc aataggctgc cggcggaggt acggaagcct atttttttat ttgccctgt 
 




























































































































































































































































D.2.5.3. Sequences of Strep-Tag II Chlorite Dismutase 
The coding sequence for chlorite dismutase from Ideonella dechloratans was obtained 
from the literature.77 The sequence was analyzed for a signaling sequence using the SignalP 4.1. 
However, this sequence (Figure D.24) was slightly shorter than the reported signaling 
sequence,77 and the reference’s reported location of the signaling location was used in 
constructing the modified cld gene. The primers were developed to exclude the hypothetical 
signaling sequences prior to the start of the mature protein (highlighted green) in the sequence 
below. 
 
Figure D.24: Signal P-4.1 assessment of the location of a signaling sequence in the chlorite 
dismutase from I. dechloratans.  
The chlorite dismutase sequence (GenBank: AJ296077.1) used to develop primers is 
included below. The legend for the color-coded regions is included at the bottom of the sequence. 
1    gctgcaggcc aagtgcggtg gtgaagagag cttcgatctg ggtgttcatc gggcgcgagg 
61   tcggcgtcag tgtcgggcgg ttgtccccga gggtcatgtt tgttgagaag tcaatttcca 
121  ctggaaacgg catagagcca aaaatatagt gttaagtttc ggagaaactc ttgacttaaa 
181  tcaaacacat aaaaaaggag aaatgcgaag attcgtgcac tttccgcttg ctcggcgacc 
241  aagccgccca gcggattccg attcttaaca ctggagtaca tcatgaaagt tcgttgcgtt 
223 
 
301  tccttagtcg ccgcagggct cctcaccatc gcaggcagcg caatcggcca accggctcca 
361  gcgcccatgc ccgcgatggc accagccgca aagccggcca tgaatacccc agttgatcgg 
421  gcgaagatac tcagcgcgcc aggcgtgttt gtggcgttct caacttacaa aattcgtccc 
481  gactacttca aagttgcatt ggctgaacgc aaaggtgcag cagatgaagt gatggcggtc 
541  ttggaaaagc acaaagaaaa agtgattgtc gacgcctacc tgacgcgcgg ctatgaagcc 
601  aagagcgact acttcctgcg cgttcatgcc tacgatgccg tagcggcgca ggcctttctg 
661  gtcgatttcc gcgccacccg ctttggcatg tactcggatg tcacggagag cctggtgggt 
721  atcaccaagg cgctaaacta tatctccaag gacaagtcgc ccgacctcaa caaggggctt 
781  tccggtgcta cctacgccgg tgatgcaccg cgctttgcct tcatgattcc ggtcaagaaa 
841  aacgctgatt ggtggaacct gacggacgag cagcgcctca aggagatgga gactcatacg 
901  cttccgacgc tgccctttct ggtcaacgtc aagcgcaagc tctaccactc gacggggctc 
961  gacgataccg attttattac ctacttcgag accaacgacc tcggagcctt caacaacctg 
1021 atgctgtcgc tggccaaggt gccggagaac aagtatcacg tgcgctgggg caatccgacc 
1081 gtgctgggta ccatccagcc catcgagaac ctcgtcaaga cgctgtcgat gggcaattga 
1141 tggcttgaat gttcggccac caggaacatg gtggccgaac gaatcgaggc gtaaatggct 
1201 tcaatagcca aactggacac gctgagtatc ggcccagcct gatacggttc ttcaaacatt 
1261 cgcaaaggag ttaagcatga acaagatcgc cgcaattctt ctctctattg gttttctgtc 
1321 aattgctgac ggggctttgg cgcaagatgg catgaaaaaa gacactatgg ccaaggaaag 
1381 catggcgaaa gaggccatga ccaaggatga catgaaaaaa cctaccatgg gcaaggacgc 
1441 aatggctaag gacggcatga tgaaaaaaga tgggatgaag aagggcgcca tgcccaagga 
 
cga – start of sequence from reference 77 
ggag – RBS 
atg – start codon 
gcc – start of mature protein77 
xxx – signal sequence 
tga – stop codon 
 
The cld gene was incorporated into a pET51b+ in order to include a Strep-tag II at the N 
terminus of the cld protein as described in Section 5.3.1. Two successful transformants were 
isolated (1:3-5 and 1:3-9), and the plasmid was sequenced to verify the accuracy of the sequence. 
The T7 promoter primer was used to amplify the 5’ portion of the sequence. The T7 terminator 
primer was used to amplify the 3’ portion of the sequence. The query sequence is the cld 
sequence listed above. 
Cld 1:3-5 with the T7 Promoter Primer 
Query  1    ATGGCAAGCTGGAGCCACCCGCAGTTCGAAAAGGGTGCAGATGACGACGACAAGGTACCG  60 
            ||||||||||||| | |||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  60   ATGGCAAGCTGGANCNACCCGCAGTTCGAAAAGGGTGCAGATGACGACGACAAGGTACCG  119 
Query  61   GATCCGGCCATGAATACCCCAGTTGATCGGGCGAAGATACTCAGCGCGCCAGGCGTGTTT  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  120  GATCCGGCCATGAATACCCCAGTTGATCGGGCGAAGATACTCAGCGCGCCAGGCGTGTTT  179 
Query  121  GTGGCGTTCTCAACTTACAAAATTCGTCCCGACTACTTCAAAGTTGCATTGGCTGAACGC  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  180  GTGGCGTTCTCAACTTACAAAATTCGTCCCGACTACTTCAAAGTTGCATTGGCTGAACGC  239 
Query  181  AAAGGTGCAGCAGATGAAGTGATGGCGGTCTTGGAAAAGCACAAAGAAAAAGTGATTGTC  240 
224 
 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  240  AAAGGTGCAGCAGATGAAGTGATGGCGGTCTTGGAAAAGCACAAAGAAAAAGTGATTGTC  299 
Query  241  GACGCCTACCTGACGCGCGGCTATGAAGCCAAGAGCGACTACTTCCTGCGCGTTCATGCC  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  300  GACGCCTACCTGACGCGCGGCTATGAAGCCAAGAGCGACTACTTCCTGCGCGTTCATGCC  359 
Query  301  TACGATGCCGTAGCGGCGCAGGCCTTTCTGGTCGATTTCCGCGCCACCCGCTTTGGCATG  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  360  TACGATGCCGTAGCGGCGCAGGCCTTTCTGGTCGATTTCCGCGCCACCCGCTTTGGCATG  419 
Query  361  TACTCGGATGTCACGGAGAGCCTGGTGGGTATCACCAAGGCGCTAAACTATATCTCCAAG  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  420  TACTCGGATGTCACGGAGAGCCTGGTGGGTATCACCAAGGCGCTAAACTATATCTCCAAG  479 
Query  421  GACAAGTCGCCCGACCTCAACAAGGGGCTTTCCGGTGCTACCTACGCCGGTGATGCACCG  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  480  GACAAGTCGCCCGACCTCAACAAGGGGCTTTCCGGTGCTACCTACGCCGGTGATGCACCG  539 
Query  481  CGCTTTGCCTTCATGATTCCGGTCAAGAAAAACGCTGATTGGTGGAACCTGACGGACGAG  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  540  CGCTTTGCCTTCATGATTCCGGTCAAGAAAAACGCTGATTGGTGGAACCTGACGGACGAG  599 
Query  541  CAGCGCCTCAAGGAGATGGAGACTCATACGCTTCCGACGCTGCCCTTTCTGGTCAACGTC  600 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  600  CAGCGCCTCAAGGAGATGGAGACTCATACGCTTCCGACGCTGCCCTTTCTGGTCAACGTC  659 
Query  601  AAGCGCAAGCTCTACCACTCGACGGGGCTCGACGATACCGATTTTATTACCTACTTCGAG  660 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  660  AAGCGCAAGCTCTACCACTCGACGGGGCTCGACGATACCGATTTTATTACCTACTTCGAG  719 
Query  661  ACCAACGACCTCGGAGCCTTCAACAACCTGATGCTGTCGCTGGCCAAGGTGCCGGAGAAC  720 
            |||||||||||||||||||||||||||||||||||||||||||||| ||||||||| ||| 
Sbjct  720  ACCAACGACCTCGGAGCCTTCAACAACCTGATGCTGTCGCTGGCCAGGGTGCCGGANAAC  779 
Query  721  AAGTATCACGTGCGCTGGGGCAATCCGACCGTGCT-GGGTACCATCCAGCCCATCGAGAA  779 
            ||||||||||||||||||||||||||||||||||| ||||||||||||||||||||| || 
Sbjct  780  AAGTATCACGTGCGCTGGGGCAATCCGACCGTGCTGGGGTACCATCCAGCCCATCGAAAA  839 
Query  780  CCTCGTCAAG-ACGCTGTCGATGGG-CAATTGA  810 
            |||||||||  || || || ||||| ||||||| 
Sbjct  840  CCTCGTCAAAAACNCTNTCNATGGGGCAATTGA  872 
 
 
Cld 1:3-5 with the T7 Terminator Primer 
Query  47   ACGAC-AAGGT-ACCGGATCCGG-CCATGAATA-CCCC-AGTTGATC-GGGCGAAGATA-  99 
            ||||| |||||  |||||||||| ||||  ||| |||| | ||| || |||  ||||||  
Sbjct  855  ACGACNAAGGTNCCCGGATCCGGNCCATNNATACCCCCAATTTGTTCGGGGNAAAGATAT  796 
Query  100  CTC-AGCGCGCCAGGCG-TGTTTGTGGCGTTCTCAACTTACAAAATTCGT-CCCGACTAC  156 
             || |  || ||||| |   ||| ||||||| ||||||||||||||| || || |||||| 
Sbjct  795  TTCAANNGCCCCAGGNGNNTTTTNTGGCGTTTTCAACTTACAAAATTNGTTCCNGACTAC  736 
Query  157  -TTCAAAGTTGCATT-GGCTGAACGC-AAAGGTGCAGCAGATGAAGTGATGGCGGTCTTG  213 
             || ||||||||||| ||||||| || ||||||||||||||||||||||||||||||||| 
Sbjct  735  NTTAAAAGTTGCATTNGGCTGAAAGCAAAAGGTGCAGCAGATGAAGTGATGGCGGTCTTG  676 
Query  214  GAAAA-GCACAAAGAAAAA--GTGATTGTCGACGCCTACCTGACGCGCGGCTATGAAGCC  270 
            ||||| |||||||||||||  ||||||||||||||||||||||||||||||||||||||| 
Sbjct  675  GAAAAAGCACAAAGAAAAAAAGTGATTGTCGACGCCTACCTGACGCGCGGCTATGAAGCC  616 
Query  271  AAGAGCGACTACTTCCTGCGCGTTCATGCCTACGATGCCGTAGCGGCGCAGGCCTTTCTG  330 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  615  AAGAGCGACTACTTCCTGCGCGTTCATGCCTACGATGCCGTAGCGGCGCAGGCCTTTCTG  556 
Query  331  GTCGATTTCCGCGCCACCCGCTTTGGCATGTACTCGGATGTCACGGAGAGCCTGGTGGGT  390 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  555  GTCGATTTCCGCGCCACCCGCTTTGGCATGTACTCGGATGTCACGGAGAGCCTGGTGGGT  496 
Query  391  ATCACCAAGGCGCTAAACTATATCTCCAAGGACAAGTCGCCCGACCTCAACAAGGGGCTT  450 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  495  ATCACCAAGGCGCTAAACTATATCTCCAAGGACAAGTCGCCCGACCTCAACAAGGGGCTT  436 
225 
 
Query  451  TCCGGTGCTACCTACGCCGGTGATGCACCGCGCTTTGCCTTCATGATTCCGGTCAAGAAA  510 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  435  TCCGGTGCTACCTACGCCGGTGATGCACCGCGCTTTGCCTTCATGATTCCGGTCAAGAAA  376 
Query  511  AACGCTGATTGGTGGAACCTGACGGACGAGCAGCGCCTCAAGGAGATGGAGACTCATACG  570 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  375  AACGCTGATTGGTGGAACCTGACGGACGAGCAGCGCCTCAAGGAGATGGAGACTCATACG  316 
Query  571  CTTCCGACGCTGCCCTTTCTGGTCAACGTCAAGCGCAAGCTCTACCACTCGACGGGGCTC  630 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  315  CTTCCGACGCTGCCCTTTCTGGTCAACGTCAAGCGCAAGCTCTACCACTCGACGGGGCTC  256 
Query  631  GACGATACCGATTTTATTACCTACTTCGAGACCAACGACCTCGGAGCCTTCAACAACCTG  690 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  255  GACGATACCGATTTTATTACCTACTTCGAGACCAACGACCTCGGAGCCTTCAACAACCTG  196 
Query  691  ATGCTGTCGCTGGCCAAGGTGCCGGAGAACAAGTATCACGTGCGCTGGGGCAATCCGACC  750 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  195  ATGCTGTCGCTGGCCAAGGTGCCGGAGAACAAGTATCACGTGCGCTGGGGCAATCCGACC  136 
Query  751  GTGCTGGGTACCATCCAGCCCATCGAGAACCTCGTCAAGACGCTGTCGATGGGCAATTGA  810 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  135  GTGCTGGGTACCATCCAGCCCATCGAGAACCTCGTCAAGACGCTGTCGATGGGCAATTGA  76 
 
 
Cld 1:3-9 with the T7 Promoter Primer 
Query  1    ATGGCAAGCTGGAGCCACCCGCAGTTCGAAAAGGGTGCAGATGACGACGACAAGGTACCG  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  60   ATGGCAAGCTGGAGCCACCCGCAGTTCGAAAAGGGTGCAGATGACGACGACAAGGTACCG  119 
Query  61   GATCCGGCCATGAATACCCCAGTTGATCGGGCGAAGATACTCAGCGCGCCAGGCGTGTTT  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  120  GATCCGGCCATGAATACCCCAGTTGATCGGGCGAAGATACTCAGCGCGCCAGGCGTGTTT  179 
Query  121  GTGGCGTTCTCAACTTACAAAATTCGTCCCGACTACTTCAAAGTTGCATTGGCTGAACGC  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  180  GTGGCGTTCTCAACTTACAAAATTCGTCCCGACTACTTCAAAGTTGCATTGGCTGAACGC  239 
Query  181  AAAGGTGCAGCAGATGAAGTGATGGCGGTCTTGGAAAAGCACAAAGAAAAAGTGATTGTC  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  240  AAAGGTGCAGCAGATGAAGTGATGGCGGTCTTGGAAAAGCACAAAGAAAAAGTGATTGTC  299 
Query  241  GACGCCTACCTGACGCGCGGCTATGAAGCCAAGAGCGACTACTTCCTGCGCGTTCATGCC  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  300  GACGCCTACCTGACGCGCGGCTATGAAGCCAAGAGCGACTACTTCCTGCGCGTTCATGCC  359 
Query  301  TACGATGCCGTAGCGGCGCAGGCCTTTCTGGTCGATTTCCGCGCCACCCGCTTTGGCATG  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  360  TACGATGCCGTAGCGGCGCAGGCCTTTCTGGTCGATTTCCGCGCCACCCGCTTTGGCATG  419 
Query  361  TACTCGGATGTCACGGAGAGCCTGGTGGGTATCACCAAGGCGCTAAACTATATCTCCAAG  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  420  TACTCGGATGTCACGGAGAGCCTGGTGGGTATCACCAAGGCGCTAAACTATATCTCCAAG  479 
Query  421  GACAAGTCGCCCGACCTCAACAAGGGGCTTTCCGGTGCTACCTACGCCGGTGATGCACCG  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  480  GACAAGTCGCCCGACCTCAACAAGGGGCTTTCCGGTGCTACCTACGCCGGTGATGCACCG  539 
Query  481  CGCTTTGCCTTCATGATTCCGGTCAAGAAAAACGCTGATTGGTGGAACCTGACGGACGAG  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  540  CGCTTTGCCTTCATGATTCCGGTCAAGAAAAACGCTGATTGGTGGAACCTGACGGACGAG  599 
Query  541  CAGCGCCTCAAGGAGATGGAGACTCATACGCTTCCGACGCTGCCCTTTCTGGTCAACGTC  600 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  600  CAGCGCCTCAAGGAGATGGAGACTCATACGCTTCCGACGCTGCCCTTTCTGGTCAACGTC  659 
Query  601  AAGCGCAAGCTCTACCACTCGACGGGGCTCGACGATACCGA-TTTTATTACCTACTTCGA  659 
            ||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||| 
Sbjct  660  AAGCGCAAGCTCTACCACTCGACGGGGCTCGACGATACCGATTTTTATTACCTACTTCGA  719 
Query  660  GACCAACG-ACCTCGGAGCCTTCAACAACCTGATGCTGTCGCTGGCCAAGGTGCCGGAGA  718 
            |||||||| ||||||||||||||||||||||||||||||||||||||||||||||||| | 
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Sbjct  720  GACCAACGAACCTCGGAGCCTTCAACAACCTGATGCTGTCGCTGGCCAAGGTGCCGGAAA  779 
Query  719  ACAAGTATCACGTGCGCTGGGGCAATCCGACCGTGCTGGGTACCATCCAGCCCATCGAGA  778 
            ||||||||| ||||||||||||||||| ||||||||||||||| ||| |||||||||||| 
Sbjct  780  ACAAGTATCNCGTGCGCTGGGGCAATCNGACCGTGCTGGGTACNATCNAGCCCATCGAGA  839 
Query  779  ACCTCGTCAAGACGCTGTCGATGGGCAATTGA  810 
            |||||||||| ||  | || |||||||||||| 
Sbjct  840  ACCTCGTCAAAACCTTTTC-ATGGGCAATTGA  870 
 
 
Cld 1:3-9 with the T7 Terminator Primer 
Query  29   AAAAGGGTGCAGATGACGACGACAAGGTACCGGAT-CCGGCCATGAATACCCCAGTTGAT  87 
            ||||||| ||| ||||||||| ||||||||| ||| |||||||||||||||||||||||| 
Sbjct  856  AAAAGGGNGCA-ATGACGACGNCAAGGTACCNGATTCCGGCCATGAATACCCCAGTTGAT  798 
Query  88   CGGGCGAAGATACTCAGCGCGCCAGGCGTGTTTGTGGCGTTCTCAACTTACAAAATTCGT  147 
            |||| ||||||| |||||||||||||||||||||||||||| || ||||||||||||||| 
Sbjct  797  CGGGNGAAGATANTCAGCGCGCCAGGCGTGTTTGTGGCGTTNTCNACTTACAAAATTCGT  738 
Query  148  CCCGACTACTTCAAAGTTGCATTGGCTGAACGCAAAGGTGCAGCAGATGAAGTGATGGCG  207 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||| ||| 
Sbjct  737  CCCGACTACTTCAAAGTTGCATTGGCTGAACGCAAAGGTGCAGCAGATGAAGTGATNGCG  678 
Query  208  GTCTTGGAAAAGCACAAAGAAAAAGTGATTGTCGACGCCTACCTGACGCGCGGCTATGAA  267 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  677  GTCTTGGAAAAGCACAAAGAAAAAGTGATTGTCGACGCCTACCTGACGCGCGGCTATGAA  618 
Query  268  GCCAAGAGCGACTACTTCCTGCGCGTTCATGCCTACGATGCCGTAGCGGCGCAGGCCTTT  327 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  617  GCCAAGAGCGACTACTTCCTGCGCGTTCATGCCTACGATGCCGTAGCGGCGCAGGCCTTT  558 
Query  328  CTGGTCGATTTCCGCGCCACCCGCTTTGGCATGTACTCGGATGTCACGGAGAGCCTGGTG  387 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  557  CTGGTCGATTTCCGCGCCACCCGCTTTGGCATGTACTCGGATGTCACGGAGAGCCTGGTG  498 
Query  388  GGTATCACCAAGGCGCTAAACTATATCTCCAAGGACAAGTCGCCCGACCTCAACAAGGGG  447 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  497  GGTATCACCAAGGCGCTAAACTATATCTCCAAGGACAAGTCGCCCGACCTCAACAAGGGG  438 
Query  448  CTTTCCGGTGCTACCTACGCCGGTGATGCACCGCGCTTTGCCTTCATGATTCCGGTCAAG  507 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  437  CTTTCCGGTGCTACCTACGCCGGTGATGCACCGCGCTTTGCCTTCATGATTCCGGTCAAG  378 
Query  508  AAAAACGCTGATTGGTGGAACCTGACGGACGAGCAGCGCCTCAAGGAGATGGAGACTCAT  567 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  377  AAAAACGCTGATTGGTGGAACCTGACGGACGAGCAGCGCCTCAAGGAGATGGAGACTCAT  318 
Query  568  ACGCTTCCGACGCTGCCCTTTCTGGTCAACGTCAAGCGCAAGCTCTACCACTCGACGGGG  627 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  317  ACGCTTCCGACGCTGCCCTTTCTGGTCAACGTCAAGCGCAAGCTCTACCACTCGACGGGG  258 
Query  628  CTCGACGATACCGATTTTATTACCTACTTCGAGACCAACGACCTCGGAGCCTTCAACAAC  687 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  257  CTCGACGATACCGATTTTATTACCTACTTCGAGACCAACGACCTCGGAGCCTTCAACAAC  198 
Query  688  CTGATGCTGTCGCTGGCCAAGGTGCCGGAGAACAAGTATCACGTGCGCTGGGGCAATCCG  747 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  197  CTGATGCTGTCGCTGGCCAAGGTGCCGGAGAACAAGTATCACGTGCGCTGGGGCAATCCG  138 
Query  748  ACCGTGCTGGGTACCATCCAGCCCATCGAGAACCTCGTCAAGACGCTGTCGATGGGCAAT  807 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  137  ACCGTGCTGGGTACCATCCAGCCCATCGAGAACCTCGTCAAGACGCTGTCGATGGGCAAT  78 
Query  808  TGA  810 
            ||| 





This appendix focused on creating perchlorate-reducing biocatalysts that facilitated their 
reuse for drinking water treatment. Immobilization strategies were pursued for both biocatalysts. 
Affinity attachment of perchlorate reductase was attempted using a Strep-tag. Chlorite dismutase 
was immobilized by spore display. However, difficulties in the molecular cloning and expression 
of these biocatalysts occurred. One difficulty was persistent throughout all of the constructs, 
while other difficulties were specific to each of the biocatalyst constructs. This discussion section 
focuses on ways to achieve successful expression of the failed constructs.  
One persistent difficulty occurred during the molecular cloning step and manifested itself 
as low efficiency in transformation experiments. Control experiments confirmed that the ligation 
step was the root of the problem. Two possible explanations were explored: 1) carry over of 
restriction enzymes into the ligation step and 2) the poor performance of the ligase. Experiments 
(self-ligation of a single cut plasmid) indicated that restriction enzyme carry over was not the 
problem. Nonetheless, all products from digestion were gel purified to mitigate potential 
restriction enzyme contamination of ligation reactions. To address the possible poor performance 
of the ligase, incubation times were varied. However, the incubation time did not impact the 
transformation efficiency. Next, new ligase was purchased. The ligase buffer was aliquoted to 
prevent degradation of ATP. In light of these actions taken, the number of successful 
transformants improved but remained low, at only 29.6% of the total possible compared to 
positive controls.  
Difficulties for each construct were also experienced. Attempts to heterologously express 
the Strep-tagged perchlorate reductase were not successful. In a previous thesis, work suggested 
228 
 
that rare codons may be responsible for early termination of protein translation preventing the 
expression of perchlorate reductase.265 Another dissertation demonstrated expression of the PcrA 
at approximately the correct size and confirmed this using antibodies.266 However, the origin and 
method of producing the antibody were not described, and no sequence information was 
included. The author noted the formation of inclusion bodies but was still able to purify the 
protein. The heterologously expressed perchlorate reductase had no perchlorate-reducing activity.  
Originally, research suggested that the operon for perchlorate reductase was small, 
comprising of four genes labeled perchlorate reductase subunit α, β, γ, and δ.69 However, the 
genes required for synthesis of perchlorate reductase has greatly expanded.72, 266 In light of the 
greater complexity of synthesis of perchlorate reductase, native expression of a Strep-tagged 
perchlorate reductase subunit α is likely the most successful route to expressing PcrA. Stepwise 
construction of the plasmid is a possible next step to achieving affinity attachment of perchlorate 
reductase (Figure D.12). 
For the spore-displayed chlorite dismutase, future efforts should focus on optimizing 
hemin concentrations to avoid Bacillus toxicity. It is well established that heme is toxic, 
especially to gram-positive bacteria.267 This toxicity is due to heme donating an electron and 
creating reactive oxygen species that cause oxidative stress to cells. However, hemin, the iron 
form used in this study, worked well for Bacillus mojavensis and Bacillus subtilis at 10 mg L-1 
when grown anaerobically.268 Heme auxotrophs of B. subtilis were grown aerobically with up to 
2.5 mg L-1 hemin and 500 mg L-1 bovine serum albumin269 to protect against the toxic effects of 
heme/hemin.270 These reports suggest that optimization of the hemin concentration may prevent 
the Bacillus toxicity observed in this work.  
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If optimization of the hemin concentration prevents Bacillus toxicity but no chlorite 
dismutase activity is observed, constructs, cotG-cld and cotG-linker-cld in pMLK83, could be 
pursued further. For the cotG-cld in pMLK83, sequencing is recommended to confirm its 
identity. This sequencing step should be done prior to transformation in Bacillus. In constructs 
with the linker sequence, stepwise ligation of the construct is recommended.   
D.4.  Conclusions 
This appendix demonstrates the ability to reuse biocatalysts by attaching them to 
surfaces. Molecular modification of perchlorate reductase has yielded insights into the 
complexity of proper expression of the biocatalyst. Perchlorate reductase was potentially toxic to 
the E. coli used to express the protein. However, gene modification facilitating biocatalyst reuse 
can be made directly in the native organism; this is the recommendation for future work. For 
spore-displayed chlorite dismutase, the required hemin supplement was toxic to Bacillus. Future 






This appendix was based on a report for CEE 597 Independent Study with Assistant 
Professor Roland Cusick. All figures, tables, and text are reproduced with permission. I 
performed all work in this appendix.  
E.1. Introduction 
Biocatalytic technologies offer rapid and complete destruction of micropollutants as has 
been demonstrated with perchlorate.64, 150 However, a recent sustainability analysis indicated 
innovation is required to make the technology economically competitive and environmentally 
sustainable. One required advancement is the improvement to the delivery of electrons.179 
Currently, to reduce perchlorate to chlorite, these electrons are provided by inorganic electron 
donors such as dithionite or organic electron donors such as ascorbic acid.150 However, both 
reactions require an electron shuttle, also referred to as a mediator, such as methyl viologen70 or 
phenazine methosulfate.118 The use of an electron shuttle contributes approximately $0.14 m-3 of 
the cost of biocatalytic drinking water treatment. The cost of this single component is 
comparable to the treatment cost of non-selective ion exchange. To minimize costs and 
environmental impacts of biocatalytic technologies, this study uses an electrochemical cell to 
provide electrons for biocatalytic perchlorate reduction.  
Electrochemical reactions source their electrons from electricity. For reduction, the 
reactions occur on the cathode, and three examples of electrochemical perchlorate reduction are 
discussed, bioelectrochemical reduction, electrocatalytic reduction, and electrobiocatalytic 
reduction. Bioelectrochemical reduction relies on bacterial populations to facilitate the reduction 
of perchlorate. One studyfound that cathodic nitrate-reducing bacteria in electrochemical cells 
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could be adapted for perchlorate reduction without the use of external shuttles.105 In addition to 
the nitrate reducing communities, cathodic perchlorate reduction was achieved with enriched, 
chlorate-reducing lake sediment and a pure culture of perchlorate-reducing Dechloromonas sp. 
PC1. Perchlorate reduction occurred even at low perchlorate concentrations and, under certain 
conditions, in the presence of nitrate. The cells could achieve perchlorate removal efficiencies as 
high as 97%. However, reaction rates limited treatment to approximately 1.5 bed volumes per 
day. Electrocatalytic reduction of perchlorate relies on the cathode material reducing perchlorate 
directly. Examples include the use of a nickel,271 rhodium,272 and ceramic.273 While these 
electrodes could reduce perchlorate, the nickel electrode also generated hydrogen. Rhodium 
electrodes required elevated temperatures and acidic media,272 and the ceramic electrodes are at 
the early stages of development.  
Electrobiocatalytic reduction (using biocatalysts in an electrochemical cell) of perchlorate 
has been demonstrated in sensor technologies. In these sensors, perchlorate reductase was 
incorporated in glassy carbon electrodes fixed to the electrode surface. The sensor showed 
linearity with respect to perchlorate concentration and minimal interference from high nitrate 
concentrations. However, the sensors required methyl viologen but provided a mechanism to 
sorb the methyl viologen to the surface of the electrode.115 While perchlorate sensors have 
demonstrated electrobiocatalytic perchlorate reduction, the focus of this work was to determine 
the necessity of the electron shuttle, methyl viologen using a cheaper cathode made from 
graphite. The requirement of the electron shuttle, methyl viologen, was evaluated using a 
combination of cyclic voltammetry and ion chromatography.  
E.2. Materials and Methods 
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E.2.1. Chemicals, Strains, Media, and Biocatalyst Preparation 
Chemicals were purchased from Thermo Fisher Scientific (Waltham, MA) unless noted 
otherwise. Ultrapure water (18 MΩ cm) was used in preparing all solutions and was obtained 
from an EMD Millipore Milli-Q System (Billerica, MA). The growth of the perchlorate-reducing 
bacteria was as previously described64 using the anaerobic media detailed in Appendix A. 
Preparation of the biocatalysts as a soluble protein fraction (SPF) was as previously described.64  
E.2.2. Activity Assays 
For a comparison to the activity of the biocatalysts in the electrochemical cells, the 
activity was also tested using a traditional biochemical assay. This assay uses the colorimetric 
methyl viologen (MV) electron donor as previously described.70 Twenty µL of SPF was added, 
and the absorbance at 578 nm was monitored for stability. Sodium perchlorate monohydrate was 
added to the reaction with a final concentration of 1 mM. This linear slope and an extinction 
coefficient of 13.1 mM-1 cm-1,124 were used to calculate the SPF activity. To normalize activity 
values, the molybdenum content of the biocatalysts was used as a surrogate for the biocatalyst 
concentration. The molybdenum content was measured using inductively coupled plasma-optical 
emission spectrometry (ICP-OES) (Perkin Elmer Optima 2000 DV, Waltham, MA). The activity 
is given in units (U), defined in this report as one µmole of MV oxidized per minute per µg of 
molybdenum based on the stoichiometry that 8 moles of MV are required to reduce 1 mole of 
perchlorate. Two controls were included. The first measured biocatalytic activity without 
perchlorate. The second measured the interaction between perchlorate with methyl viologen.  
The reduction of perchlorate was quantified in end-point assays using ion 
chromatography (IC) with an Ion Pac AG-16 and AS-16 Hydroxide-Selective Anion-Exchange 
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Column on a Thermo Scientific ICS-2100 system with an ASRS 300 Self-Regenerating 
Suppressor (Waltham, MA).125 The system setup included 50 mM potassium hydroxide eluent, 
1.0 mL min-1 eluent flow rate, 1,000 µL injection loop, suppression at 193 mA, and 250 µL 
sample volume. The detection limit for perchlorate was 10 µg L-1.  
E.2.3. Electrochemical Experiments 
To test electrobiocatalytic reduction, perchlorate reduction was observed in an 
electrochemical cell with and without the electron shuttle. The reactions were performed in a 
glass microbial fuel cell comprised of 2-100 mL media bottles each with two side arm ports 
(Adams & Chittenden Scientific Glass, Berkeley, CA, Figure E.1). In addition to the side arm 
ports, the bottles had a side flange. The flanges of the bottles were connected sandwiching a 
cation exchange membrane (Fujifilm Manufacturing, Tilburg, The Netherlands). An Ag/AgCl 
Reference Electrode (RE-5B, BASi, West Lafayette, IN) was used and, unless otherwise noted, 
all voltage values are reported against the Ag/AgCl electrode. The cathode was a 1 cm long, 3.05 
mm diameter cylindrical graphite electrode (99.9995% purity, Alfa Aesar, Ward Hill, MA) with a 
titanium lead. The cathode was polished using a 0.05 µm alumina MasterPrep Suspension on a 
MicroCloth (Buehler, Lake Bluff, IL). The anode was a mixed metal oxide electrode with a 
titanium lead. The reactions were buffered in 50 mM Tris Chloride buffer (pH 7.5) or 10 mM 
phosphate buffer (pH 7.0) and sparged using an 80:20 mixture of nitrogen and carbon dioxide. 
The concentration of the shuttle, methyl viologen, ranged from 0 to 200 µM. Mixing in the cell 




Figure E.1: Schematic of the electrobiocatalytic cell using electricity to supply electrons for 
perchlorate reduction. 
Using a VMP3 (Bio-Logic Science Instruments, France), potential was applied and 
current measured. Cyclic voltammetry was performed under four conditions: with and without 
electron shuttle in the presence and absence of perchlorate-reducing SPF. Once optimal 
conditions were determined using cyclic voltammetry, the system was operated as a potentiostat, 
and current was monitored to observe perchlorate reduction. After completion of runs up to 8 
hours, the final perchlorate concentration from the solution in the cathode was measured using 
IC.  
E.3. Results and Discussion 
E.3.1. Free Perchlorate-Reducing Biocatalysts 
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Before beginning the electrochemical experiments, the activity of the SPF was 
determined using methyl viologen as an electron donor. The value, 146.7 ± 21.8 U (µg Mo)-1, 
was consistent with previously reported values64 and closely aligns with the maximum 
biocatalytic rate of 162.5 ± 8.4 U (µg Mo)-1.150 The SPF had a molybdenum content of 383 ± 47 
µg Mo L-1.  
E.3.2. Methyl Viologen Reduction 
The graphite electrode had high resistance (17.9 Ω) across the lead. This high resistance 
suggested that the ability of the cathode to supply electrons might be limited. The resistance’s 
impact was therefore first tested using a compound readily reduced: the electron shuttle, methyl 
viologen. To briefly introduce the cyclic voltammetry approach, the system current is monitored 
through a sweep of the potential. As the experiment progresses through the forward sweep, the 
potential decreases, and the decreasing current (Figure E.2, black arrow) is used to monitor 
reduction reactions. At a set value, the sweep reverses (reverse sweep) and the potential 





Figure E.2: Cyclic voltammetry of 200 µM methyl viologen in phosphate buffer (green), 100 
µM methyl viologen in phosphate buffer (red) versus phosphate buffer control (blue). Final 
profiles are presented after 5 cycles to minimize drift and oxygen contamination. Current is 
measured in milliamps and voltage is reported in volts. The black arrow indicates the forward 
sweep and its direction. 
The reduction of methyl viologen in phosphate buffer began at a potential of -0.2 V 
compared to the phosphate buffer control (Figure E.2). This value corresponded well with 
previously published values of the first methyl viologen reduction step from an oxidation state of 
+2 to +1  occurring at -0.446 versus the normal hydrogen electrode (NHE).274 A second reduction 
step could be occurring at a -0.6 V which corresponds to the final reduction step of methyl 
viologen reported at -0.88V versus NHE.274 However, this step is not desirable as it leads to the 
formation of insoluble methyl viologen. The shape of the peak was broader than expected; 
however, this was not explored further. 
A common buffer for biocatalytic applications (Tris-Cl) was also tested. No change in the 
cyclic voltammetry profiles was observed between the two buffers (Figure E.3). The first and 
second reducting steps of methyl viologen occurred at similar potential values. While the general 
shape of the curve did not change, the peaks corresponding to the reduction and oxidation were 
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more resolved. The implications of the difference in the peak shape were not explored further. 
For both types of buffer, the electrode was able to reduce methyl viologen.  
 
Figure E.3: Cyclic voltammetry of 100 µM methyl viologen (red) versus control (blue) in Tris-
Cl buffer. Final profiles are presented after 5 cycles to minimize drift and oxygen contamination. 
Current is measured in milliamps and voltage is reported in volts. 
E.3.3. Cyclic Voltammetry Profile of the Biocatalysts 
After confirming that the electrode could interact with methyl viologen, the ability of the 
biocatalysts to directly accept electrons from the cathode was studied. In a Tris-Cl buffered 
setup, 20 µL of the biocatalysts was added to the cathode. The cyclic voltammetry in Figure E.4 
showed a slight downward shift. The peak associated with a reduction step was again very broad. 
The reduction step could come from the perchlorate reducing biocatalysts. However, as the 
biocatalysts were added as soluble protein fractions, the observed reduction could be from other 
biocatalysts. Using purified biocatalysts could confirm that perchlorate reductase is being 
reduced. However, at the time of these experiments, purified perchlorate reductase was not 
available.  

























Figure E.4: Cyclic voltammetry of the perchlorate-reducing SPF (red) versus the control (blue) 
in Tris-Cl buffer. Final profiles are presented after 5 cycles to minimize drift and oxygen 
contamination. Current is measured in milliamps and voltage is reported in volts. No additional 
shuttle was added to the system. 
E.3.4. Perchlorate Reduction  
The final experiment attempted to measure perchlorate reduction directly. To begin, 100 
µM of the electron shuttle was included with the SPF, to maximize the possibility of reduction 
(Figure E.5). Without perchlorate, this profile was similar to a cyclic voltammetry profile without 
SPF (e.g., an experiment with only methyl viologen (Figure E.3)). The similarity of the profiles 
indicated that the reduction of methyl viologen was the predominant reaction in the system. 
Upon addition of perchlorate to a final concentration of 1mM, the current profile shifted slightly 
positive. The shift in current could be consistent with methyl viologen donating electrons to 
perchlorate reductase.  























Figure E.5: Cyclic voltammetry of the SPF with 100 µM of methyl viologen with (blue) and 
without (red) 1 mM perchlorate. Final profiles are presented after 5 cycles to minimize drift and 
oxygen contamination. Current is measured in milliamps and voltage is reported in volts. No 
additional shuttle was added to the system. 
To confirm the reduction of perchlorate in the electrobiocatalytic cell, the system was 
operated as a potentiostat at -0.4 V for 8 hours. The first reduction step of methyl viologen was 
confirmed at -0.2 V, so this system should readily reduce the shuttle. With reduced methyl 
viologen available, the perchlorate biocatalysts should be able to accept electrons from the 
shuttle and reduce perchlorate. After the experiment, this was confirmed using ion 
chromatography.  Unfortunately, no difference in perchlorate concentration was detected. The 
detection limit of the ion chromatography protocol was 10 µg L-1 meaning that a small change in 
perchlorate concentration was possible. However, this concentration difference only corresponds 
to less than 1% of the perchlorate. Due to these low perchlorate-reducing rates, a perchlorate-
reducing system without the shuttle was not tested. 
To determine if the biocatalytic activity was limiting the system, the theoretical amount 
of perchlorate removed using free biocatalytic activity was calculated. The biocatalyst dose in 
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the electrochemical system corresponded to 0.0077µg molybdenum equivalents of perchlorate-
reducing biocatalysts. The activity of the free biocatalysts could reduce 67.8 µmoles of 
perchlorate or 67.8% of the perchlorate in the cell. The system was not kinetically but physically 
limited. This could include a limitation in the rate of electron transfer from the electrode to the 
shuttle.  
E.4. Conclusions 
While the cyclic voltammograms suggested perchlorate reduction occurred in the 
electrobiocatalytic system, the activity was slow. Improvements to the system are required to 
achieve practical applications in drinking water treatment. In addition, the system still used an 
electron shuttle; however, this particular system could facilitate the reuse of methyl viologen115 
mitigating its costs and environmental impacts.  
Concerning the electrochemical system, the small surface area of the graphite electrode 
could be limiting the electron transfer and the subsequent perchlorate-reducing rate. One 
potential mechanism limiting the rate of transfer is the diffusion of the shuttle to the surface of 
the electrode. This is supported by the observation that increasing the shuttle concentration 
resulted in a downward shift in the cyclic voltammetry profile. Improving the available electrode 
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